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ABSTRACT
Parkinson’s disease (PD) is an incurable, neurodegenerative movement
disorder, impacting nearly one million Americans. By 2030 the number of
people with PD (PwPD) is expected to double and with this growing
population, informal caregiver responsibility will also increase. Nutritional
status worsens as PD progresses, which impacts cognition, body composition,
ability to perform activities of daily living (ADL) and quality of life (QOL), and
increases caregiver burden. Nutritional screening and intervention for PwPD
can improve health outcomes, but are often excluded from PD treatment
plans.
Given the negative impact of PD on mobility and increased caregiver
burden, digital technology could improve access to health care services for
PwPD and their caregivers, making them excellent candidates for digital
health. Digital health services (i.e. wearable devices, videoconferencing,
phone apps) are used in PD management across many health disciplines, but
have not been implemented for nutritional management of PD. Understanding
how nutritional status changes overtime for PwPD, and including PwPD and
their caregivers in the formative stage is critical to developing effective digital
health services. The aim of this body of research is to: 1) describe how the
nutrition status of PwPD changes overtime, 2) describe the diet quality and
self-reported nutrition concerns of PwPD and their informal caregivers, 3)

collect formative data around digital health to manage nutrition for PwPD and
their caregivers through dyadic interviewing.
The first chapter focuses on tracking the nutritional status of eight
PwPD over four years and examines how disease sequelae, conditions that
result from PD, may influence nutritional status. Findings reveal that the
majority of PwPD were either at “possible-” or “at nutrition-” risk throughout the
four years. There was a modest decrease in weight and body mass index.
Findings suggest that PwPD can benefit from ongoing nutrition screening
throughout the course of PD.
Chapter two evaluates the diet quality via Healthy Eating Index (HEI)2015 scores and self-reported nutrition concerns identified from qualitative
interviews of twenty PwPD and their informal caregivers. This chapter also
explores if a consistent pattern existed between nutrition concerns coded and
diet quality scores of PwPD and caregivers. Mean HEI-2015 scores of PwPD
and caregivers translate to an F letter grade and both PwPD and caregivers
have intake inconsistent with the Dietary Guidelines for Americans.
Participants also have low HEI-2015 component scores for whole grains, fatty
acid ratios, and greens & beans. Qualitative themes specifically around dietary
concerns related to PD sequelae include: change in appetite, amount eaten
and/or weight, gastrointestinal issues, food-medication management,
chewing/swallowing issues, change in taste/smell. No consistent pattern
between HEI-2015 scores and self-reported nutrition concerns were detected.

Findings suggest this population could benefit from nutrition services to better
health outcomes.
Chapter 3 examines twenty PwPD’s and their caregivers’ perception
and acceptance of digital health for managing nutrition and health through
semi-structured dyadic interviews and questionnaires. This study also
evaluates the participants’ level of digital competence. Phrases from
interviews related to perceptions of digital health were sub-coded into three
categories: Perceived Usefulness, Perceived Ease of Use and Awareness of
Digital Health. Phrases related to Acceptance of digital were sub-coded into
Accept, Neutral or Reject. An Average Dyadic Acceptance Rate for digital
health was obtained through averaging the percent of phrases coded as
Accept from each interview transcript. To integrate the two data sets,
qualitative codes were transformed into variables and compared to digital
competence scores. Twenty-five (62.5%) participants used the internet for at
least 5 health-related purposes. The Average Dyadic Acceptance Rate was
54.4%. Dyads rejected digital health devices if they did not see the added
benefit. The majority of phrases coded revealed participants found digital
health useful, but hard to use, and about half of the phrases coded indicate
dyads needed education about existing digital health mediums. Findings
suggest dyads are accepting of technology but are not utilizing technology to
its full potential. Perceiving technology as hard to use and digital competence
scores, implies education is warranted prior to providing a digital nutrition
service.

This body of research supports the need for nutrition screening and
services among both PwPD and caregivers, who present with poor diet quality.
Findings from this study also suggest more research is needed to figure out
how to increase acceptability of digital health among this population. However,
low diet quality scores, current technology usage, and perceived usefulness of
digital health suggests technology may be a way to increase access to
nutrition professionals among the PD community to promote better health
outcomes.
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PREFACE
This dissertation is presented in manuscript format and contains three
chapters that are from two different studies through the University of Rhode
Island. Upon completion of the final dissertation submission, three manuscripts
will be submitted for publication to the specified journal highlighted on each
manuscript title page. Chapter one will be submitted to Movement Disorders,
chapter two will be submitted to the Journal of the Academy of Nutrition and
Dietetics, and chapter three will be submitted to Health and Social Care in the
Community.
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Abstract
Background: Parkinson’s disease (PD), a neurodegenerative disease, results
in motor and non-motor changes that can impact nutritional status. How
nutrition assessment markers change longitudinally has not been examined.
The purpose of this study was to track the nutritional status of people with
Parkinson’s disease (PwPD) over time.
Methods: This study was an observational, longitudinal study examining
people with PwPD with assessments analyzed at baseline, year 2 and year 4.
The assessments included: the dietary screening tool (DST), height and
weight to calculate body mass index (BMI), fasting glucose and lipid profiles,
and blood pressure. A one-way repeated measures ANCOVA compared
outcomes variables over time.
Results: Eight PwPD were assessed. The baseline age was 67.1±4.0 years
and time since diagnosis was 8.1±7.5 years. There was no change in mean
DST scores overtime (64.0±13.8 vs. 66.4±8.8 vs. 64.3±13.2) and majority of
participants were at possible or at nutrition risk at each assessment.
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Participants experienced weight declines (176.3±29.7lbs vs. 169.0±25.5lbs,
hp2=0.01) and BMI (27.6 kg/m2 vs. 26.6±2.2, hp2=0.02) from baseline to year
4. The number of PwPD with elevated glucose (>100mg/dL) increased from
one to four, but the number of PwPD with suboptimal HDL-C decreased from
four to two.
Conclusion: The presence of nutrition risk, experienced weight loss, and
changes in biochemical and clinical values, suggest that interdisciplinary
intervention strategies may need to be designed and tested in this population.
Key words: Parkinson’s disease, nutritional status, diet quality, longitudinal
study, cardiometabolic risk
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Introduction
Parkinson’s disease (PD) is an incurable, progressive
neurodegenerative disease that traditionally occurs in the second half of life.1
Over 900,000 Americans are diagnosed with PD2,3, and that number is
expected to double by 2030.3 People with PD (PwPD) typically live about 15
after diagnosis and just recently researchers are investigating what post one
year from diagnosis.4 Parkinson’s disease-specific sequelae, conditions that
result from PD, impact motor and non-motor function5 and worsen as the
disease progresses.5 Common motor sequelae (slowness of movement,
tremors, and balance issues), and common non-motor sequelae (changes in
smell and taste, gastrointestinal issues and difficulty swallowing), are all
associated with compromised nutritional status.6-8 Monitoring these changes
overtime provides how nutrition health outcomes among PwPD change
overtime in light motor and non-motor sequelae.
While PD sequelae tracking is a part of normal care, comprehensive
nutrition assessment have not been incorporated, and this impairs the ability to
provide effective, critical nutrition intervention.9 To our knowledge, this is the
first study to track sequelae while concurrently completing a nutrition
assessment. Nutritional and weight status in PwPD varies over the course of
the disease.8 These fluctuations can occur due to decline in cognitive and
physical functioning.8 Fluctuations in weight and nutrition status can further
compromise body composition, biochemical and clinical levels, cognitive and
physical functioning,7,10,11 quality of life (QOL), and are associated with longer
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hospital stays.12,13 The purpose of this longitudinal, observational study was to
track the nutritional status of PwPD over four years. A secondary aim of this
study was to describe changes in PD sequelae, as these sequelae may help
explain the possible changes in nutritional status that occur. It was
hypothesized that change in motor and non-motor sequelae overtime can
influence nutrition status and dietary intake, which in turn can impact health
outcomes measured by biochemical, anthropometric and clinical data (Figure
1).
Methods
This was an ancillary study of a five-year observational, longitudinal study
assessing the nutritional, cardio-metabolic, cognitive and physical function
status of PwPD and acquired brain injury (ABI) (Longitudinal Study of
Communication, Nutrition and Physical Activity). To be eligible for the original
study, persons recruited via flyers, word-of-mouth, and announcements in
support groups, had to be between 18-85 years of age and one-year post-PD
or -ABI diagnosis; for this study, we only used data from PwPD. Participants
completed assessment visits (~3 hours each) at the University of Rhode
Island’s Speech and Hearing Clinic every six months for five years.
Specifically, for this study, PwPD’s were assessed at baseline, years two and
four. The University’s Institutional Review Board approved this study (IRB
HU1314-006) and subjects provided written consent in accordance to the
Declaration of Helsinki before enrolling.
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Assessments.
Nutrition assessment includes the examination of anthropometric
measures, biochemical markers, clinical data, and dietary intake.14,15
Comprehensive nutrition assessments examined change in nutrition status
overtime. This included assessments of diet quality, biochemical,
anthropometric, and clinical data. To assess diet quality, participants
completed the dietary screening tool (DST), a 25-item questionnaire validated
and used to identify dietary patterns and nutritional risk in older adults.16 A
total of 105 points can be achieved and scores can be categorized as: at risk
(<60), possible risk (60-75), and not at nutrition risk (>75). Serum total
cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density
lipoprotein cholesterol (HDL-C), triacylglycerol, and glucose were obtained
using a finger stick (Cholestech® LDX system, Hayward, CA) after a 12-hour
fast. Blood pressure was measured using an automatic blood pressure
machine. Height and weight were measured in duplicate and used to calculate
body mass index (BMI, kg of body weight/height in meters2). The following
criteria were used to characterize suboptimal assessment markers: 1) BMI >28
kg/m2;17 2) systolic >130 mmHg and diastolic blood pressure >80 mmHg; 3)
total cholesterol (TC) >200mg/dL; 4) high-density lipoprotein cholesterol (HDLC) <40mg/dL; 5) low-density lipoprotein cholesterol (LDL-C) >100mg/dL; 6)
triacylglycerol (TAG) >150mg/dL; 7) fasting glucose >100mg/dL.
The following assessments were used to describe change in disease
sequelae. The short physical performance battery (SPPB)18 assessed
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physical functioning. The Repeatable Battery for the Assessment of
Neuropsychological Status (RBANS) 19 assessed cognitive function; scores
<80 were indicative of cognitive impairment. Both the Swallowing Quality of
Life (SWAL-QOL) Survey20 and a timed swallow test (ml/s) 21 assessed
swallow function. A SWAL-QOL score of <75% and a time swallow speed of
<10ml/s was considered suboptimal. Finally, a medical history questionnaire is
used to identify health-related conditions and changes in health conditions at
each assessment visit.
Statistical Analysis. Data were analyzed in SPSSv26. Categorical
variables are represented as numbers and percentages and continuous
variables are reported as mean±standard deviations. Data were assessed for
normality and non-normally distributed data were transformed (square root or
reflect and square root) for analyses, mean±standard deviations of variation
before transformation are reported. A repeated measures analysis of
covariances was used to examine change overtime among outcome variables.
Time since diagnosis was used as a covariate. A Bonferroni adjustment was
made for multiple comparisons. Analyses were 2-tailed and a p<0.05 indicates
statistical significance. Participants were then individually analyzed for
suboptimal scores across each outcome variable and the frequency of suboptimal scores were reported.
Results
Eight PwPD were analyzed over four years. At baseline, the mean age
was 67.1±4.0 years and ranged from 62-72 years. The average time since

7

diagnosis was 8.1±7.5 years, ranging from 1-23 years. Six out of eight
participants were male (75%). All participants identified as Caucasian. One
participant reported attending some college, another had a college degree,
and six achieved a post-baccalaureate degree. At baseline, two participants
identified as smokers but quit during the first two years of the study. Three
participants had deep brain stimulation, and one participant had the diagnosis
of PD with Lewy Body Dementia. Two PwPD had thyroid conditions, and one
PwPD had a history of a myocardial infarction.
Nutrition Assessment Markers. There was no significant change in
nutrition assessment markers overtime (Table 1). At baseline and year 2,
seven participants were at possible- or at nutrition- risk, while six participants
were at possible- or at- nutrition risk at year 4. Three PwPD had BMI scores
>28kg/m2 at baseline, which decreased to two PwPD at years 2 and 4. For
one PwPD height and weight could not be measured at year 4 due to
functional decline. Over the four years, four participants experienced a ten
pound or greater weight loss. One PwPD remained within one pound of their
baseline body weight, and one PwPD experienced a six-pound weight gain.
The number of PwPD with elevated systolic blood pressure (SBP)
increased from four to seven overtime, but the number of PwPD with elevated
diastolic blood pressure (DBP) decreased from five to two overtime. Only one
participant had elevated total cholesterol at baseline, two participants had
elevated total cholesterol at year 2 and one participant had elevated total
cholesterol at year 4. At baseline three participants had elevated LDL-C, while
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four PwPD had elevated LDL-C at year 2 and three at year 4. Four participants
presented with low HDL-C at year 1, which decreased to two participants at
years 2 and 4. At baseline, three PwPD had abnormal fasting TAG levels,
while one PwPD at year 2 and two PwPD at year 4 had elevated fasting TAG
levels. One PwPD had elevated fasting glucose levels at baseline and year 2,
however four participants had elevated levels at year 4. All participants had at
least one suboptimal lab value or blood pressure reading at each visit.
Disease Sequelae. Outcome variables used to describe disease
sequelae at each time point are summarized in Table 2. At baseline all
participants had RBANS scores indicative of normal cognitive functioning. At
year 2 (37.5%, n=3) had RBANS scores <80 and 50% (n=4) had RBANS
scores <80 at year 4. Three PwPD (37.5%) had SPPB scores <10 at baseline,
while four (50%) had SPPB scores <10 at years 2 and 4. At baseline two
PwPD had SWALQOL scores <75%, while four participants had suboptimal
scores at year 2, and two PwPD at year 4. Two participants had suboptimal
timed swallow speeds (<10 seconds) at baseline, and four participants had
suboptimal timed swallow speeds at years 2 and 4.
Discussion
Findings indicate most PwPD were at nutrition risk overtime,
experienced weight loss and presented with multiple cardiovascular risk
factors. While there was no significant mean change in outcome variables
related to cognition, physical functioning or swallowing, many participants
exhibited decline in these areas over time.
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Nutrition Related Outcome Variables. Throughout this study most
PwPD were at possible or at nutrition risk. Previous research has found up to
63% of PwPD to be categorized as with malnutrition or at risk for malnutrition
22

, however there is limited research regarding the overall diet quality of

PwPD. The current study adds to previous research regarding weight status
among PwPD. Previous research has found over 50% of PwPD to experience
weight loss but present with elevated waist circumference.8,22
This study also adds to the body of research on biochemical and clinical
assessment markers that may help not only assess nutritional status, but also
cardiometabolic status. Our sample presented with multiple cardiometabolic
risk factors throughout the course of the study despite the modest decline in
weight. Overtime there was an increase in HDL-C levels among PwPD, while
not significant, there was large effect size. Additionally, the number of PwPD
with low HDL-C levels decreased by year 4. Previous research suggests a
cardiometabolic protective effect of PD and theorizes that optimal HDL-C
levels among PwPD may explain this theory.23 While improvements in HDL-C
levels were observed, the number of participants with elevated fasting glucose
and triglycerides increased. This may be attributed to the change in taste
PwPD experience, as an affinity for sugar and sweets is common8, which can
impact glucose and triglyceride levels.
Disease Sequelae Outcome Variables. The increase in the number of
PwPD with suboptimal cognition, physical functioning, and swallowing is
consistent with the literature.24 At year 4, 50% of PwPD in this study had
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suboptimal assessment markers related to cognitive, physical, and swallow
function. Past research has found a relationship between physical activity
level and/or physical functioning with cognition and well-being measures
among PwPD.25,26 The decline in swallow function among participants may
help explain the presence of weight loss and consistently poor diet quality
among PwPD. Previous research has found PwPD with dysphagia are more
likely to experience unintentional weight loss and to avoid foods that can be
part of a nutritious diet, such as fruits and vegetables.10 Current findings,
along with this previous research, support the need for an interdisciplinary
treatment approach for managing PD to promote health-related QOL.
Study Strengths and Limitations. This is the first study to evaluate
the change in nutritional status among a cohort of PwPD over four years in
conjunction with change in motor and non-motor sequelae. This study
provides subjective and objective data that provides a holistic picture of how
the nutrition and health status of PwPD can change overtime. Finally, the
interdisciplinary nature of this study can help inform future screenings and the
care management of PwPD. Study results can be incorporated into the World
Health Organization International Classification of Functioning, Disability, and
Health (ICF) model has been used a framework to assess PwPD’s health,
health related function and QOL.25 The ICF model consists of five domains
that cover all aspects related to a person’s health status and human function
and include: 1) body functions and structures, 2) activities, 3) mental health
factors, 4) environmental factors, and 5) personal factors.25 Future should can
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expand upon this interdisciplinary assessment of PwPD to also screen for
mental health factors.
While this study is novel, it is not without limitations. Our small sample
size warrants tracking of a larger cohort of PwPD overtime. To see
significance differences in DST scores, a total of 28 participants would have
been needed to achieve a power of 0.80 and a large effect size (hp2=0.25).
Based on our sample size of eight participants a power of 0.05 was achieved.
The generalizability of study findings is limited by the fact that the majority of
our participants were highly educated, white, male, and recruited from the
University’s Speech and Hearing Clinic. However, epidemiological studies
have reported the majority of American PwPD are white, and this could be due
racial and socioeconomic disparities in receiving treatment for PD.27
Additionally, one participant’s physical functioning had declined so much from
baseline that a height and weight was not obtained at year 4. However,
inability to complete certain assessments sheds light onto the progression and
realities of PD. Future research should track a larger, more diverse sample of
PwPD to better understand how nutritional status changes throughout the
course of PD and explore if a synergetic relationship exists between nutrition,
cognition, physical functioning, and disease progression.
Conclusion
This study adds to the body of literature finding PwPD to have poor
nutritional status and diet quality.9,28 Participants in this study experienced
weight loss and changes in biochemical and clinical values, which supports
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the need for routine, interdisciplinary assessment for PwPD to identify and
treat disease sequelae and promote health-related QOL. Future research
should explore the efficacy of interdisciplinary interventions. This
interdisciplinary team should include nutrition professionals, such as registered
dietitians. Additionally, due to the observed decline in cognitive and physical
functioning among PwPD research should also consider including informal
caregivers whose role around buying, preparing, and serving nutritious foods
may increase as PD advances.

Chapter 1 Table and Figures
Figure 1: Propose Mechanism of How Disease Sequalae Impact Nutrition
Status Which May Further Impact Health Outcome

Motor and NonMotor Sequelae

Nutritional
Status and Diet
Intake
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Biochemical,
Anthrpometric,
Clinical Values

Table 1: Nutrition Assessment Markers Among PwPD Over 4 Years
DST
Weight (lbs.) a
BMI (kg/m2) a
SBP (>130 mmHg)
DBP (>80 mmHg)
TC (>200mg/dL)
LDL-C (100mg/dL)
HDL-C (<40mg/dL)
TAG (>150 mg/dL)
GLU (>100mg/dL)a
Statin Medication (n(%))
BP Medication (n(%))

Baseline
64.0±13.8
176.3±29.7
27.6±3.4
141.4±22.4
81.1±10.4
175.1±25.2
104.0±22.6
44.1±17.4
134.9±68.3
89.0±9.4
6(75)
4(50)

Year 2
66.4±8.8
169.0±29.2
26.6±3.1
140.3±17.2
78.8±14.2
165.1±33.2
93.75±30.9
49.0±17.7
112.9 ±45.7
89.2±7.2
6(75)
4(50)

Year 4
64.3±13.2
169.0±25.5
26.6±2.2
144.1±14.5
80.1±12.4
163.9±22.0
87.4 ±36.2
48.1±12.4
143.0±80.4
95.0±12.2
6(75)
3(37.5)

p
0.8
0.9
0.9
0.06
0.9
0.6
0.99
0.53
0.88
0.66
NA
NA

hp2
0.04
0.01
0.02
0.38
0.46
0.07
0.0
0.1
0.02
0.07
NA
NA

a

n=7; effect size 0.01=small, 0.06=moderate; 0.14=large. Abbreviations: DST=dietary
screening tool, BMI=body mass index, SBP=systolic blood pressure, DBP=diastolic blood
pressure, TC=total cholesterol, LDL-C=low-density lipoprotein cholesterol, HDL-C=high
density lipoprotein cholesterol, TAG=triacylglycerol, GLU=glucose, BP=blood pressure

Table 2: Change in Disease Sequelae (Cognition, Physical Function,
Swallowing) Among PwPD Over Four Years
RBANS
SPPB
SWALQOL
Swallow Speed (ml/secs)

Baseline
Year 2
93.0±13.3 88.6±22.4
8.8±2.1
9.9±1.8
77.3±12.4 72.5±12.2
15.7±9.8 15.01±11.1

Year 4
81.6±24.2
8.4±3.3
75.6±16.1
13.5±10.6

p
h p2
0.4 0.1
0.8 0.03
0.3 0.2
0.8 0.03

n=7; hp2 values can be interpreted as: 0.01=small effect, 0.06=moderate effect, 0.14=large
effect. Abbreviations: RBANS=Repeatable Battery for the Assessment of Neuropsychological
Status; SPPB=short physical performance battery; SWALQOL=swallowing quality of life
a
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Abstract
Background: People with Parkinson’s disease (PwPD) are often at nutritional
risk. Limited research exists regarding the diet quality or nutritional concerns of
PwPD and informal caregivers. Using patient-caregiver dyads is an innovative
model to assess nutrition and understand dietary needs.
Objective: Data collected from dyads were used to evaluate the diet quality
and describe self-reported nutrition concerns of PwPD and their caregivers.
Whether or not there was a consistent pattern between nutrition concerns and
diet quality among PwPD and caregivers was also explored.
Methodology: A mixed-methods study design assessed 20 PwPD-caregiver
dyads. During home visits, semi-structured, dyadic interviews were audiorecorded for qualitative data and anthropometrics and questionnaires were
collected. Two phone 24-hour recalls were completed to collect dietary intake.
Dietary data was assessed for diet quality using the Healthy Eating Index
(HEI)-2015 scoring metric.
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Statistical Analyses Performed: Diet quality descriptives for PwPD and
caregivers were reported as mean±standard deviation. Qualitative data was
analyzed in NVivo and inter-coder reliability was >90%. Qualitative data was
charted into framework matrices and reported as frequencies to quantify
codes. A side-by-side comparison of themes and HEI-2015 scores for each
participant was conducted.
Results: Mean participant age was 68.1±11.2 years. Mean HEI-2015 scores
for PwPD was 58.3±12.4 and 58.1±10.6 for caregivers, translating to an F
letter grade. Dietary concerns related to PD sequelae included: change in
appetite or amount eaten, gastrointestinal issues, food-medication
management, chewing/swallowing issues, and change in taste/smell. A large
amount of variation between HEI-2015 scores and self-reported nutrition
concerns were detected.
Conclusions: Poor diet quality may be attributed to self-reported nutrition
concerns. Presence of poor diet quality and nutrition concerns among dyads
suggests including both nutrition professionals and caregivers to promote
nutritional health among PwPD. Future research should examine the number
of nutrition concerns to help identify readiness to make dietary changes
among dyads.
Keywords (5 key words minimum): Parkinson’s disease, caregivers,
nutrition, dietary intake, mixed methods, diet, food and nutrition
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Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative movement
disorder that impacts nearly one million Americans.1,2 Disease stage and
sequalae (conditions that result specifically from PD), physiological factors and
treatments and associated side effects of PD can compromise dietary intake
and quality.3,4 Disease sequelae impact motor (slowness of movement,
shuffling/freezing gait, muscle rigidity5,6) and non-motor (fatigue, cognitive
changes, difficulty swallowing, change in taste and smell, gastrointestinal
issues3,7-9) function, which can worsen overtime and impact dietary intake,
nutritional status, and body composition3 Suboptimal weight status and body
composition can further impact physical function and cognition10-12, quality of
life (QOL), and health outcomes.13 Consequently, informal caregiver
responsibilities increase as PD progresses,14 and caregivers are typically
responsible for performing the majority of activities of daily living (ADL) for
people with PD (PwPD),15 including assisting with or doing the buying,
preparing, and consuming meals and snacks.16,17
Nutrition is integral in managing PD.3 However, there is limited research
related to diet quality among PwPD and caregivers, populations who are at
risk for poor dietary quality. To help improve dietary patterns in at-risk
populations, understanding food choices and exploring acceptable sources of
nutrition advice and support is essential.18 The Healthy Eating Index (HEI)2015 is a diet quality index that assesses the compliance with the Dietary
Guidelines for Americans (DGAs).19 The DGAs are evidenced-based
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recommendations informed by diet quality’s impact on health outcomes, such
as weight status, diabetes, cancer and cardiovascular disease.19,20
Adhering to the DGAs could help PwPD meet the requirements for what
are several nutrients of concern, such as fiber21, fluid21, vitamin D22, vitamin
E23, omega-3 fatty acids23, and protein22. These nutrients can be obtained
through an adequate diet that aligns with the dietary guidelines. However,
research has found that PwPD have poor diet quality inconsistent with dietary
patterns that promote health, such as the DGA or the Mediterranean Diet
Pattern.24,25 Findings warrants the exploration of differences in overall dietary
patterns between PwPD and their informal caregivers.26
It is particularly important to assess the diet quality of caregivers, as
caregiver stress and burden can adversely affect caregiver’s psychosocial and
physical functioning, which can compromise care provided and the health of
the patient-caregiver dyad27,28. Research has examined the nutrient intake of
PwPD and their spouses26, but has not specifically analyzed the diet quality in
the context of the patient-caregiver dyads. Additionally, exploration of nutrition
concerns of these dyads and how these concerns compare to diet quality have
not been explored. Compared to the general population, caregivers for PwPD
are more likely to have depression, anxiety, decreased health status27, and/or
poorer QOL29, which may impact diet quality. Additionally, given the later
onset of PD, most caregivers are older and have their own medical conditions
that may require dietary modifications.30
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Qualitative work is needed to explore PwPD’s and their caregivers’ views
on dietary intake and decisions that impact that intake. Such nutrition
research has been used in similar populations, like older adults and their
informal caregivers, to better understand factors impacting dietary choices and
inform appropriate and acceptable services.31,32 This qualitative work has also
been conducted to better understand various aspects of care among PwPD
and their caregivers, such as coping with the disease33,34, managing cognitive
changes35, and QOL.36 However, such an approach has not been used to
understand the nutrition concerns of this population.
Understanding the diet quality and the nutrition concerns of both PwPD
and their caregivers can inform nutrition services for managing PD, and how
best to facilitate dietary management from patient perspective. Additionally,
gathering this information can help identify general services required to
facilitate the process of learning to live with PD.37 As a result, to effectively
design a nutrition intervention for PwPD and caregivers, assessing dietary
quality as well as collecting qualitative information related to their nutrition
concerns is vital to develop an effective and sustainable nutrition service. The
main purposes of this study were to: 1) evaluate the diet quality among PwPD
and their informal caregivers; 2) describe the self-reported nutrition concerns
among PwPD and their informal caregivers; and 3) explore if there was a
consistent pattern between self-reported nutrition concerns and dietary quality
of PwPD and informal caregivers.
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Methods
A concurrent mixed-method design38 was used to assess diet quality and
nutrition concerns of PwPD and their informal caregivers. This mixed-methods
design was chosen to gain a more complete understanding of nutritional
needs of PwPD and caregivers through comparing and synthesizing both
quantitative and qualitative data.38 Data was collected over four assessments
completed between November 2018 and April 2019. Participants were
recruited from support groups throughout New England, New York, and New
Jersey via announcements and flyers at community centers, via healthcare
providers, and through popular press coverage from the University.
Assessment 1 was an informational phone call during which participants were
screened for eligibility and informed about the study protocol. Both the PwPD
and their informal caregiver were required to participate and needed to be
community-dwelling, English-speaking, and ≥18 years old. Participants also
needed to score >18 on the Telephone Montreal Cognitive Assessment (TMoCA), a cognitive screening tool.39,40 At the beginning of Assessment 2,
which was an in-person visit, the study protocol was reviewed and both PwPD
and their informal caregiver completed the informed consent process.
Participants completed a timed-swallow test, questionnaires, and a semistructured, dyadic interview. Assessments 3 and 4 were phone calls during
which participants completed two 24-hour recalls. Findings from this study
were a part of a larger study seeking to inform features of a digital health
nutrition intervention. Approval from the University of Rhode Island’s
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Institutional Review Board (HU1819-001) was obtained.
Data Collection
Nutrition assessment data are highlighted in Table 2. The two 24-hour
recalls included one week and one weekend day, and were conducted using
the gold-standard, multiple-pass interview method.41 Participants received a
food amounts booklet to help estimate and report accurate portion sizes. The
24-hour recalls were entered into Nutrition Data System for Research
Software 2017 (NDSR, University of Minnesota, Minneapolis, MN) and
analyzed for total energy and nutrient intake. The NDSR data were assessed
for diet quality using the HEI-2015 scoring metric.42 Outputs from NDSR were
used to calculate HEI-2015 component scores derived using SAS codes.42
Total HEI-2015 scores are based on 1-100; the higher the score, the better the
diet quality. A graded approach was used to categorize HEI-2015 scores
(A=90-100, B=80-89, C=70-79, D=60-69, and F=0-59).42
During Assessment 2, height was measured using a stadiometer (Seca,
Birmingham, UK) to the nearest 0.5 cm in duplicate and then averaged and
weight was obtained using a calibrated scale (Tanita HD351 digital scale,
Arlington Heights, IL) to the closest 0.1 kg and in duplicate and then averaged.
These values were used to calculate body mass index (BMI, kg of body
weight/height in meters2). A foot-to-foot bioelectrical impedance analysis
device (Tanita BF-556, Arlington Heights, IL), estimated body fat percentage.43
Body fat was not obtained for participants with implanted medical devices.
Waist circumference was measured at the top of the hip bone using Gulick
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anthropometric tape (Fabrication Enterprises Inc. White Plains, NY) in
duplicate and averaged.44 Finally, participants also completed a medical
history and demographic information (age, gender, race/ethnicity, education
level, employment status) survey.
Semi-structured, dyadic interviewing was used to capture information
related to dietary intake and nutrition concerns using a pre-prepared
moderator guide (Appendix A). The research team developed the moderator
guide with reference to previous literature.3,37,45 Twenty-four opened- and
closed-ended questions were used that fit into one of three main domains: PD
and Diet, Accessibility of Nutrition and Health Information, and Digital Health
for PD. Semi-structured dyadic interviews also contained three closed-ended
questions which provided insight into PwPD’s and caregivers’ perceptions of
healthy eating and its usefulness for managing disease. Interviews were
conducted in the participants’ homes by a doctoral candidate who was also a
registered dietitian (DL) and audio recorded using a digital recorder. The mean
length of interviews were approximately 39 minutes and interviews lasted from
21 to 64 minutes in length.
Data Analyses
Quantitative data analyses. Quantitative data was analyzed using SPSS
v26 (IBM Corp, Summers, NY). Descriptive statistics are reported as
mean±standard deviation for continuous variables and percentages and
frequencies for categorical variables. Outliers were identified using boxplots
(points that extend more than 1.5-box lengths from the edge of the box)
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among the following HEI-2015 variables: HEI-2015 Total Scores, Protein, and
Refined Grains component scores. To explore differences between PwPD and
caregivers, independent samples t-tests were used for all normally distributed
continuous variables and Mann-Whitney U tests examined differences
between non-normally distributed continuous variables. Finally, the percent
and frequency of PwPD and caregivers who met >80% of adequacy and
moderation HEI-2015 components scores were calculated. A p-value of <0.05
indicated statistical significance.
Qualitative Data Analyses. Qualitative data was analyzed using the
framework analysis method46 and Colaizzi’s Strategy in Descriptive
Phenomenology.47 The following steps were taken to analyze transcripts.
Recordings were transcribed verbatim and DL checked transcripts for
accuracy. Transcripts were analyzed by DL and a trained research assistant
(KS). The analyses focused on five questions from the moderator guide
related to diet and nutrition.
Before coding individually, KS and DL read through all of the transcripts
and developed a list of initial impressions and themes within three categories:
Dietary Concerns Related to PD Sequelae, Other Nutrition Concerns, and
Perceptions of Diet (Figure 1). Dietary concerns were coded deductively while
themes that emerged from the transcripts were coded inductively and fell into
the category of Other Nutrition Concerns or Perceptions of Diet. Both DL and
KS coded one transcript from each batch independently and met to compare
and reconcile coding. Then DL and KS created a working analytical
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framework and agreed upon codes to use for analyzing the remaining
transcripts. The transcripts were uploaded to NVivo12 (QSR International Pty
Ltd, AU) and coded separately by DL and KS. An inter-coder reliability was
calculated, with an agreement >93% achieved.48
DL and KS compared codes and reconciled differences between codes,
until a consensus was reached, and codes were finalized. To ensure
information related to dietary intake was not overlooked in other sections of
the transcripts, DL went through all of the transcripts and coded the remaining
sections. KS reviewed the codes to verify coding structure, and added
additional codes when needed, and DL and KS discussed differences in
coding and collapsed themes. The larger research team and DL met to further
collapse and finalize themes.
Data Integration. The research team reviewed both data sets and
considered the qualitatively-coded themes in conjunction with the findings from
the statistical analyses of the HEI-2015 scores. Qualitative data was charted
into framework matrices and reported as frequencies using NVivo12 to
quantify codes within the over-arching category of Dietary Concerns Related
to PD Sequelae. This frequency data derived from the qualitative themes and
a side-by-side comparison of themes were compared with individual HEI-2015
Scores for each participant. Data was interpreted and connections were
explored between HEI-2015 scores and frequency of self-reported Dietary
Concerns Related to PD sequelae from PwPD and their caregivers.
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Results
Twenty dyads were assessed. Participant characteristics are
summarized in Table 1. All participants identified as Caucasian and one PwPD
identified as Hispanic. Sixteen of the twenty dyads lived together. Ninety
percent of PwPD were taking levodopa-containing medication, ranging from 37 times per day.
To help describe our study population and support the research aims,
Table 2 highlights diet assessment data of PwPD and caregivers. Both PwPD
and caregivers had near optimal percent body fat and waist circumference
though BMI scores indicated both groups were overweight. Dyads were
consuming slightly below the acceptable macronutrient distribution range
(AMDR) for carbohydrates, slightly above the AMDR range for fat and within
the AMDR range for protein. People with PD consumed 0.9±0.4 g/kg body
weight protein per day and caregivers consumed 0.9±0.2 g/kg body weight per
day. While dyads were below the dietary reference intake for most vitamins
and minerals, the majority were taking supplements. There was no difference
in nutrition assessment variables between PwPD and caregivers.
Dietary Quality Among PwPD and Caregivers.
Total HEI-2015 and component scores for PwPD and caregivers are
summarized in Table 3. Low HEI-2015 scores indicates poor diet quality
consistent with the national average.49 Fifty-five percent of PwPD and 65% of
caregivers had total HEI-2015 scores that translates to an F letter grade.42
Examination of HEI-2015 and component scores for PwPD and caregivers are
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summarized in Figure 2 and highlights the number of PwPD and caregivesr
who achieved >80 of maximum scores for total HEI-2015 scores and
component scores.
Qualitative Results: Self-Reported Nutrition Concerns
Dietary Concerns Related to PD Sequelae. There were 182 phrases
coded into the category Dietary Concerns for PD Sequelae (Table 4). The
major themes related to PD Sequelae are highlighted in Figure 1. Phrases
where dyads described how PD impacted mealtime and eating ability were
coded as Mealtime Related Issues. The major areas discussed around these
meal-time related issues included three-major sub-themes: Chewing and
Swallowing; The Time it Takes to Cook or Consume a Meal; and Physical
Sequelae. Phrases where participants reported cutting up their food smaller,
modifying textures to consume foods, coughing during meals, or taking more
effort to chew their food, were coded as Chewing and Swallowing.
•

“He has been advised to cut things into small pieces often, and to drink
fluids as you eat” –CG17

Many participants also described how physical changes related to PD
impacted their ability to eat certain foods and mealtime. Phrases were coded
as Physical Sequelae when dyads described how tremor and other physical
changes impacted their ability to consume certain foods.
•

“Primarily, the tremor affects my ability to get soup or things on a fork
up to my mouth” – PD2

Another sub-theme within Mealtime Related Issues was the Time It Takes
to Cook or Eat a Meal. Several participants described how the length of time to
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prepare a meal or consume a meal could diminish their appetite or impact
meal enjoyment.
•

“I’m done and the dishes are already done, but I’m waiting for his dish”
– CG14

Phrases related to a Change in the Amount Eaten, Appetite, or Weight Status
were coded when participants described an increase, decrease or no change
in appetite, amount of foods consumed and/or change in weight status. Most
of the phrases coded described a decrease in appetite. However, some
participants did notice they were eating more than they used to.
•
•

“My appetite is less than it used to be, there is no doubt about it.” –
PD6
“I’ve always been able to eat a lot and consume the calories very well.
Parkinson’s you just have to eat.” – PD17

Only in four interviews did participants describe change in weight status.
One participant reported an increase in weight due to the medications. Two
participants reported that their weight decreased. Another reported that their
weight stayed the same since being diagnosed.
•

“I’m kind of grateful you’re losing weight in that when and if you fall, I’m
gonna have to help you get back up, and the more you weigh, you
know I’m better off if you don’t weigh as much.” - CG14 to PD14

Phrases where dyads described managing issues such as constipation,
diarrhea, and nausea were coded as Gastrointestinal Issues; most of these
phrases coded were constipation-related.
•

“A little bit of constipation…I try to eat a lot of salad lately, try to
compensate a little.” – PD18

•

“I think for myself sometimes I tend to overcorrect, so then it’s you
know, say my stool has been running loose, then I overcorrect, and
then I’m in a constipation phase.” – PD10
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Phrases where dyads discussed issues with spacing levodopa
containing medication and high protein meals or where dyads described sideeffects of medication that impacted dietary intake were coded as Managing PD
Treatment and Diet.
•

“I found online that milk is one of the worst proteins to have with my
medications, so I have been spacing out having my milk more than an
hour from when I take my meds. I used to mix the MiraLAX with milk,
but now I will mix it with Gatorade… I noticed that my medication lasts
45 minutes longer.” – PD01

•

“The first medication that I was on for Parkinson's increased my
appetite and caused insomnia. And of course, if you are awake, you are
going to pick on food items, so I wound up putting on some weight for
about a year.” - PD7

Phrases were coded as Taste and Smell when participants described how
loss of taste and/or sense of smell impacted their food choices and ability to
enjoy foods. Many reported a higher affinity for sweet tasting foods such as ice
cream and desserts, while others reported trying to decrease their sugar
intake.
•

“I’ve come to love ice cream, I have it every single night almost, I didn’t
used to do that…” - PD16

•

“I lost my sense of smell in 1992…way before my Parkinson’s
diagnosis, yes, but I think they relate loss of smell to Parkinson’s. So, it
took some of the enjoyment of food...” - PD05

Phrases where dyads described trying to increase their fluid intake or
recognizing they needed more fluids in their diet were coded as Fluid and
Thirst.
•

“We’re trying to increase the amount of water weight that I drink” PD13 about fluid intake and managing low blood pressure.
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Other Nutrition Concerns. Five themes emerged within the category of Other
Nutrition Concerns (Figure 1). In total, 143 phrases were coded related to
Other Nutrition Concerns. Phrases around Understanding Nutrition Claims
were coded in 19 out of 20 interviews. Phrases were coded as Understanding
Nutrition Claims when dyads expressed a desire to better understand healthy
eating, nutrition claims, nutrition for overall health, or nutrition claims for
managing PD.
•

“As I spoke to you earlier, the difference between good cholesterol and
bad cholesterol, so that I’m making better choices.” – PD19

•

“Probably for my dad in particular it would be if for Parkinson's, do they
recommend a higher protein, lower fat, lower carb diet? Or do they
recommend complex carbs with protein? Maybe he could eat a
healthier diet than he does.” – CG07

Within the theme Managing Life were three sub-themes: Managing Other
Conditions with PD, Managing PD and Life, and Managing Diet and Life.
Besides managing Parkinson’s disease, many PwPD had other health
conditions they were dealing with, including: musculoskeletal issues, weight
management, endocrine issues, gastrointestinal issues, cardiovascular issues,
and brain disorders.
•

“Well one thing we’ve learned, because he does have a tendency to
[get] gout, there’s certain vegetables to avoid that will contribute to uric
acid forming in the joints.” – CG17

•

“I sort of have breakfast, but don’t really have lunch, and then at dinner
I eat a lot…I think it’s more my Concerta wears off, and then um,
because it’s considered an appetite suppressant, and then I’m just
really hungry.” – CG12
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Within the Managing Life theme was also the sub-theme, Managing PD and
Life. Participants described challenges with overcoming life events and
challenges and managing PD.
•

“Well Parkinson’s definitely makes you more emotional. I’ve always
been an emotional person. I cried when we got married.” – PD14

A few participants described day-to-day and life events that could impact their
dietary intake, such phrases were coded as Managing Diet and Life. One
participant felt dealing with personal matters impacted their dietary choices but
felt PD did not.
•

“People who don’t think you’re just going through a fad or trying to be
effected by something, when really you’re just trying to eat healthy,
especially for a medical condition, you know, ‘oh well she’s on one of
those diets or she’s being one of those people’” – PD10

•

“I have been not watching what I eat over the past 18 months, but it
does not have to do with Parkinson’s, it has to do with stress… stress
eating - not feeling good and eating the wrong foods.” – PD20

Many participants described how they were currently involved with
complimentary care services to help manage PD. Phrases where participants
described partaking in exercise programs, acupuncture, dietary changes, or
support groups were coded as Alternative Practices or Medicine.
•

“There was a cleanse that was put out by Kripalu, the yoga center, it's
like a 3 week cleanse to purge your body of various toxins, you know
it’s hard, but once you get into it its really good, you feel really healthy
and vibrant” –PD11

•

“My acupuncturist, who I respect and think is bright, tells me ‘don’t eat
peanuts’ and I love peanuts…I asked her why she said something I
didn’t understand, but I stopped eating peanuts, and same thing with
milk, she said stop eating dairy so I stopped eating yogurt and milk.” –
PD05
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When discussing food intake and dietary choices, many participants were
not sure that their dietary intake changed as a result of having PD. Some did
not feel having PD impacted their food intake, dietary choices or preferences.
Several participants could not distinguish if changes they experienced with
food were a result of having PD or just a natural part of the aging process.
•

“I generally felt better on the Keto diet because I lost a little weight, but,
um, as far as Parkinson’s symptoms I’m not aware.” –PD02

•

“No, I don’t eat a lot, but I don’t know if that’s Parkinson’s or not.
Indirectly it probably is, because I don’t have my smeller” –PD16

The final theme related to the category Other Nutrition Concerns was
Dietary Needs of Caregivers. Several interviews revealed caregivers had their
own dietary concerns that may differ from the PwPD or were managing their
own health conditions that required dietary modifications, including
neurological conditions such as multiple sclerosis and essential tremor. Many
caregivers were also the ones buying and preparing foods or impacted by their
loved one’s dietary challenges.
•

“I feel really badly for [him] because he has got nothing to eat because
just being in the kitchen thinking about food is awful but he's not
wasting away, so...” -PD15

•

“I mean I call him almost every day ‘got any ideas for dinner?’, but I
think for the most part it all falls on me. I think that he really does think
that if he ate better, he might feel better, so again it’s on me.’’ –CG18

Perceptions of Diet. In total 113 phrases were coded within the category
Perceptions of Diet. Phrases coded as Perceptions of Diet fit into three subthemes (Figure 1). Of the 72 phrases coded as Perceived Usefulness of Diet
for Managing PD, 73.6% of these phrases described how dyads thought
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dietary choices were useful for Managing PD, while 19.4% of phrases coded
described how dyads were not sure or neutral regarding the role diet plays for
managing PD. Only 6.9% of phrases coded described how participants
thought a healthy diet was not useful for managing PD. As a result, there were
mixed perceptions as to how useful diet can be for managing PD. The
following quotes are examples of responses to the question, “How important is
it to follow an eating plan for managing PD.”
•

“It’s very important, I don’t know if you would call it an eating plan, but
it’s important to know what you are going to eat and when you are
going to eat it and figure out how to back up from what time it is now
and to dinner and when you should start taking your medicines and put
it in proper order.” -PD12

•

“I think more science needs to be done there, I think there needs to be
some things that they find that [some foods] are especially good...some
fruit that comes from Asia somewhere.” –CG16

For the sub-theme, Perceived Usefulness of Diet for Managing Health,
85% of phrases coded indicated participants found following a diet useful for
managing overall health and only 15% of phrases coded indicated participants
found following a diet to be useless for managing overall health.
•

“I don’t count calories. I eat what I eat.” –PD04
“But you need to! We need to be more cognizant of the caloric intake
because it affects how much you weigh, and if you lost 15 pounds, your
core would be much more manageable. As would mine be! …one isn’t
independent as each other. So caloric intake does count! You just don’t
think it does.” -CG04
A third theme within the category of Perceptions of Diet was Perception

of Own Diet Quality. Of the 21 phrases coded, 76% of phrases coded
described participants who perceived they had good dietary quality, while 14%
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of phrases coded were linked to participants who perceived they had poor diet
quality. Only 2 interviews and 9.5% of the phrases coded reflected that
participants recognized that their diet could be improved or that they were
interested in making improvements in their diet quality; these phrases were
coded as Neutral.
•

“Only that I know that I should have more fruits and vegetables.”-PD15

•

“We need a healthier diet. We do eat like fish once a week at least, but
we also eat like pizza, you know... But yeah I think we need to eat
healthier, we definitely need to eat healthier. He tries to, he’s a lot better
at it than I am.” –CG18

Integration of Quantitative and Qualitative Data
The frequency of themes coded within the category Dietary Concerns
Related to PD Sequelae were compared with HEI-2015 scores to detect if any
pattern between self-reported concerns and diet quality existed. Given the
large variation between HEI-2015 scores and Self-Reported Nutrition
Concerns Related to PD sequelae. Several PwPD reported a change in taste,
including a preference for sweeter foods. However, about 50% of participants
had high added sugar moderation scores, indicating that their diets are low in
added sugar. Sodium scores indicate excess salt intake may be a concern for
PwPD and caregivers. Higher salt intake may be attributed to change in taste
as well as the intake of convenience and processed foods.
Discussion
This study is the first to examine PwPD’s and caregivers’ diet quality in
conjunction with self-reported dietary concerns related to managing PD.
Findings from this study indicate PwPD and caregivers have poor diet quality
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as well as nutrition concerns regarding PD sequelae and their own nutrition
literacy. Qualitative analyses revealed dyads also believe that a healthy diet
may be important for managing PD and overall health. However, there was no
pattern between HEI-2015 scores and Nutrition Concerns Related to PD
Sequelae. Findings from this study can be used to provide tailored nutrition
counseling and inform nutrition interventions among PwPD and caregivers.
This study adds to the body of literature of dietary quality and PD
management by providing objective dietary quality data which is scarce. Our
study supports the caregiver as an integral part of the care provided to PwPD
and without including caregivers’ dietary management for PD may be
incomplete. Total HEI-2015 scores of both PwPD and their caregivers was
comparable to the average HEI-2015 scores for Americans of 59, or an F.50
Compared to the national HEI-2015 component for Americans, dyads scores
indicate PwPD and caregivers are doing a better including whole grains in
their diets and limiting added sugar intake.50 Mean added sugar component
scores were similar to American older adult scores.50 Dyads may need some
education on how to incorporate protein and healthy fat into their diets as well
as to minimize sodium intake.
Few studies have examined diet quality and patterns among PwPD but
nutrition status has been extensively examined. Past research shows that
PwPD have compromised nutrition status and are at nutrition risk3,13,24. Our
findings were similar to key findings from Cassani et al25, who found no
differences in summary scores assessing adherence to the Mediterranean diet
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between PwPD and controls; results also showed both groups could be
making dietary choices that better adhere with the Mediterranean diet.
Marczewska et al.26 examined daily intake among PwPD and their spouses
and found no difference in average daily energy intake, but did find differences
in individual food groups such as vegetable protein and carbohydrates. Our
study adds to this research by looking at over all dietary quality and adherence
to the DGAs, rather than in terms of individual nutrients.
Obtaining self-reported nutrition concerns of PwPD and their caregivers
adds to the body of patient-centered care research. Dyads expressed dietary
concerns related to PD sequelae, such as mealtime related issues, change in
appetite, and gastrointestinal issues. Findings from our study indicate
participants want to increase nutrition literacy, have pre-existing perceptions
around nutrition intake, and are using complimentary care services. These
findings expands upon previous research which has found PwPD and
caregivers want to be involved in the communication and decision making of
their care.51 Past research shows high levels of education and treatment of a
movement disorder specialist were significantly related to PwPD using
complementary health service.52 The majority of dyads in our study had at
least a college degree and most PwPD were receiving treatment from a
movement disorders specialist. Young Shin et al.52 found exercise and
vitamin supplements were most commonly reported forms of complimentary
healthcare. Many of our participants reported in their medical history
questionnaire to be taking various supplements to manage health.
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In addition to better understanding dietary quality and concerns among this
population, our study expands upon previous research describing the day-today challenges of navigating PD and sheds light onto how this may impact not
only diet quality but overall health-related QOL. The emerging theme from our
study, Managing Life, supports previous literature published by Smith and
Shaw,37 which described the existential challenge shared by PwPD and their
loved ones. Finally, exploring these self-reported nutrition concerns from this
study may be able to help better understand the diet quality of participants in
this study is warranted.
The lack of pattern consistency between HEI-2015 scores and the number
of self-reported nutrition concerns related to PD sequelae may indicate our
participants may be in varying stages of the Transtheoretical Model.53 For
instance, Dyad 16, the dyad with the highest HEI-2015 scores, also had the
highest number of phrases coded within Self-Reported Nutrition Concerns
Related to PD Sequelae (Table 4). This occurrence may indicate that this dyad
was actively making dietary changes to minimize nutrition concerns and more
cognizant of their dietary choices compared to other participants. The dyad
with the second highest HEI-2015 scores, Dyad 4, had only two phrases
coded within Self-Reported Nutrition Concerns Related to PD Sequelae. This
suggests this dyad was actively managing their nutrition concerns. Most
dyads had HEI-2015 scores ranging from 43-70 and 9-12 phrases coded
around nutrition concerns. Findings suggest assessing dyads readiness to
make dietary changes could be beneficial for helping to improve diet quality.53
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Self-reported perceptions and actual dietary patterns may vary due to
alterations in perception that PwPD experience as part of the disease. These
findings, combined with poor diet quality, suggest this population can benefit
from nutrition education to improve diet quality and nutrition knowledge.
Low adequacy and moderation HEI-2015 component scores may shed
light on some of the self-reported nutrition concerns that came up during semistructured dyadic interviews. The sub-theme Mealtime Related Issues coded
in dyadic interviews may account for low dietary scores and influence dietary
choices and help to explain overall low HEI-2015 total and component scores
among dyads. Our participants were not meeting maximum adequacy in areas
of fruits, vegetables, and whole grains, sources of fiber which may help to
reduce self-reported complains of constipation among our population. Future
interventions should help PwPD obtain adequate fiber, manage dietary protein
intake and reduce consumption of sodium and saturated fat. Low dairy intake
among PwPD may be a concern. The literature shows that osteoporosis and
osteopenia can impact up to 91% of women and 61% of men with PwPD.54
Most of our participants were taking supplements, including supplements to
support bone health, which could be why nutrition for bone health did not
appear as a self-reported nutrition concern. Understanding nutrition concerns
among dyads may be a way to address nutrients of concern unique to PD and
in turn help improve diet quality scores. Similar HEI-2015 scores between
caregivers and PwPD indicate that caregivers can also benefit from nutrition
education, especially since the majority of the dyads were living together.

41

Findings from this study can also help to inform digital nutrition
interventions, which are lacking in this population. Tailored nutrition counseling
by a registered dietitian that includes both the PwPD and caregiver could be
beneficial for this population. Nutrition counseling can help to increase nutrition
knowledge and promote dietary behavior change.55,56 Nutrition interventions
should address the nutrition concerns discussed in semi-structured interviews
among PwPD and caregivers as a way to help improve diet quality seek to
help improve diet quality. Subsequently, including caregivers could optimize
the health of the patient-caregiver dyad.27,28 In addition to managing PD, both
PwPD and caregivers were dealing with other health conditions that may need
dietary attention and can help reduce caregiver strain. Couple-oriented
interventions improve spousal coping strategies, promote disease related
stress and anxiety management, increase self-efficacy, and help couples
manage changes caused by PD.57
Strengths and Limitations. This novel study had several strengths.
Several measures were taken to ensure accuracy of the dietary intake
information. To reduce recall bias, we used the multiple pass method, the gold
standard for collecting dietary recall information.41 Enrolling both PwPD and
caregivers also helped increase accuracy of dietary information. For example,
several male participants, both PwPD and caregivers, needed assistance from
their spouse to report dietary intake during 24-hour recalls. To measure diet
quality, HEI-2015 was used, which is a validated, comprehensive measure of
dietary intake that is linked to adherence of 2015-2020 DGAs.42 The mixed-

42

method study design collected both quantitative and qualitative data that
provides an in-depth understanding of dyads’ diet quality and nutrition
concerns that may help explain diet quality. The use of semi-structured dyadic
interviews promotes interaction between participants to provide detailed
information regarding their nutrition concerns and PD management.58 Finally,
this study promotes the inclusion of PwPD and their caregiver as part of the
healthcare team and the concept of patient-and caregiver-centered care for
managing PD.
Despite study strengths, this study has several limitations. Findings from
our study are not generalizable to all PwPD. Most of our participants were
educated and all of them identified as Caucasian. Cognitive status was an
inclusion criterion to enroll in this study and as a result most of our participants
had low reliance on caregivers and were able to perform activities of daily
living with minimal assistance. However, research supports including
caregivers early at disease onset and encourages caregivers to partner with
healthcare providers to help cope with disease progression.59 A limitation of
the HEI-2015 assessment measure is that it does not assess fluid intake.
Many of our participants complained about a change in thirst, which could
impact negatively impact hydration status. Cassani et al25 found that PwPD
drank significantly less fluid compared to healthy controls. Finally, requests for
personal health information, including disease stage, were sent to physicians’
office but we were unable to obtain this information for all 20 PwPD.
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Future Research.
Concerns about low nutrition literacy in addition to poor diet quality among
study participants may be explained by dyads’ limited access to nutrition
education. During semi-structured interviews, when asked “Where do you get
information about foods and diets for people with PD?” most dyads described
getting information from support groups or attending one or two education
sessions. Only one PwPD reported working with a dietitian overtime to
manage nutrition and PD. Future research should explore barriers PwPD and
caregivers have for accessing nutrition professionals. Future work should also
explore ways to improve access to nutrition professionals through expanding
other healthcare professionals’ knowledge of nutrition services as well as
promote policy changes to expand insurance coverage for medical nutrition
therapy among PwPD. This is important since several participants reported
obtaining dietary recommendations that were not evidenced-based or from
non-nutrition experts.
Conclusion
This mixed-methods study focused on describing the diet quality and
self-reported nutrition concerns of PwPD and their caregivers. Healthy Eating
Index-2015 scores indicate PwPD and caregivers have low adherence to
current dietary guidelines and present with dietary concerns related to PD.
Poor diet quality and the self-reported nutrition concerns indicates dyads can
benefit from nutrition education and support the inclusion of caregivers and
nutrition professionals for managing nutrition and health.
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Chapter 2 Tables and Figures

Figure 1: Flow Chart of Qualitative Data by Major Categories and SubThemes

Figure 1 Abbreviations: PD=Parkinson’s disease; GI=Gastrointestinal Issues
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Figure 2: Frequency of PwPD and Caregivers with >80% Adequacy and
Moderation Component Scores
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Table 1: Descriptive Characteristics of PwPD and Caregivers
Characteristics

PwPD

Caregivers

Range

P

Age (years)

69.7±9.2

66.4±13.0

39-89

0.4

Gender n(%)
Male
Female

13(65)
7(35)

4(20)
16(80)

NA

0.01

6(30)

1(5)

3(15)

5(25)

NA

0.11

11(55)

14(70)

Employment Status n(%)
● Retired
● Part Time
● Full Time

15(75)
3(15)
2(10)

10(50)
2(10)
8(40)

NA

0.09

Years Since Diagnosis

7.6(5.4)

NA

0.3318.0

NA

T-MoCA

19.8±1.5

20.4±1.1

18-22

0.2

NA

17(85)
2(10)
1(5)

NA

NA

Education n(%)
● HS Diploma/Some
College
● Technical
Training/Trade
School/Associates
● > College Degree or
Greater

Caregiver Relationship (%)
● Spouse/Partner
● Child
● Friend

Independent samples t-tests and chi square analyses performed. A statistical significance was indicated
at a p-value of <0.05. Abbreviations: T-MoCA=Telephone Montreal Cognitive Assessment.
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Table 2: Diet Assessment of PwPD and Caregivers
Diet Assessment Variables

PwPD
(n=20)

Caregivers
(n=20)

Range

Height (in)

66.1±3.3

65.1±3.8

57.5-70.7

Weight (kg)

77.3±19.9

77.4±16.4

35.6-116.6

BMI (kg/m2)

27.1±5.4

28.3±5.7

15.4-43.1

% Body Fat (n=33)*

29.1±8.8

34.2±7.8

13-49

Waist Circumference (in)

39.4±6.0

39.4±6.3

25.2-52.4

1887.4±728.1

1752.7±465.8

908.8-3344.4

% Calories from CHO

44.2±9.6

41.5±8.0

24.4-57.0

% Calories from Fat

36.7±6.7

37.7±7.2

24.7-50.3

%Calories from Protein

15.9±4.1

17.2±3.8

10.6-27.11

% Calories from Sat Fat

12.8±3.1

13.3±2.8

6.6-18.5

Anthropometrics

Nutrient Intake
Kcalorie Intake

Analyses did not include dietary supplements; independent samples t-tests performed and a statistical
significance was indicated at a p-value of <0.05. Mann-Whitney test for non-normally distributed data (
g/kg protein; % calories from protein); %BF n=16 PwPD and 17 CG (implantable devices such as DBS
and Pacemaker) Abbreviations: DRI=dietary reference intake; BMI=body mass index, Avg=average
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Table 3: HEI-2015 Scores of PwPD and Caregivers
PwPD

Caregivers

Range

58.3±12.4

58.1±10.6

37.7-83.4

Total Fruit (0-5)

2.9±1.9

2.5±1.7

0.0-5.0

Whole Fruit (0-5)

3.3±2.0

3.2±1.9

0.0-5.0

Total Vegetables (0-5)

2.6±1.9

3.4±1.6

0.1-5.0

Greens and Beans (0-5)

2.5±1.9

2.6±2.2

0.0-5.0

Whole Grains (0-10)

4.8±3.4

5.0±3.1

0.0-10.0

Dairy (0-10)

5.9±3.0

7.1±2.4

1.1-10.0

Total Protein (0-5)

4.6±0.7

4.7±0.6

2.8-5.0

Sea Food and Plant Protein (0-5)

3.6±1.9

2.9±2.2

0.0-5.0

Fatty Acid Ratio (0-10)

3.9±2.9

3.0±2.3

0.0-10.0

Refined Grains (0-10)

7.0±3.1

8.0±2.6

0.0-10.0

Sodium (0-10)

5.5±3.7

4.8±3.8

0.0-10.0

Added Sugars (0-10)

7.6±2.5

7.4±2.6

1.2-10.0

Saturated Fat (0-10)

4.1±3.4

3.6±2.8

0.0-10.0

HEI-2015 Scores
Total Score (0-100)
Adequacy Component:

Moderation Component:

Group differences ran using independent samples t-tests and Mann-Whitney U tests, p-value
of <0.05 indicated statistical significance. Abbreviations: HEI-2015=healthy eating index-2015
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Table 4: Number of Times Nutrition Concerns Related to Parkinson’s Disease
Sequelae Were Coded During Dyadic Interviews: A Side-By-Side Comparison
with HEI Scores.
Dyads
Dyad 1
Dyad 2
Dyad 3
Dyad 4
Dyad 5
Dyad 6
Dyad 7
Dyad 8
Dyad 9
Dyad 10
Dyad 11
Dyad 12
Dyad 13
Dyad 14
Dyad 15
Dyad 16
Dyad 17
Dyad 18
Dyad 19
Dyad 20
Total
Phrases
Coded

Total Nutrition
Concerns Related
to PD-Sequelae
9
4
1
2
9
11
10
7
7
11
11
12
11
19
13
21
10
9
5
0

Total HEI-2015 Scores
PwPD
Caregivers (n=20)
(n=20)
65.7
43.7
44.9
41.8
63.1
62.8
83.0
78.7
45.1
51.8
46.6
70.3
48.6
43.7
54.5
54.3
54.3
54.5
62.9
63.1
63.1
62.9
59.8
54.6
59.3
56.6
70.7
61.0
46.1
57.2
81.4
83.4
47.0
57.5
60.5
51.1
71.0
59.3
37.7
53.8
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Abstract
In order to deliver tailored nutrition education via digital mediums for people
with Parkinson’s disease (PwPD) and their information caregivers, this study
examined the perception and acceptance of digital health for managing
nutrition and health. Digital competence was also assessed. Using a mixedmethods design, qualitative data was collected through semi-structured,
dyadic interviews and quantitative data through questionnaires from 20 dyads
(20 PwPD and 20 caregivers). Data was collected in the Northeastern United
States through home visits and phone interviews during the 2018-2019
academic year. Interview transcripts were deductively coded using the
framework analysis method. Phrases related to Acceptance of digital were
sub-coded into Accept, Neutral or Reject. Phrases related to perceptions of
digital health were sub-coded into Perceived Usefulness, Perceived Ease of
Use and Awareness of Digital Health. Quantitative data were analyzed using
descriptives, independent samples t-tests and chi-square. To integrate this
data, qualitative codes were transformed into variables and compared to
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digital competence scores. A mean acceptance rate for digital health was
calculated through examining the mean percent of phrases coded as Accept
from interview transcripts. Twenty-five (62.5%) participants used the internet
for at least 5 health-related purposes. The mean acceptance rate was 54.4%.
Dyads rejected digital health devices if they did not see the added benefit. The
majority of phrases coded revealed participants found digital health useful, but
hard to use, and about half of the phrases coded suggest dyads needed
education about existing digital health mediums. There was no difference in
mean digital competence scores between PwPD and caregivers (28.6±12.6).
Findings reveal dyads were accepting of and use technology, but not to its
fullest potential. This may be attributed to perceiving technology as hard to
use. This finding combined with digital competence scores, reveal education is
warranted prior to providing a digital health intervention to deliver nutrition
services.
Key words: Parkinson’s disease, digital health, caregivers, nutrition
education, mixed methods
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What is known about this topic:
•

Increased disease burden with Parkinson’s disease progression
compromises the health of the caregiver and the person with Parkinson’s

•

The healthcare plan often overlooks nutrition and the caregiver in
managing Parkinson’s

•

Digital health is an effective healthcare delivery mechanism, but little is
known about how Parkinson’s patients’ and caregivers’ perceptions of
receiving nutrition and improving their own care

What this paper adds:
•

Digital health and technology are convenient tools and provide Parkinson’s
patients and caregivers with new evidence-based knowledge on
Parkinson’s-related issues

•

Parkinson’s patients and caregivers are accepting of technology to manage
nutrition, despite it being challenging.

•

The digital competence scores indicate some training will be needed prior
to implementing a digital health intervention
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Introduction
Parkinson’s disease (PD) is an incurable, progressive
neurodegenerative movement disorder that traditionally occurs in the second
half of life (Fahn, 2003). Over 900,000 Americans are diagnosed with PD
(Borlongan et al., 2013), and it costs the United States over $14 billion per
year (Kowal, Dall, Chakrabarti, Storm, & Jain, 2013). This cost is related to
disease-related motor (e.g., postural instability, bradykinesia, muscle rigidity,
resting tremors) and non-motor sequelae (e.g., cognitive decline, change in
taste in smell, constipation). Sequelae resulting from PD, also compromise
dietary intake and nutritional status (Barichella, Cereda, & Pezzoli, 2009), and
warrant innovative nutrition care to help improve health outcomes (LoBuono et
al., 2015). However, the unique nutrition services needed for PwPD are an
under-recognized component of care (Vikdahl, Domellof, Forsgren, & Haglin,
2015). Additionally, PwPD can have limited access to all healthcare providers
due to sequelae, age, and location, even with the presence of the caregiver
(Dorsey et al., 2016). The increase in informal caregiver burden as the disease
progresses is grossly under-estimated; the majority of informal caregivers
spend up to 40 hours per week caring for a PwPD (Parkinson’s Australia Inc.,
2015). As a result, an improved healthcare model that addresses nutrition and
includes the caregiver is needed to facilitate PD management.
Digital health describes technologies that enhance managing and
tracking health status (Thomas & Bond, 2014), and include mediums such as
videoconferencing, smart phones, internet applications, wearable devices, and
online social networks. People with PD are promising candidates for digital
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health because a visual assessment is needed as part of on-going care by a
team but PwPD can have limited mobility, visuospatial impairment, and
decreased access to transportation (Achey et al., 2014). Digital health
increases access to health and nutrition services (Meyer et al., 2019; Siddique
et al., 2019; Stillerova, Liddle, Gustafsson, Lamont & Silburn, 2016; Ventura
Marra, Shotwell, Nelson, & Malone, 2017), enhances quality of care (Espay et
al, 2016), allows healthcare providers to obtain visual, objective and
continuous data (Stamford, Schmidt, & Friedl, 2015), decreases healthcare
inefficiencies, offers more personalized services and social support (Attard &
Coulson, 2012; Shah et al., 2015), reduces burden and medical costs for
PwPD (Dorsey et al. 2013), and offers caregiver support (Shah et al., 2015).
People with PD and caregivers are receptive to using technology, especially if
there is an added value, such as improving disease management (Ozanne et
al. 2018; Schulz et al., 2016). However, research has not directly examined
the use of digital health for managing nutrition-related PD concerns
In 2019, the World Health Organization published recommendations for
implementing digital health interventions (World Health Organization, 2019).
They recommend tracking a client’s health status and using videoconference
to complement, rather than replace, in-person health services in a
standardized protocol with infrastructure that promotes patient privacy. To
facilitate the adoption of mobile health technologies for PD management, the
Movement Disorder Society Task Force on Technology proposes to identify
clinically relevant and patient-centered digital outcomes, utilize technological
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mediums where the benefits exceed the burden for patients, and deliver a
reliable intervention (Espay et al., 2019). The development of these digital
nutrition services should include the views, needs and preferences of informal
caregivers, as they are confronted with the evolving roles, increased
responsibilities, and planning for the trajectory of PD (Ducharme et al., 2009;
Espay et al., 2019).
This current study was part of a larger, cross-sectional study, which
examined technology preferences and completed comprehensive nutrition
assessments of PwPD and their informal caregivers (LoBuono et al., In
Preparation). The purpose of this study was to examine PwPD’s and their
caregivers’ perceptions and acceptance of digital health. This study also
describes digital competence among PwPD and their caregivers.
Methods
Study Design
We used a mixed-methods, convergent design to compare and
synthesize qualitative and quantitative data (Creswell and Plano Clark, 2018),
and to fully capture dyads’ perception and acceptance of digital health. How
these self-reported experiences may inform digital competence were also
examined. A mixed-methods design was selected to allow for a better
understanding of the experiences that dyads have in relation to digital health
and their needs and their preferences toward using technology for health- and
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nutrition-related purposes (Espay et al., 2019; Creswell and Plano Clark,
2018).
Semi-structured, dyadic interviews and questionnaires were used to
collect qualitative and quantitative data from PwPD (n=20) and their informal
caregivers (n=20). The PwPD and their informal caregiver were interviewed
together, but questionnaires related to digital competence and technology use
were completed individually. Ethical approval for this study was provided by
the University of Rhode Island’s Institutional Review Board (HU1819-001).
Theoretical Framework
The structure of this mixed-method study and interpretation of results
were based on two theories. The technology acceptance model (TAM)
provides a basis for understanding external factors that influence ender users’
perceptions, attitudes, and intentions to use technology (Davis, Bagozzi, &
Warshaw, 1989. This study concentrated on the early stages of the
development of digital health nutrition services, in which PwPD and caregivers
provided personal opinions and preferences to inform the creation of a userfriendly, evidenced-based, digital nutrition service. The inclusion of informal
caregivers is based on the emerging middle-range theory of transitions
(Meleis, Sawyer, Im, Hilfinger, Messias, & Schumacher, 2000). A transition is
the change from one state or condition to another, and includes life
development stages, like progressing through a disease and becoming an
informal caregiver. Collecting data from PwPD and caregivers provides a more
complete perspective to better understand the transition dyads face as the role
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of the caregiver evolves and the disease condition progresses, especially in
relation to dietary management (Meleis et al., 2000).
Sampling, Recruitment and Eligibility
Study recruitment and data collection went from October 2018 through
April 2019. Emails, flyers and announcements at support groups for PwPD
and community centers were used to recruit participants. Prior to the first study
visit, dyads completed an informational phone call about the study and were
screened for eligibility. Eligibility criteria were, both PwPD and their caregiver
had to be community-dwelling, 18+ years old, and English-speaking, and both
had to participate. All participants needed to score >18 on the Telephone
Montreal Cognitive Assessment (T-MoCA), which is a cognitive screening tool
(Castanho et al., 2014; Pendlebury et al., 2013). Transportation or prior
technology use was not required to participate. Both PwPD and caregivers
completed the informed consent process, and signed consent forms and each
participant received a signed copy of the consent form.
Twenty-five dyads expressed interest. Five dyads did not continue with
the study due to scheduling conflicts or low T-MoCA scores. Eighteen dyads
were eligible, enrolled and interviewed. Two of these dyads included couples
who were both living with PD and identified as each other’s informal caregivers
and were double counted as a PwPD and a caregiver. As a result, 20 dyads
were included in analyses. Dyads were from Rhode Island, Massachusetts,
New York, and Connecticut. We aimed to interview up to 20 dyads as
previous research among PwPD and caregivers indicated this is where data
65

saturation was reached (Boersma et al., 2016; Zizzo, Bell, Lafontaine, &
Racine, 2017). Saturation was reached in this study after the fourteenth
interview.
Qualitative Data Collection and Analysis
The 24-question moderator guide, informed by the previous literature and
the research team was organized to capture three main domains: PD and Diet,
Accessibility of Nutrition and Health Information, and Digital Health for PD.
From these domains, participants’ acceptance and perception were assessed.
A copy of the moderator guide is provided in Appendix N. Prior to starting the
study, interviews were piloted with two dyads and questions were modified
based on participant feedback. Interviews were conducted in the participants’
homes (facilitated by DL) and were audio-recorded using a digital recorder.
The mean interview length was 39 minutes (range 21-64 minutes).
Operational definitions of terms (technology, digital health, smart phones,
smart watches, apps, videoconferencing) were provided during interviews.
Photo prompts were used to help describe different technological devices and
digital health tools and this was particularly important for understanding
acceptance of devices.
Qualitative data was analyzed using deductive and inductive reasoning.
Transcripts were deductively-coded using the framework analysis method
(Gale, Health, Cameron, Rashid, & Redwood, 2013), which is a seven-stage,
systematic procedure that has been used previously in healthcare research
and is often used when answering specific research questions. Transcripts
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were inductively-coded using Colaizzi’s Strategy in Descriptive
Phenomenology (Shosha, 2012) to identify emerging themes; this
interpretative approach draws an understanding of participants’ “lived
experiences” of living with PD (Hycner, 1985).
The following steps were taken to analyze the data. Recordings were
transcribed verbatim and DL checked transcripts for accuracy (stage 1).
Transcripts were divided into three batches. DL and a trained research
assistant (KS) analyzed one batch at a time. Separately, DL and KS coded for
the following overarching a priori themes related to digital health: perception
(perceived usefulness, perceived ease of use, awareness of digital health,
image of technology) and acceptance (accept, neutral, reject). Themes related
to perception and acceptance were identified a-priori adopting components of
TAM (Davis, Bagozzi, & Warshaw, 1989). The model hypothesizes that
perceived usefulness and perceived ease of use jointly determine acceptance,
which can influence intention to use and actual behavioral use of technology
(Davis, Bagozzi, & Warshaw, 1989).
Before coding individually, KS and DL read through an entire batch of
transcripts and developed a list of initial impressions and themes and then
coded a priori (stage 2). Both DL and KS coded one transcript from the batch
independently and in duplicate (stage 3). The two researchers compared and
reconciled coding, and there was a strong agreement between authors on the
transcripts reviewed. During this discussion the two researchers developed a
working analytical framework and agreed upon which codes to use on the
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remaining transcripts (stage 4). The transcripts were uploaded to NVivo12
(QSR International Pty Ltd, AU) and coded separately by DL and KS. An intercoder reliability was calculated and found acceptable (Bazeley and Jackson,
2013; Saladaña, 2016), with an agreement >80% achieved for each
overarching theme. DL and KS met to discuss coding differences and came to
consensus. The research committee and DL met to collapse and finalize
themes (stage 5). Data was then charted into framework matrices using
NVivo12 to display codes within each theme (stage 6). The number of phrases
coded within themes were summed to calculate frequencies and percentages.
Data was interpreted, and connections related to digital competence and
technological preferences of PwPD and their caregivers were made (stage 7).
Although a priori themes helped to inform this framework, a phenomenological
and iterative approach throughout each stage of the analyses was also taken
to identify emerging themes that may impact technology use among this
population. Both DL and KS contributed to the framework development with
the advisement of the dissertation committee.
Quantitative Data Collection and Analysis
Both PwPD and caregivers completed demographics, medical history,
dietary screening tool (Bailey et al., 2007), and digital competence (Measuring
Digital Health Skills across the EU: EU Wide Indicators of Digital Competence,
”European Commission, 2014) and technology use survey (“2015 Health
Information National Trends Survey”, Kontos, Blake, Chou, & Prestin, 2014;
National Cancer Institute, 2015; Nelson et al., 2004). The specific questions
used in each questionnaire are provided in Appendices P and Q.
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Questionnaires examining technology use and digital health use, combined
with qualitative data, informed dyads’ acceptance of digital health. Questions
related to where participants accessed health information and ease of
obtaining health information was integrated with qualitative perception data.
To further describe the population, PwPD completed the 39-item
Parkinson’s Disease Questionnaire was administered (PDQ-39, Jenkinson,
Fitzpatrick, Peto, Greenhall, & Hyman, 1997) to asses health-related quality of
life, and caregivers completed the Multidimensional Caregiver Strain Index
(MCSI) to assess caregiver burden (Stull, 1996). Height and weight were
collected, and body mass index was calculated.
Quantitative data was analyzed using SPSSv26 (IBM Corp. Summers,
NY). All data were normally distributed. Categorical variables are represented
as frequencies and percentages, and continuous variables are reported as
mean and standard deviations. Independent sample t-tests examined
differences between PwPD and caregivers for continuous variables. A chisquare analysis explored differences for categorical variables. A p-value <0.05
indicates statistical significance.
Data Integration
Acceptance of digital health was analyzed by assessing current
technology use and purpose, as well as digital health usage from
questionnaires and through themes coded from qualitative interviews.
Phrases/sentences related to acceptance were categorized as Accept,
Neutral, or Reject. To calculate acceptance rate among qualitative interviews,
the number of phrases coded as Accept, Neutral, or Reject were counted and
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totaled. The total number of phrases coded as Accept were divided by the
total number of phrases coded across the three acceptance categories to
calculate acceptance rates among each dyad. The percentages were
averaged to calculate an Average Dyadic Acceptance Rate (n=20). Codes
from the qualitative interviews were transformed into variables and reported as
percent and frequencies. Side-by-side table displays of frequencies derived
from perceptions and acceptance (qualitative data) and digital competence
scores (quantitative data) were created and interpreted to better describe the
population and readiness for a digital health intervention. A Pearson
correlation was used to explore if there was an association between the
percentage of phrases coded as Hard to Use and the Average Dyadic
Acceptance Rate.
Results
Participant demographics are highlighted in Table 1. All participants
identified as Caucasian and one PwPD identified as Hispanic. The majority of
caregivers (85%) were spouses/partners, while two caregivers were children
of PwPD and one was a friend; 80% of dyads lived together.
Acceptance of Digital Health
All dyads had access to a laptop or desktop computer and internet
connection at home. The majority of participants (n=17 PD and 19 CG) owned
a smart phone and 60% (n=11 PD and 13 caregivers) owned a tablet. Five
dyads reported owning an Alexa. One home owned an Amazon Firestick,
another had a smart TV, and another reported using a DVR to record shows
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regularly. Most participants (65%) did not own a smart watch (Apple Watch or
FitBit), while 17.5% reported owning a smart watch but stopped using it and
the remaining 17.5% were currently using a smart watch.
The reasons dyads used technology and the internet are provided in
Tables 2a and 2b. Twenty-five (62.5%) participants used the internet for at
least five or more health related purposes such as looking for health
information for themselves or someone else, looking for information to manage
PD, and discussing health concerns with friends/family. Five participants
reported not using any technology or do not use the internet for health-related
purposes.
There were 466 phrases/sentences coded from the interviews related to
Acceptance of digital health and 52.1% of the phrases were coded as Accept.
While 23.4% of phrases were coded as Neutral and 24.5% of phrases were
coded as Reject. Phrases coded as Accept described the following: the
various ways participants used technology in their everyday lives, how they
used the internet to find information for managing PD, and/or participants’
interest in trying a form of digital health to manage health. The majority of
participants reported going to the internet first to look up heath-related
questions, especially for managing PD issues. Participants reported using
digital health technologies such as patient portals, automated blood pressure
cuffs, glucose meters, webinars, and apps to manage diet (e.g. Lose It and the
Weight Watchers App) and track steps. Several participants reported setting
alarms on their phone as reminders to take their medications
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PD02: “We’ve done the Weight Watchers app, which is very
helpful...you can scan a product's label and it tells you how many points
per serving”
Those participants who had a high acceptance of technology reported
how their enjoyment for using technology contributed to their desire to try
digital health for managing nutrition and/or PD. For instance, when asked
about what digital health products they would be interested in for managing
food and eating, PD06 stated, “I am the type, if it is digital, I try it.” When
asked what makes technology and digital health useful, CG05 explained,
“I enjoy using it, if you enjoy something you will use it, you can get all
that information from so many resources there, I like apps”
Phrases and responses to questions were coded as Neutral when
dyads expressed moderate interest for using digital health or specific digital
health mediums. For instance, when asked if they would like to try a certain
digital health medium and why, some participants were only interested in
trying the product if it would benefit their provider. Other participants were
interested in trying some products, such as dietary applications and wearable
devices, but predicted they would likely lose interest in these mediums over
time. For example, when asked if interested in using a Bite Counter, a watch
that tracks motion to count bites and estimate calories consumed, PD05
stated:
“If you could tell me that the results would be useful to you, then I
would do it as a personal favor since you drove all the way down here!”
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When another dyad was asked if they would be interested in taking pictures of
meals and snacks for a nutrition professional to review, a caregiver
responded:
CG17: “If nutrition was an issue there might be a reason to do it… if the
doctor recommended it.”
Other participants said they felt they did not need certain digital health
mediums at the moment but may want to take advantage of them in the future
as PD progressed. For example, when asked if interested in using a wearable
device to monitor gait changes, PD08 stated:
“I’m not at the place where I need that yet, I’d imagine down the road,
maybe.”
Finally, some participants discontinued their use of digital health
mediums, such as wearable devices and dietary tracking apps. One
participant stopped using FitBit (a wearable technology device that measures
personal health data) due to physical limitations unrelated to PD, which
decreased their ability to walk and no longer had many steps to track. This
participant reflected,
PD14: “Well when I first got my FitBit and I was kicking out 10,000 a
day, and I kept getting all these messages about how good [I’m]
doing…”
Another participant stopped using his FitBit because it did not have enough
technological features.
PD12: “I just stopped using [FitBit] after a while …it didn’t have enough
features, but I mean I did like that it kept track of how often I went up
and down the stairs…”
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Phrases that were coded as Reject were typically due to certain digital
health mediums or devices. However, some phrases coded were related to a
rejection or skepticism of technology in general. For example, when asked if
they were interested in using MyFitnessPal, an app to track dietary intake, one
dyad stated:
PD09: “I don’t think I’m at the risk of eating too much or eating the
wrong things.”
CG09: “I’m just not interested in knowing that much detail”
When asked how they would like to receive health information, several
participants reported preferring hardcopies of literature rather than information
provided digitally.
PD07: “I like reading the information, so rather than email or electronic
form, I like to see a paper with the information on it. That way I can
reference it any time I want.”
Perceptions of Digital Health
There were 189 phrases/sentences coded across the 20 dyadic
interviews related to perceptions of digital health. Phrases related to
perceptions were categorized as Perceived Usefulness, Perceived Ease of
Use, and Awareness of Digital Health. Frequencies of phrases/sentences
coded are summarized in Table 3.
Perceived Usefulness. When examining dyadic data related to
perceived usefulness, 50% of dyadic interviews mentioned digital health or
technology as Useful. Many of these participants noted that technological
advancement could help them not only manage PD but maintain their
independence.
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PD06: “I think I will be able to stay driving until the day I die because of
autonomous cars. I have no problem with it. I think we are very lucky for
the age we are that it is happening now.”
Other participants reported finding certain digital health technologies useful
specifically for managing diet. For instance, when debating the usefulness of
MyFitnessPal with her spouse, a caregiver stated:
CG04: “We need to be more cognizant of the caloric intake because it
affects how much you weigh, and if you lost 15 pounds, your core
would be much more manageable.”
Many participants, 50% (n=10PwPD, n=10caregivers) felt that it would be
helpful to work with a nutrition professional to manage eating for PD.
PD16: “Well I think it's always good to have access to [a dietitian] that you can
ask questions to, but I don’t know how much they would be able to do for
Parkinson’s.”
Phrases were coded as Neutral for Perceived Usefulness when participants
reported mixed feelings about the benefits of technology or if they were unsure
if nutrition services could benefit PD. Supporting quotes from caregivers and
PwPD are summarized below.
CG17: “To me a computer is a tool… and I’m not going to sit in front of
a screen, when I have other things to do.’’
PD10: I just type it in and whatever comes up I skim through, and some
of it seems valuable and reliable, and some of it seems like a marketing
scheme”
Phrases that were coded as Useless when participants reported seeing little
value or benefit from using technology. These participants may have also
found nutrition interventions to be useless. For example:
PD04: “Some of [technology] is very useful but the majority of it is junk.”
CG20: “The information that came from [FitBit] was useless”
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In addition to questions around technology, during interviews dyads were
also asked to rate how important they felt it was to follow an eating plan for
PD. Forty-five percent of dyads agreed that it was important (n=10PwPD,
n=8caregivers) to follow a healthy eating plan to manage PD, while 35%
(n=6PwPD, n=8caregivers) reported: they were unsure, were neutral, or felt
the question was not-applicable because they had not thought about the
importance of healthy eating for PD.
Perceived Ease of Use. When examining Perceived Ease of Use among
participants, 70% of interviews contained phrases that were coded as Easy to
Use, while 95% of interviews had phrases coded as Hard to Use. For those
phrases/sentences coded as Easy to Use, participants often stated how
technology helps them easily access health information. When asked if there
was anything that prevents them from learning how to use a technological
device or the internet, CG20 responded, “No, it makes life easier.”
Participants described certain mediums as easier to use than others to access
nutrition and health information. For instance, many found email and
videoconferencing as an easy medium to receive nutrition information, and
several felt that taking pictures of their meals to be reviewed by a dietitian
would take little effortful and would be helpful.
CG13: “I can certainly check an email easily. That’s probably the
simplest, easiest way to get information”
PD11: “I think it's easier to make an appointment, you have more
flexibility through a skype session.”
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Phrases/sentences were coded as Neutral Ease of Use when participants
perceived digital health and technologies as neither difficult nor hard to use.
Phases/sentences were also coded as Neutral Ease of Use when participants
that were actively using technological devices but reported some annoyances
or inconvenience when using the device. However, if these inconveniences did
not deter participants from using the device or technological medium, the
related phrase or sentence was also coded as Neutral Ease of Use. For
instance, one participant summarized her experience with ordering her mealdelivery subscription online:
PD19: “[Sun Basket’s] a little bit time consuming, when [on the website],
I feel I need time to go through it all, but I do it and it’s fine”
Phrases/sentences related to accessing nutrition and health information were
also often coded as Neutral Ease of Use. Many participants either had not
thought to look for nutrition information specifically for PD or felt that finding
nutrition information was easy, but interpreting this information was a
challenge. For instance, when asked how easy or difficult is it to find
information related to healthy eating, 55% (n=11PwPD, 11CG), said it was
difficult or somewhat difficult. While 17.5% of participants responded neutral or
felt the question was not applicable, with the rationale that they did not know
nutrition was important or had not been looking for nutrition information prior to
this study.
CG01:”[It’s] easy to find, difficult to follow.”
CG13: “I would say we haven’t really looked for it yet.”
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Phrases/sentences were coded as Hard to Use when participants expressed
difficulty with using technology. Most phrases coded as Hard to Use were
stated by the PwPD.
PD09: “It’s [technology] become more complex I think, that bothers me
too. I want it to be simpler like it used to be. it’s just become more
complex and I just don’t l know how to do things now.”
PD11: “… the cognitive limitations and challenges that come with
Parkinson’s, you know you can’t always read something and
immediately translate it into what it is you’re supposed to be doing… so
sometimes that’s frustrating because if you don’t understand it you
aren’t going to use it.”
Some participants specifically stated understanding nutrition information could
be a challenge and may impact their experience utilizing digital health to
manage nutrition,
CG12: “…I feel that nutrition is a particularly difficult topic because
[there’s] so much conflicting information out there.”
Awareness of Digital Health. Phases/sentences related to the theme
Awareness of Digital Health were coded as Aware, Somewhat Aware and Not
Aware. Phrases/sentences that showed dyads understood what digital health
was, were coded as Aware. For instance, CG07 defined digital health as,
“I guess it would be … a broad term for categories that would have to
do with your health and using technology to manage, look up
information, to maintain your health, monitor your health.”
Phrases/sentences that revealed a limited understanding of digital health or
provided an incomplete definition of digital health were coded as Neutral. For
instance, PD04, defined digital health as, “I have no idea other than going
online and getting some information, but I don’t see that as being a useful
tool.” Phrases/sentences indicating participants did know what digital health
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was were coded as Not Aware. For example, PD12 stated the term digital
health “means not being married to your device continuously all day long.”
Digital Competence.
There was no difference in total digital competence scores among
PwPD and caregivers, the mean score translates to about a 63.6%
competence level (Table 1). Responses to individual questions form the digital
competence questionnaire are summarized in Table 4; the majority of
participants (>80%) felt comfortable finding information, reading or
downloading news, and seeking health information. All caregivers and all but
two PwPD felt comfortable sending emails. Most participants also felt
comfortable buying goods online and internet banking. Participants may need
some assistance with using social media and uploading self-created content.
About half of the participants may need assistance with completing a videocall.
Data Integration
The Average Dyadic Acceptance Rate calculated from dyadic
interviews was 54.4%. A side-by-side display of individual digital competence
scores among PwPD and caregivers, the mean acceptance rate, and percent
of phrases coded as Hard to Use were compared (Table 5). Overall, it appears
that dyads with higher digital competence scores had higher acceptance rates
for technology. However, these acceptance rates could be influenced by the
fact that in several dyads, one person was much more comfortable using
technology than the other. For instance, within Dyad 01, the PwPD had a
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much higher digital competence score compared to their caregiver (62.2% v.
17.8%), which may help explain an acceptance rate of 58% and 50% of
phrases being coded as Hard to Use. Whereas within Dyad 05, both PwPD
and the caregiver had high digital competence scores (91.1% and 97.8%
respectively), and an acceptance rate of 80%. During this interview, 50% of
phrases coded as hard to use. There was a negative, significant association
between the number of phrases coded as Hard to Use and the Average
Dyadic Acceptance Rate (r=-0.522, p=0.018).
Discussion
This is the first study to analyze the perceptions and acceptance of
digital health and digital competence among PwPD and their informal
caregivers. It is also the first study aimed to obtain this data to help design a
digital nutrition service for dyads. Findings from our study show, the majority of
PwPD and their caregivers are currently using technology and have access to
technological devices that can be equipped with digital health apps to facilitate
delivery of nutrition services. Dyads find technology and digital health
mediums useful, but hard to use. Digital competence scores and responses to
individual questions provide insight to aspects of technology where PwPD and
caregivers may need education and support. Digital health may be a viable
medium to increase access to nutrition information related to managing PD,
but the added benefits of these services must be clearly communicated to
participants.
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Acceptance. An average dyadic acceptance rate of 54.4% calculated
from qualitative phrases coded reveals dyads were interested in specific
aspects of technology for assisting with managing PD and nutrition, but also
disinterested in technological mediums where they did not see the added
benefit. For instance, many dyads were not interested in tracking food or steps
or using wearable devices, as they were not interested in knowing that much
detail about their health. However, many dyads expressed interest in
videoconferencing with a dietitian, receiving nutrition email updates or taking
photos of their food to be reviewed by a dietitian. Participants were using
technology to email, search the internet, pay bills, and shop online. Over 55%
of dyads used social media and participated in videoconference and watched
videos, indicating these tools may be viable mediums to bring nutrition into the
home. These findings show that a convenient, user-friendly digital health
intervention that provides tailored nutrition information could be a way to
improve access to care for this population.
Findings from our study build upon previous research examining the
acceptance of technology and digital health among PwPD and their
caregivers. Past research has found PwPD and caregivers are interested in
using digital health for managing PD (Dorsey et al, 2016; Schulz et al, 2016).
A recruitment webpage for a US-based randomized control trial utilizing virtual
house calls for PwPD received 11,000 individual views worldwide (Dorsey et
al, 2016). Ozanne et al (2017) found that PwPD saw the potential for wearable
devices to improve treatment and felt this benefit outweighed the

81

inconvenience of having to wear a sensor. A study completed by Duroseau
and colleagues (2016) examined acceptance among PwPD for using multiple
electronic mediums to receive instructions and communicate with healthcare
providers and found that older PwPD had a less favorable view of using
technology to learn about their care plan and communicate with healthcare
providers. Our studies expand upon previous research by specifically
examining the acceptance of these technological mediums to receive nutrition
information and interact with nutrition experts and includes the opinion of
caregivers.
Perceptions. Findings from qualitative analyses reveal that dyads
perceive technology and digital health to be useful, but hard to use. Interviews
revealed many of our participants, were also not aware of what the term digital
health meant. These perceptions expand upon previous research examining
views of PwPD around digital health. In a study completed by Duroseau et al
(2016), nearly 65% of PwPD reported they were willing to use electronic
methods and 48% believed using technology to communicate with providers
would help to better understand their care (Duroseau et al, 2016). When
stratifying participants by age, those 65 and over were less likely to believe
using technology to communicate with a healthcare provider would enhance
their understanding of care; this is attributed to the fact that older patients may
not be as comfortable with using technology (Duroseau et al, 2016). This
research, as well as our current study, indicates optimal communication
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mediums among PwPD may vary based on patient demographics and that
training older PwPD to use technology may be warranted.
Digital Competence. Findings support the need for educational
training of digital health mediums among PwPD and their informal caregivers
before implementing a digital health intervention. The reported reasons dyads
were using technology matched their responses to the individual questions on
the digital competence questionnaire. For instance, most participants are
comfortable with corresponding via email, searching for health information and
services, and shopping online. However, installing new devices and using
social networks may be problematic for some participants. To help increase
competence and perceived ease of use, future research could look to models
such as Cyber Seniors®, an intergenerational program where college and high
school students help older adults learn about technology (Rusnack &
Cassady, 2014; Leedahl et al, 2018). Additionally, more information is needed
about PwPD’s and caregivers’ knowledge of nutrition for managing PD and
health literacy to ensure this population is accessing accurate and reliable
nutrition information.
Data Integration. There was a negative, significant association
between the number of phrases coded as Hard to Use and the Average
Dyadic Acceptance Rate. This relationship combined with the lack of
awareness of digital health among dyads and how nutrition can help manage
PD, may help explain why dyads rejected certain digital health mediums.
Finally, within dyads, digital competence scores varied, with one person within
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the patient-caregiver dyad having a higher digital competence score than the
other. This may account for the acceptance rate falling just above 50%. Future
research should consider exploring ways to increase the acceptance rate
among PwPD and caregivers, as well as educating dyads about how digital
health can help enhance disease management. Research should also explore
the facilitators and barriers for digital health adoption among dyads.
Strengths and Limitations. Our study design promotes patient- and
caregiver-centered care for managing PD and supports both as part of the
healthcare team. Additionally, the utilization of mixed-methods study design
provides an in-depth understanding of dyads’ perception, acceptance and
current level of digital competence. The use of semi-structured dyadic
interviews is a strength, as dyadic interviews promote interaction between
participants to help provide detailed information with regard to their experience
on the topic of interest (Morgan, Eliot, Lowe, & Gorman, 2016). As a result,
findings from this study can be incorporated in the TAM (Davis, Bagozzi, &
Warshaw, 1989) and the emerging middle range theories of transition (Meleis
et al, 2000).
While this study is novel it is not without limitations. The majority of
participants were educated, Caucasian and had access to technology.
Additionally, our participants were all from the northeast region of the United
States. As a result, findings may not be generalizable to PwPD in other
regions of the country or from marginalized populations. Additionally, since
cognitive status was an inclusion criterion to enroll in our study, many of our
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participants did not fully rely on caregivers and were able to perform many
day-to-day activities on their own. However, including caregivers early at
disease diagnosis and encouraging caregivers to partner with healthcare
providers can help reduce stress and family conflict (Roth, Fredman, & Haley,
2015). Another limitation of this study is that the digital competence survey is
not a validated tool, however items were adopted from the European Union
Wide Indicators of Digital Competence, which is seen in the literature to create
a digital competence framework (Görgényi Hegyes, Csapó, & Fekete Farkas,
2017). Future research should explore validating this instrument among both
the general population and the PD community. Additionally, similar survey
questions around technology acceptance have been used to survey PwPD in
previous research (Duroseau et al, 2016). A final study limitation is that
disease stage was only obtained from some of the PwPD. Requests were sent
to physician offices for personal health information, but we were not able to
obtain this information for all 20 PwPD.
Implications. Results from this study can be used to help design and
implement an acceptable digital health service to assist PwPD and caregivers
manage nutrition. For this service to be accepted among dyads the benefits of
utilizing technology and healthy eating must be clearly communicated to endusers. Training of the digital health service must be provided prior to
implementing an intervention. Experts suggest when designing digital health
interventions specifically for PwPD, developers should consider both PwPD
and caregiver views, needs and preferences (Espay et al., 2019). Our findings
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support recommendations presented by Duroseau and colleagues (2016), who
suggest services be tailored to meet the technological preferences of PwPD
and exploration of these preferences through qualitative research. These
remote services can help increase access to nutrition information among
PwPD and caregivers and have the potential to improve health-related quality
of life, disease and caregiver burden.
Conclusion. This mixed-methods study focused on describing the
acceptance and perceptions of digital health to manage nutrition for PwPD and
their caregivers, as well as describe their level of digital competence. Results
indicate mixed acceptance rates for technology and digital health mediums
among dyads, possibly due to many participants perceiving digital health as
useful, but hard to use. Digital competence scores suggest dyads participating
in a digital health nutrition intervention will need some training prior to study
participation. Findings from this study complement existing literature regarding
digital health for managing PD and helps to better understand the opportunity
to use digital health as an avenue to include nutrition and caregivers in the PD
care plan. Future studies should explore digital health and technology as tools
to provide evidenced-based nutrition and health knowledge to PwPD and
caregivers. Prior to launching a digital health service to manage nutrition,
dyads will need training and technical support.
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Chapter 3 Tables and Figures

Table 1: Participant Demographics
Descriptive Variables

PwPD (n=20)

Caregivers (n=20)

Range

Age (years)

69.7±9.2

66.4±13.0

39-89

Gender n(%)
Male
Female

13 (65)
7 (35)

4 (20)
16 (80)

NA

Education n(%)
● HS Diploma/Some College
● Technical Training/Trade
School/Associates
● > College Degree or Greater

6 (30)
3 (15)

1 (5)
5 (25)

11 (55)

14 (70)

Employment Status n(%)
● Retired
● Part Time
● Full Time

15 (75)
3 (15)
2 (10)

10 (50)
2 (10)
8 (40)

NA

T-MoCA

19.8±1.5

20.4±1.1

18-22

Years Since Diagnosis

7.6±5.4

NA

0.33-18.0

Disease Burden (PDQ-39)

21.7±3.5

NA

3.12-50.01

Caregiver Burden (MCSI) †

NA

12.6±8.2

0-26

BMI (kg/m2)

27.09±5.4

28.3±5.7

15.4-43.1

DST Scores

56.95±9.3

59.5±10.7

37-81

10 (50)
10 (50)
0 (0)

11 (55)
8 (40)
1 (5)

NA

27.5±12.8

29.7±12.6

0-45

Nutrition Risk n(%)
● At Risk
● Possible Risk
● Not At Risk
Digital Competence

NA

Data reported as n(%) for categorical variables and mean±sd for continuous variables; †n=19;
Abbreviations: HS=high school, T-MoCA=Telephone Montreal Cognitive Assessment, BMI=body mass
index, DST=dietary screening tool.
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Table 2a: Distribution of Technological Purposes Among PwPD and
Caregivers Reported in Frequencies and Percentages
Variables n(%)
Email
Social Media
Videos (Youtube)
Video Conference
Search Internet
E-banking/paying bills
E-Shopping

PwPD
(n=20)
18 (90)
10 (50)
13 (65)
11 (55)
17 (85)
14 (70)
15 (75)

Caregivers
(n=20)
20 (100)
12 (60)
14 (70)
8 (40)
17 (85)
17 (85)
16 (80)

Table 2b: Description of Internet Use for managing Health Among PwPD and
Caregivers Reported in Frequencies and Percentages
PwPD
(n=20)

Caregivers
(n=20)

phi

Look for health or medical information for
yourself

15 (75)

18 (90)

0.197

Looked for health or medical information for
someone else

11 (55)

17 (85)

0.327

Looked for information about managing
Parkinson’s disease

13 (65)

14 (70)

0.053

Participated in online forums or support
groups for people with similar health or
medical issue

1 (5)

4 (20)

0.227

Used a website to help you with your diet,
weight or physical activity

7 (35)

8 (40)

0.052

Looked for a healthcare provider

7 (35)

5 (25)

-0.109

Downloaded health information to a mobile
device, such as an MP3 player, cell phone,
tablet computer, or electronic book device

8 (40)

4 (20)

-0.218

Shared health information on social media
sites (Facebook, Twitter)

1 (5)

2 (10)

0.095

Exchanged support about health concerns
with family and friends

12 (60)

12 (60)

0.00

Kept track of personal health information
such as care received, test results, or
upcoming medical appointments

11 (55)

12 (60)

0.051

Watched a health-related video on YouTube

10 (50)

6 (30)

-0.204

Variables n(%)

Values are reported as n(%). Chi Square Completed (looked for health info for someone else
phi=0.327, p=0.008) Effect size reported as phi (0.1 = small; 0.30=medium; 0.5=large).
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Table 3: Themes for Acceptance and Perception of Digital Health
Summarized by Number of Phrases Coded, Percent of Comments, and
Number of Dyads Mentioning Acceptance or Perception within Each Category

Acceptance
Accept
Neutral
Reject
Perceived Usefulness
Useful
Neutral
Useless
Perceived Ease of Use
Easy to Use
Neutral Ease of Use
Hard to Use
Awareness of Digital Health
Aware
Neutral Awareness
Not Aware

Number of
Phrases
Coded

Percent of
Comments

466
243
109
114
29
22
4
3
104
22
12
70
56
11
17
28

54.4%
23.4%
24.5%
75.9%
13.8%
10.3%
21.2%
11.5%
67.3%
19.6%
30.4%
50%
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Number of Dyads
Mentioning
Code/Theme Within
Each Category
20
20
20
19
11
10
4
3
20
14
10
19
20
8
13
16

Table 4: Those Participants Who Responded Slightly or Strongly Agree to
Individual Digital Competence Questions Among PwPD and Caregivers
Reported by Frequency (Percentage)
Digital Competence Question n(%)

PwPD
(n=20)

Caregivers
(n=20)

Phi

Searching and finding information about goods and
services

18(90)

18(90)

0.0

Reading or downloading news/newspapers/news
magazines

16(80)

17(85)

0.07

Using copy/paste tools

13(65)

13(65)

0.0

Seeking health information

17(85)

17(85)

0.0

Sending/receiving emails

18(90)

20(100)

0.23

Using videocalls, such as skype

11(55)

10(50)

-0.05

Participating in social networks

11(55)

12(60)

0.05

Posting messages on social networks

9(45)

12(60)

0.15

Uploading self-created content to any website to be
shared

7(35)

7(35)

0.0

Sharing talents and ideas with on social networks

6(30)

9(45)

0.16

Sharing interests and ideas with those you know

13(65)

16(80)

0.17

Connecting and installing new devices

12(60)

12(60)

0.0

Internet banking

13(65)

14(70)

0.05

Buying or ordering goods or services for private use
(last 12 months) over the internet

16(80)

15(75)

-0.06

Making an appointment with a practitioner via a website

12(60)

14(70)

0.105

Chi Square Analyses Completed to compare between group differences; phi co-efficient used
to report effect-size: small=0.01, medium=0.30, larger=0.50
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Table 5: Data Integration: Side by Side Display of Digital Competence Scores
(total scores(%)), Acceptance Rates Calculated From Semi-Structured
Interviews
Dyads
Dyad 1
Dyad 2
Dyad 3
Dyad 4
Dyad 5
Dyad 6
Dyad 7
Dyad 8
Dyad 9
Dyad 10
Dyad 11
Dyad 12
Dyad 13
Dyad 14
Dyad 15
Dyad 16
Dyad 17
Dyad 18
Dyad 19
Dyad 20

PwPD Digital
Competence

Caregiver Digital
Competence

Acceptance Rate
(%)

28 (62.2)
33 (73.3)
34 (75.6)
18 (40)
41 (91.1)
41 (91.1)
31 (68.9)
4 (8.9)
25 (55.6)
39 (86.7)
40 (88.9)
45 (100)
16 (35.6)
32 (71.1)
21 (46.7)
23 (51.1)
16 (35.6)
0 (0)
19 (42.2)
44 (97.8)

8 (17.8)
26 (57.8)
25 (55.6)
31 (68.9)
44 (97.8)
33 (73.3)
45 (100)
25 (55.6)
4 (8.9)
40 (88.9)
39 (86.7)
41(91.1)
29 (64.4)
7 (15.6)
31 (68.9)
35 (77.8)
14 (31.1)
42 (93.3)
39 (86.7)
36 (80)

58.3
90.0
80
31.6
80.0
78.9
50.0
31.8
31.8
69.4
69.4
51.7
25.0
48.1
39.3
48.4
31.8
44.8
57.1
69.2

Hard to Use
(% phrases
coded)
50.0
25.0
0.0
60.0
50.0
25.0
50.0
100
100
87.5
87.5
55.6
50.0
75.0
80.0
50.0
75.0
83.3
100
66.7

Digital Competence scores are reported for both PwPD and Caregivers and are reported as total
score(percentage). Acceptance Rate reported which was calculated by dividing phrases coded as
Accept by total number of phrases coded related to Accept, Neutral and Reject for each interview.
Percent of phrases coded as hard to use in each interview were calculated by dividing phrases coded as
hard to use by total phrases coded related to Ease of Use.
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APPENDIX A: Review of the Literature
I.

What is Parkinson’s Disease

Parkinson’s disease (PD) is an incurable, progressive
neurodegenerative movement disorder that traditionally occurs in the second
half of life.1 Over 900,000 Americans live with PD, approximately 60,000 new
cases are diagnosed each year2,3, and the national economic burden of PD
exceeds $14.4 billion.4 The life expectancy from PD onset of diagnosis to
death is approximately 15 years.5,6 The number of people with PD (PwPD)
living in the US is expected to double by 2030 due to the growing number of
people over 65 and an increase in life expectancy for PwPD. As a result,
researchers and clinicians have recently started investigating symptoms and
clinical features of PwPD 20 years out.7
The exact etiology of PD remains unknown but it is hypothesized to
arise from an interaction between environmental and genetic factors resulting
in degeneration of neurons.8 Parkinson’s disease results when there is a
disruption of dopaminergic neurotransmission within the basal ganglia of the
brain.9 Dopamine are neurotransmitters that control motor function and
movement control, as well as reward-motivated beahavior.9 As a result of PD,
dopaminergic neurons in the substantia nigra are decreased. Within the
residual dopaminergic neurons, Lewy bodies (deposits of alpha-synuclein)
present.9 The basal ganglia, located in the forebrain, controls voluntary
movement, procedural and habitual learning, eye movement, cognition and
emotion.10 The substantia nigra, part of the basal ganglia circuitry, located in
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the mid-brain, plays a role in movement and reward.10 As PD progresses,
problems extend beyond motor deficits and can impact nutrition, weight
management, cognitive and physical functioning.
The diagnosis and therefore the prevalence and incidence of PD varies
by age, geographic location, race, and gender.11 Prevalence of PD increases
with age, with the age of onset around 60 years old,8 and impacting 2.6% of
Americans who are 85-89 years of age.8 Parkinson’s disease infrequently
occurs under the age of 40 years old and early onset increases the probability
genetics may play role.12 Rates of PD are highest in the Midwest and
Northeast regions of the United States (US), with rates being up to 10 times
higher than rates in the Western and Southern regions of the US.11 There is a
higher occurrence of PD among males, with a male to female ratio of 3:2.12,13
Whether or not PD is more prevalent among whites versus non-whites needs
further exploration.11 Research regarding the prevalence of PD across race
and ethnicity is consistent and inconclusive.11,14
Parkinson’s disease can be characterized as idiopathic PD (primary
parkinsonism) or non-idiopathic PD (secondary or atypical parkinsonism).9 It is
estimated that up to 85% are diagnosed with idiopathic PD15 and respond well
to dopaminergic medications. Those with non-idiopathic PD do not respond
well to dopaminergic medications.9 Idiopathic PD can be characterized into
two main subtypes: tremor dominant (TD) and postural instability gait difficulty
(PIGD).16
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Currently there is no cure for PD. Levodopa, a medication that
produces dopamine in the central nervous system, is the most common
medication used to control motor sequelae.17,18 Levodopa is cost-effective14
and considered the most efficacious treatment because it improves motor
function, quality of life (QOL), and reduces morbidity and mortality.15 An “on’’
state is when motor symptoms subside when levodopa is taken, and an “off
state” is where levodopa wears off before the next dose and PD motor
symptoms are present. Off periods can result in functional disability and can
be characterized by stiffness, slowness, tremor, as well as cognitive and mood
changes.19 The negatives of levodopa treatment are: 1) causes motorsymptoms which impact HRQOL and ability to perform activities of daily living
(ADLs); and 2) over-time, patients build up a tolerance to levodopa and may
require higher levodopa doses and eventually the medication loses
effectiveness.20
About 6.5 million informal caregivers provide substantial help for
medical and dietary management for older adults living with disability.21
Informal caregivers are any unpaid family member or friend who provides the
majority of care.22 Almost 55% of caregivers for older adults assist with
medication management23, and caregivers of PwPD likely play an integral role
in managing food-drug interactions, given their role in managing dietary intake
for PwPD.24 With an increase in life expectancy for PwPD but no cure for PD,
the socioeconomic and personal burdens for PwPD and their informal
caregivers will also rise, which includes an exponential increase in excess
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medical spending.4,12,25 As the disease progresses, informal caregiver
responsibility increases and caregivers will be play a central role in utilizing
digital health to access care for their loved one with PD.26
In general, caregivers spend 24+ hours per week caring for their loved
one22, but caregivers of PwPD spend up to 40 hours per week performing
care-related duties.27 Compared to the general population, caregivers for
PwPD are more likely to have depression, anxiety, decreased health status28,
and/or poorer QOL29, which is partly attributed to observing the physical and
cognitive decline of their loved one with PD29. Caregiver stress and burden
can adversely affect caregiver’s psychosocial and physical functioning, which
may compromise the care provided and the health of the patient-caregiver
dyad.28,30. Specific to neurodegenerative diseases, caregivers are confronted
with evolving roles and responsibilities, and need to plan for the trajectory of
PD.31 Couple-oriented interventions improve spousal coping strategies,
minimize stress and anxiety, and increase self-efficacy to manage disease
progression.32
II.

Disease Progression
Parkinson’s disease-specific sequelae, conditions that result specifically

from PD, impact motor and non-motor function. Disease sequelae can present
20 years prior to diagnosis (Figure 1).33 Motor and non-motor sequelae can
vary depending on the stage of PD. The Hoehn & Yahr (H&Y) scale is a five
stage scale that examines PD severity based primarily on ratings of motor
sequelae.34 In stage 1 the patient exhibits unilateral symptoms, while in stage
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2 the patient presents with bilateral symptoms. Those with stage 3 PD
experience balance impairment but are still physically independent, while
those in stage 4 exhibit severe disability but able to stand or walk unassisted.
Stage 5 is the most advanced stage and the person needs a wheelchair or is
bedridden unless assisted.
Figure 1: “Clinical Symptoms and Time Course of Parkinson’s disease
Progression”33

The Unified Parkinson Disease Rating Scale (UPDRS) is a tool to
monitor disease trajectory and inform treatment plans for PwPD. The rating
scale assess motor and non-motor sequelae and consists of five sections: 1)
Mentation, Behavior, and Mood, 2) Activities of Daily Living (ADL), 3) Motor
Sections, 4) Modified Hoehn and Yahr Scale (H&Y), and 5) Schwab and
England ADL scale. Higher UPDRS scores indicate more severe disability
present, with the highest possible score being 199.35
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Older age at diagnosis and disease duration are independently
associated with a higher prevalence of motor and non-motor sequelae that can
result in disability.7 Due to its heterogenous and degenerative nature, research
proposes to view PD as a complex syndrome, rather than a disease.36 As a
result, a comprehensive clinical assessment including biomarkers to assess
motor and non-motor symptoms of PD is warranted to better treat and
attenuate PD progression.37 Tracking how disease sequelae impacts
nutritional status overtime is also essential to provide adequate nutrition
interventions.38
a. Motor Sequelae
Motor sequelae can be caused as a result of PD or emerge as a side
effect of PD medication.35 Levodopa-responsive motor sequelae include:
dyskinesia (involuntary movement) and motor fluctuations including unpredictable and sudden “off” stage, where levodopa medication suddenly
stops working throughout the day.35 Non-levodopa-responsive motor
symptoms include: tremors, hypomimia (poker face/lacking expression),
rigidity, bradykinesia (slowness of movement) and hypokinesia (decreased
movement), gait disturbances, freezing gait, balance issues, frequent falls, as
well as dysphagia (difficulty swallowing) and speech difficulty. Decline in gait
and balance as the disease progresses results in fall frequency.39,40 Since so
many symptoms do not respond to levodopa treatment, the most effective
form of medication for managing PD, an interdisciplinary care team is needed
to treat PwPD holistically to manage disease sequelae.41
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i. Physical Functioning
Motor sequelae progress overtime and can compromise physical
functioning.42,43 Resting tremor is usually the first and most visible symptom of
PD and it impacts one’s legs, jaw, tongue and/or hands. Up to 90% of PwPD
experience resting tremor, joint stiffness and/or muscle rigidity44. Resting
tremor rarely cause disability among individuals since relief or diminution
occurs during voluntary movement.44 Bradykinesia is one of the most
disabling characteristics of PD, impacting up to 90% of PwPD.45 Bradykinesia
is disabling as it cause freezing (i.e., sudden, short and transient inhibitions of
movements) during other movements, such as walking, driving, talking,
moving hands or writing.45 Freezing gait is one of the main risk factors for falls
among PwPD.46 Nearly 68% of PwPD fall at least once per year47, compared
to one third of community-dwelling adults over the age of 65.48,49 Bradykinesia
can progress into akinesia or the inability to initiate or continue movement.50
Akinesia can present as freezing gait (i.e., trouble initiating gait and or turning
while walking), speech problems, and incapacity to perform smooth and rapid
alternating finger movements.50
Change in balance and gait lead to disability among PwPD,
compromising ability to perform activities of daily living (ADLs), independence
and QOL. Balance and gait issues typically become more compromised as
the disease progresses but can also impact physical functioning in earlier
stages of disease. Parkinson’s disease gait is characterized by slower walking
speed, smaller steps, larger stride length variability, and less arm swing
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compared to healthy controls.51 Slowing of gait and worsening of motor
sequelae over a time and this is a concern among PwPD as it can reduce
functional independence, which in turn can decrease quality of life.52
Research has also analyzed how physical functioning and ambulatory
ability in PwPD changed overtime42,43. Cavanaugh et al42 conducted a 2-year,
prospective longitudinal study, assessing the ambulatory decline and evolving
components of disability among 17 PwPD and found the dose and intensity of
ambulatory activity significantly decreased. At the same time, the daily dose of
levodopa increased overtime.42 Findings from this study indicate natural
ambulatory activity may be a strong indicator of physical decline, especially in
early stages of disease51. Natural ambulatory activity is a subset of physical
activity behaviors that entail stepping (walking, climbing stairs, mowing the
lawn, jogging) and are used as a measurement strategy to assess physical
activity, posture and movement.53 Findings from this support the need for
ambulatory activity monitoring to be included in the PD plan. Research is
needed to examine how ambulatory activity changes beyond two years.
Another prospective, longitudinal study observed a significant decline in
motor function and self-reported physical activity levels from year two to four in
those living with early stage PD.43 Higher levels of physical activity among
PwPD were significantly associated with ability to perform ADLs, slower
progression of motor symptoms and cognitive decline.43 Physical disability and
inability to perform ADLs can also decrease access to healthcare services that
would better manage the disease.54
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Finally, States et al.55 examined change in physical functioning after
one, three and five years of attending an exercise program for PwPD. Fiftynine percent of participants completed one year of the exercise program, while
39% completed three years and 29% completed five years. Those participants
that were categorized as consistent exercisers (PwPD who completed at least
half of the exercise classes for at least one year) showed modest, but
significant improvements in hand-grip strength, balance scores, and a sixminute walk test.55 However, at years 3 and 5, no changes in these variables
occurred, indicating consistent exercise may help PwPD maintain their
functional status despite living with a neurodegenerative disease. Findings
from this study support the need for an interprofessional team to successfully
implement a supportive community-based exercise program to support
participation of PwPD overtime.
Decline in mobility or ambulatory ability as PD progresses can not only
increase risk for falls, but may also inhibit one’s ability to carry out general
(bathing, dressing, eating, toileting, getting in and out of bed, mobility both
inside and outside of the home56) and instrumental ADLs (laundry, preparing
meals, shopping, banking, managing money56).57 As a result, PwPD may need
assistance with buying, preparing, and consuming meals and snacks.
Additionally, research has found a relationship between physical activity level
and/or physical functioning with cognition and well-being measures such as
QOL and depression among PwPD.58,59 Such findings support the need for an
interdisciplinary treatment approach for managing PD to promote health-
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related QOL. However, more research is needed to understand how this
relationship changes over the course of PD. Limited information also exists
around the relationship between physical, cognitive, and swallowing functions,
and their multi-faceted relationship with nutritional status in PwPD and how
this interaction changes overtime.38
ii. Swallow Function
Similar to the decline in mobility, a decline in swallow function can
hinder the ability to swallow medication60, decrease one’s ability to consume
nutrient rich foods and compromise nutritional status.61 Dysphagia is a
condition where one experiences difficulty swallowing food and can occur
anywhere between the oral cavity to the stomach;62 including difficulty initiating
swallow and getting food stuck in the top or middle of the esophageus.62
Oropharyngeal dysphagia, difficulty or inability to chew and mix food with
saliva and move it to the back of the mouth with the tongue to the esophagus,
is the most common form of dysphagia among PwPD.63 Dysphagia among
PwPD can be caused by impaired cognitive processing, which can result in
difficulty initiating swallowing as a resulting of hypometabolism in the
supplementary motor area and dysfunction of the anterior cingulate cortex,
causing impaired cognitive processing.64 It is estimated that up to 90% of
PwPD will experience dysphagia throughout the course of their disease65,
while prevalence of dysphagia only impacts 2-16% of the general population.66
Symptoms of dysphagia include regurgitation, chest pain, aspiration,
persistent coughs, sore throat, loss of appetite, hoarseness, hiccups, painful
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swallowing, heartburn.62,67 Regular swallow screenings are warranted among
PwPD, rather than relying on self-reported concerns about swallowing among
PwPD.68
In a cross-sectional study, Miller and colleagues68 examined the
frequency of impaired swallowing via a 150mL timed swallow test, how
impaired swallowing relates to disease progression and frequency of selfreported swallowing issues among PwPD. 68 Results from this study found that
23% of participants could not completely drink the full 150mL glass of water
provided during the swallow evaluation and there was a moderate association
between swallow function performance and UPDRS II (ADLs) and III (motor
function) scores.68 Sixty-six percent of participants believed they did not have
a swallowing problem but performed below average on the timed-swallow
test.68
To help manage dysphagia and reduce risk of choking, swallow
maneuvers and exercises, postural adjustments, and modified textures (puree,
mechanical, soft foods) and fluid consistencies (thin liquid, nectar and spoonthick) can be prescribed.69 For PwPD prescribed a dysphagia diet, nutrition
guidance is needed to help meet adequate nutrition and hydration needs.70
Caregivers may also have a significant role in helping PwPD adhere to a
dysphagia diet, especially as the disease progresses and cognitive decline
emerges.71 The risk of developing dysphagia coupled with nutrition risk
present among PwPD warrants the need for ongoing nutrition and swallow
screening and collaboration between speech therapists and registered
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dietitians.41
Dysphagia can negatively impact dietary intake and increase nutrition
risk. One study found that the majority of patients with dysphagia patients do
not find mealtime enjoyable and 41% reported having anxiety or panic during
meals.67 Since dysphagia can disrupt mealtime, diet quality and nutrition risk is
a concern among PwpD. Specifically, the amount consumed, and quality of
the food consumed is compromised, which can impact body composition.
Consequently, patients with dysphagia present with smaller calf and arm
circumference, indicative of muscle wasting and under-nutrition.62 Difficulty
swallowing among PwPD has been well-studied67, but the exact interaction
between nutritional status and swallow functioning and how this changes
overtime among PwPD has not been examined.
Matushima et al.72 conducted a cross-sectional study to assess the
association between factors related to swallowing difficulty in 237 PwPD in
Japan. This study also wanted to better understand behavior patterns behind
the food types selected to cope with malnutrition and describe optimal
characteristics of caregivers helping to manage swallowing difficulties their
loved-one with PD is experiencing. Findings from this study indicate severity
of swallowing difficulties was associated with increased age and more
advanced disease. Only 11 participants reported using care foods for
managing dysphagia, which included home delivery meals adhering to
dysphagia diets or a la carte pre-prepared foods designed for those with
dysphagia. The 11 participants consuming care foods were significantly older
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and none of these participants presented with a lower BMI. Dietary
modifications to manage dysphagia, were more likely to occur when PwPD
lived with an informal caregivers, particularly children.72 Findings indicate care
foods may be effective in managing dysphagia and nutritional status but
research assessing a larger sample of PwPD overtime is warranted.72 The
issue of care foods and its impact on health-related quality of life (HRQOL)
among PwPD is also warranted, as PwPD experience non-motor sequelae,
such as depression and apathy.
b. Non-Motor Sequelae
Non-motor sequelae are being recognized as neglected aspects of PD,
and effect up to 88% of PwPD.73 Non-motor sequelae include: change in
mood (anxiety, depression, apathy), fatigue, pain, cognitive decline (dementia,
memory, concentration attention), psychosis (hallucinations or delusions),
excessive sweating, bladder urgency, dizziness, and/or orthostatic
hypotension.7,74 Many non-motor sequelae among PwPD can impact dietary
intake and nutritional status, and include: dysphagia, change in taste and
smell, gastrointestinal issues (gastroparesis, constipation, acid reflux).61,75
Dysphagia, while characterized as a motor symptom when assessing PD
severity via the UPDRS is considered a mixed motor and non-motor
symptom.74
A cross-sectional study examining presence of non-motor symptoms
among 89 PwPD self-reported a mean of 11 non-motor symptoms.76 Nonmotor sequelae tend to vary with fluctuations in motor sequelae associated
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with on/off states74, and are key causes of loss of independence and caregiver
strain.77 In a prospective study, Duncan and colleagues78 evaluated impact of
non-motor symptoms on HRQOL among newly diagnosed PwPD and found
depression, anxiety, poor concentration, memory issues, insomnia and
incomplete bowel emptying had the greatest impact on HRQOL.78
Subsequently, screening and managing these non-motor symptoms should be
prioritized early at diagnosis.78
i. Parkinson’s Disease, Mood, and Mental Health
Up to 50% of PwPD have anxiety, depression, and/or sleep
disturbances.79,80 Apathy, depressed mood, and anhedonia (inability to feel
pressure) are characteristics for clinical diagnosis of depression and are
related the low levels of norepinephrine (hormone), dopamine and serotonin
(neurotransmitters) among PwPD and associated with more severe motor
sequelae.81
Storch et al.74 examined the frequency and severity of nonmotor
fluctuations among 100 PwPD, as well as the association of nonmotor and
motor sequelae and found presence of fatigue, anxiety, depression, and pain
is associated with poorer HRQOL independent if non-motor symptoms were
present in the on or off state.74 Non-motor symptoms were more severe in the
off state than the on state.74 Fatigue was the most frequently reported nonmotor symptom, impacting 88% of PwPD.74 The second most common nonmotor symptom reported was issues with concentrations/attention, reported by
67% of PwPD, while dysphagia was least commonly reported (29%).74
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However, lack of energy may impact the ability to prepare and consume food,
while decline in concentration can impact the way nutrition education is
presented.
Medication to treat psychiatric conditions can also impact well-being and
physical functioning among PwPD. Benzodiazepines, prescribed to treat
anxiety, can impact cognition, alertness, and gait, and increase fall and
fracture risk.82 However, selective serotonin reuptake inhibitors and
norepinephrine reuptake inhibitors used to treat depressive symptoms among
PwPD can improve depressive symptoms and freezing of gait but have little
impact on feelings of apathy.83 Unfortunately, gastrointestinal events may be
more common in PwPD managing depressive symptoms with SSRIs (nausea,
diarrhea, abdominal stomach, vomiting) which can further impact dietary
intake and quality.83
In addition to non-motor sequelae, PwPD and their informal caregivers also
experience stigma as a result of living with a progressive disease, which can
further impact well-being. Maffoni et al.84 conducted a literature review of
qualitative studies examining stigma among PwPD and caregivers and found
stigmas included: disgrace, shame, embarrassment, feeling awkward, horrible,
terrible or dishonorable. Findings revealed that stigma presents as a complex,
multi-faceted construct that is linked not only with the physical decline PwPD
experience but also the undesirable self-image and loss of self-efficacy and
independence that emerges from the progressive disease84; many PwPD felt
shame because of physical dependence on caregivers to do even simple
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tasks.84 Stigma was also linked to relational and communication problems,
where many PwPD attribute voice and articulation sequelae a contributor to
stigma. It is important to recognize PwPD and their caregivers journey of living
with PD to recognize their inner psychological needs to optimize care
provided.84
ii.

Cognition, Mild Cognitive Impairment and Dementia in PD

Cognitive dysfunction can occur early in diagnosis85,86, and eventually up to
40% of PwPD present with dementia.79 Cognitive symptoms are strongly
associated with increased economic burden and nursing home placement, as
well as morbidity, disability, and compromised QOL for PwPD and their
informal caregivers, increasing caregiver burden.87-89 Common cognitive
issues that emerge among PwPD include impairments in executive function,
working memory and attention.90 Kudlicka et al86 examined executive function
impairment in those living with mild to moderate PD and found PwPD to more
frequently have issues with attention control assessments than those
assessing abstract thinking performance. Research indicates PwPD with mild
cognitive impairment (MCI) are more likely to have issues with performing
cognitive set-shifting tasks involved in decision making. 91 Among PwPD with
mild cognitive impairment there is an increased presence of disability and
physical impairment, which can impact QOL.25 Cognitive deficits among PwPD
are predictive of the development of dementia and as a result longitudinal
assessment and management of cognition in this population is warrant.90,92
Arie and colleagues92 conducted a five-year, prospective study of 57
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participants saw a significant decline in cognitive scores in both those with TD
and PIGD. However, findings from this study suggest, PIGD participants
exhibited a larger magnitude of cognitive decline, particularly in the area of
executive function and motor-cognitive skills. Despite these differences, this
study found no difference in HRQOL or disease burden between PIGD and
TD.92 However, future research needs to examine the longitudinal change of
nutritional status presents as changes in cognition occur.
In a mixed-methods study, Raein et al.88 interviewed dyads comprised of
PwPD and their informal caregivers to determine subjective cognitive
complaints. Findings from 22 dyads participating in focusing group identified
subjective cognitive complaints across the following domains: memory,
language and communication, attention and processing speed, executive
functioning and episodic confusion/fluctuations in thinking ability.88 Dyads
described subjective complaints that are not often objectively assessed when
measuring cognitive status, such as fluctuations in cognitive abilities, lapses in
prospective memory, and issues with recalling names, an issue distinct from
an issues with general word-finding. 88 Those PwPD without dementia
reported more subjective cognitive complaints compared to observed cognitive
complaints reported by their informal caregiver.88 The top treatment priority
among PwPD was related to language (recall, word finding, difficulty following
instructions), while for informal caregivers the top treatment priority for PwPD
were related to executive function (improving decision making abilities and a
reduced desire to start tasks). 88 Findings suggest practitioners should

114

consider the unique aspects of cognitive decline in PwPD by examining both
subjective and objective cognitive functions. Understanding cognitive deficits
and self-reported cognitive concerns can help better design, develop and
deliver effective nutrition education.
iii.

Sensory and Perception Changes

People with PD experience sensory changes and reduced insight, which
can impact decision making, cognition, physical functioning, swallowing ability
and food intake. Such changes include increased saliva production, drooling,
change in the ability to taste and smell, altered time and vision perceptions,
deficits in perception of loudness, failure to identity emotion and prosody, and
inability to change or shift sets quickly.93-96 More than 50% of PwPD report
issues with drooling97 and approximately a quarter of PwPD experience issues
with frequent drooling97; people with PD are five times more likely to
experience issues with drooling than healthy controls. Drooling frequency is
associated with disease severity.97 Speech language pathologists are critical
for the care team in helping PwPD manage drooling. Changes in tactical
function, thermal, nociceptive (perception or pain), and proprioceptive
(perception of self-movement and body position) sensations also occur among
PwPD.96
These sensory changes among PwD are either pure disorders of
conscious perception or disorders of sensorimotor integration (“the use of
sensory information to guide movement”).96 Disorders of conscious
perception can cause elevations in the sensory threshold, while disorders of
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sensorimotor integration occurs when there is an alteration in the interaction
between sensory input and motor output.96 Despite normal cognitive
functioning, PwPD have a decreased sensitivity to visual sensory and
cognitive stimuli, which implies alterations to the visual cortical and subcortical
areas, along with possible impacts on the retina.98 It is also speculated that
dopaminergic treatments worsen sensory impairments (e.g. postural
instability), by disrupting the primary somatosensory cortex, found in the
postcentral gyrus of the brain.99 As a result, how PwPD perceive situations,
their own health status and dietary intake, as well as process nutrition and
health education may be impacted. Multiple modalities and repetition to
educate PwPD may be warranted.100
Cognitive-linguistic changes can impact QOL and day-to-day functioning of
PwPD. While nearly 75% of PwPD experience a speech disorder at some
stage in the disease, PwPD have an impaired perception of their own speech
loudness as well as impaired perception of verbal emotions when interacting
with others.94 It is proposed that altered perception of own speech loudness is
due to the inconsistency between perceived level of effort and produced vocal
loudness.101 Meanwhile, inability to detect verbal emotion may be due to
compromised working memory, executive function, and acoustic
processing.94,102 As a result, on-going monitoring cognitive status among
PwPD is vital. This information is also important for health professionals
providing ancillary services and education to PwPD to design and implement
effective services.
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In addition to lack of insight about perceived loudness and interpretation of
emotional parody, PwPD also can have challenges with shifting tasks and
perception of time. 93,95 When examining the change in muscle responses
when provided a cue to complete two different tasks, PwPD needed to perform
the original task several additional times before switching to the new task. 95
Those PwPD taking levodopa did not see improvements in their ability to
change tasks quickly.95 Findings of this study should be taken into account
when designing nutrition education and assessment programs for PwPD.
Temporal information processing is another sensorimotor integration process
altered among PwPD and may explain some PD symptoms, such as poor time
perception.84 Research has found PwPD tend to underestimate time, and it is
proposed dopamine deficit may cause a delay in the body’s internal clock.
Distortion of time is a concern among PwPD as time perception is fundamental
for the relationship between humans and their environment. As a result, how
PwPD perceive their surroundings and experiences may be altered. How
alterations of perceptions among PwPD impact nutrition assessment, dietary
recalls and nutrition education has not been explored. Changes in perception
also warrant the inclusion of caregivers to provide insight on the diets of their
loved one living with PD.

III.

PD Management
a. Treatment Options for Managing PD
i. Pharmacologic Anti-Parkinson Treatment
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Dopamine Agonists. Dopamine agonists, while less effective and
potent than levodopa, are usually used as the initial medication for PD.9
Compared to levodopa, they are associated with a lower risk of motor
fluctuations and dyskinesia for the first five years of treatment.9,103 Dopamine
agonists bind to dopamine receptors to mimic the neurotransmitter
dopamine.104 However, overtime levodopa is usually used in conjunction with
dopamine agonists to control advancing symptoms.9 Those on dopamine
agonists are more likely to experience non-motor side effects compared to
those on levodopa (Figure 2).105 Nutritional side effects of dopamine agonists
include weight gain and compulsive behaviors, such as excessive spending
and eating, which can impact health-related QOL among PwPD.9,61

Figure 2: Incidence of adverse effects in Parkinson’s disease for trials of
Dopamine Agonists (with and without levodopa) versus Levodopa Alone105

Levodopa Containing Medications. Levodopa is the most effective
medication for treating PD motor sequelae, because it improves function, QOL
and reduces morbidity and mortality among PwPD.18 The medication is
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converted to dopamine in the brain and is administered to increase striatal
dopamine levels.18 It’s tolerability and efficacy was improved by combining
levodopa with dopa-decarboxylase inhibitor (carbidopa-levodopa).18 While
levodopa is the gold standard for managing PD motor sequelae, overtime
PwPD can build a tolerance to levodopa and the medication can become
ineffective. The response time where levodopa is effective and motor sequelae
is minimized is known as the “on” time. The “off” time is the period before the
next levodopa dose is consumed and motor sequelae are present. Figure 3
highlights the change in levodopa response over the progression of PD.18,106
Those with early stage PD seem to have a prolonged response to levodopa
containing medication with longer “on” times and shorter “off” periods. As the
disease progresses, the short half-life of levodopa and increase tolerance,
medication duration of action and motor benefit wears off quicker before the
next dose is scheduled. In advanced PD, adverse effects of levodopa, such as
dyskinesias during the “on” time emerge and levodopa becomes ineffective.
As a result, PwPD have to take levodopa more frequently and often at higher
doses.18 To optimize the effectiveness of levodopa, levodopa containing
medications are not usually prescribed in the early stages of PD and
introduced later as motor sequelae become more pronounced. Levodopa also
competes with absorption with neutral amino acids found in animal protein,
and if consumed with high protein meals the medication is less effective.
People with PD taking levodopa-containing medication are encouraged to wait
30-minutes to an hour between consuming a high protein meal and taking their
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levodopa containing medication.61 As a result, working with a Registered
Dietitian (RD) to manage medication and nutrient timing is essential to prolong
the effectiveness of levodopa-containing medication.41
Figure 3: Change in Levodopa Response Over the Course of PD18,106

Other Pharmacologic Treatments for PD. Anticholinergic agents and
MAO-B Inhibitors can also be prescribed to treat PD but are less common due
to their adverse effects or ineffectiveness. Side effects of anticholinergic
agents include confusion, impaired memory, constipation, blurred vision,
urinary retention, dry mouth and glaucoma.9 MAO-B Inhibitors, while produce
less side effects, are ineffective when used alone to manage PD. Side effects
of MAO-B Inhibitors include insomnia, nausea, anorexia, hallucination, and
potential interaction with medications such as selective serotonin reuptake
inhibitors and meperidine. Many PwPD receive a combination of medications
to manage PD which may have side-effects that impact, dietary intake,
medication-interactions and health-related quality of life. These side-effects
can impact adherence to medication and working closely with a neurologist,
pharmacist and RD can help optimize medication effectiveness.
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Pharmacologic Adherence. People with PD taking anti-parkinson
medication often need to take a steady level of medications throughout the
day. As PD advances medication management becomes more complex and
PwPD may have to take anti-parkinson medication every 2-3 hours. However,
with advanced disease, motor and cognitive deterioration may make adhering
to such complex medication treatment too difficult for PwPD on their own,
resulting in greater amount of time, effort and family support needed to
manage medications regiments.107,108 In the US it is estimated that 27.3-67%
of PwPD have poor adherence to anti-parkinson medication management.108111

In an exploratory, qualitative study, Shin et al108 interviewed 16 PwPD
and five informal caregivers to better understand challenges to anti-parkinson
medication adherence and strategies used by PwPD and caregivers to
overcome these challenges. Challenges among participants included
medication responses, cost of medication, or forgetting to take medications.108
Those who described medication response as a reason for missing doses was
because they did not notice any difference or effects after taking their antiparkinson medication.108 Several participants also noted that the cost of
medication was a burden, despite coverage from their insurance company.
Participants also had a concern about protein and levodopa interaction,
describing uncertainty about the time they were supposed to wait to consume
a high protein meal after taking medication and difficulty scheduling daily
routines around meal times.108 Finally, a few participants reported not taking
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their medication at the prescribed time because they forgot.108 Strategies
used by PwPD and caregivers to facilitate medication adherence included
seeking knowledge about the medication, seeking advice from family and
friends, using pillboxes to keep track of medications or using alarms and
smartphones to set reminders to take their medication.108 Findings from this
study can help inform medication adherence interventions among PwPD to
minimize food-drug interactions and optimize medication effectiveness. In
addition to using smart phones for medication adherence, digital health
technologies, such as cloud technologies are being used internationally to
promote medication safety and adherence in aged societies.112 Such findings
advocate or exploration of how cloud technologies and digital health may
support medication safety and adherence among PwPD.112
ii. Deep Brain Stimulation
Deep brain stimulation (DBS) is an established and effective treatment
strategy for those living with advanced PD.113 This surgical procedure involve
implanting a device that delivers small electric shocks to areas of the brain. In
PwPD the target areas of the brain include the subthalamamic nucleus (STN)
or the globus pallidus pars interna (GPi).113 Deep brain stimulation can
effectively help manage motor fluctuations and dyskinesias. Findings found
the motor benefits from DBS were sustained over 36 months and longer
longitudinal evaluation is warranted.113 When targeting STN specifically, there
is a significant reduction oral medication required among PwPD.113 However,
DBS targeting the STN does seem to improve depressive symptoms to the
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significant extent as stimulation to the Gpi.113 Research suggests veterans
with PD who received DBS compared to those who received usual care have
longer survival rates.114 Stroupe and colleagues115 compared the healthcare
utilization and costs of veterans with PD who received DBS compared to those
who did not over five-years and found average healthcare costs for veterans
who received DBS were $77,131 higher ($162,489 vs $85,358). However,
when excluding costs for DBS procedures and complications, there was no
significant difference in average total healthcare costs between veterans that
received DBS and those who did not.115 When assessing the economic value
of DBS, a cost benefit analyses should be taken into consideration, including
the survival benefits of DBS.114,115 In addition to medication and surgical
treatment for managing PD, ancillary services can help curtail disease
progression.
b. Ancillary Services for Managing PD
Rehabilitative and complimentary medicine programs are being promoted
to compliment pharmacological and DBS treatment.41 This includes physical
therapy and speech therapy, occupational and exercise regiments.41 Lee
Silverman Voice Therapy Big (LSVT BIG Therapy) consists of five tasks
focusing on large trunk and extremity functional movements,116 and requires
PwPD to attend four sessions per week for four weeks.117 The therapy
improves physical functioning among PwPD and helps manage PD related
feelings of fatigue and depression.118 Exercise programs help prevent falls,
optimize body composition, and improve physical functioning and ability to

123

perform ADL.119 Exercise programs that can benefit physical functioning and
overall health of PwPD include: treadmill120 and resistance training121, Tai
Chi122, dancing123, biking124 and boxing.125
Visits with a speech language pathologist (SLP) are also a vital part of
the PD treatment plan, as the SLP can evaluate, diagnose and treat
swallowing and cognitive-linguistic issues that develop among PwPD.126 The
SLP is also vital in prescribing appropriate modified textured and fluid
consistencies to help reduce risk of choking and aspiration pneumonia. An
SLP can also provide swallowing exercises to strengthen muscles related to
swallowing and improve QOL.127 The SLP can also treat speech and voice
disorders that emerge from PD, which include mono-pitch, reduced loudness,
slowed and slurred speech or inaccurate articulation.128 Lee Silver Voice
Treatment LOUD (LSVT LOUD) is an effective form of speech therapy for
managing speech disordered related to PD.128 The treatment requires PwPD
to attend one-on-one sessions four days a week for four weeks.128 The onehour sessions have been found to increase vocal loudness and functional
communication among PwPD. Both LSVT Loud and BIG require tone ups and
to keep up with the exercises in between the 4-week sessions.129 For PwPD to
have added benefits of such programs, high frequency and repetition is
needed and this can be time consuming for PwPD and their informal
caregivers and prevent PwPD from accessing an interdisciplinary treatment
plan.
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c. The International Classification of Functioning, Disability and
Health
The International classification of Functioning, Disability and Health (ICF) is
framework approved by the World Health Organization to describe and classify
functioning and disability among adults and children living with health-related
conditions.130 The ICF can be used with the International Classification of
Disease and Related Health Problems (ICD) to provide a comprehensive
picture of a person’s health. Health is defined by the World Health
Organization as “the complete physical, mental and social functioning of a
person and not merely the absence of disease.130” With this proposed
definition, ICF is an essential component.130 The framework can be used to in
interprofessional practice, to promote person-centered care and to establish a
common language across disciplines, including for those working with
PwPD.130,131
The ICF framework is broken down into two major components: 1.
Functioning and Disability and 2. Contextual Factors. Figure 4 has been
adopted to capture the major components when working with PD.130
Functioning and disability factors include: body functions and structures,
activity and participation.130 Body functions and structure describe the actual
physical and psychological status of the person. While activity and
participation describes their ability to function and participate in desired
activities. Functional status includes mobility, communication, interpersonal
relationships, ability to safely feed oneself, self-care, and knowledge
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acquisition and application.130 Contextual factors include environmental
factors and personal factors. Environmental factors are those factors that can
influence one’s health that are not within the person’s control (family,
government policies, cultural beliefs and work). Personal factors (race, gender,
age, education level and coping styles) may influence how a person manages
their disability and activities they participate in. 130 The domains within each
factor are highlighted in Figure 5.
Figure 4: World Health Organization’s 2001 ICF Model Adopted for PwPD130

Figure 5: World Health Organization’s 2001 ICF Major Components and
Domains130
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Vojciechowski and colleagues131 completed a literature review to
describe and quantify the development use of IFC and portray the different
components of IFC that have been used in PD. Only four studies have
examined the relationship between IFC and PD. Questionnaires and
assessments administered among PwPD and their relationship between ICF
domains are summarized in Figure 6.131 Findings from this review concluded
more research is needed to better examine the association between the ICF
and PD. 131 Additionally, ICF and its relationship to PD outcomes following a
health intervention is also warranted.131 Adoption of the ICF for PD and
understanding the relationship between ICF and PwPD outcomes, can help
better track changes among PwPD and provide a universal language between
the healthcare team, and promotes PwPD and their caregivers at the center
of the careteam.130
Figure 6: Questionnaires and Function Tests Related to the ICF Domains and
PD131

Abbreviations: Mini-BESTest=balance, evaluation systems test; MoCA=Montreal
cognitive assessment; GDS=geriatric depression scale; FTSST=five times sit to stand
test; FES 1 e FOG=falls efficacy scale, freezing of gait; PDQ-39=PD questionnaire-39
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Components of the ICF model cover aspects of health-related QOL and
allows for interaction between domains as a result ICF can serve as a
predictor for health-related QOL and health status.58 The model is encouraged
to be used by physical therapists among PwPD to guide daily functioning and
identify specific needs.58 How ICF can be used across other help
professionals, such as RDs, for the treatment plan of PwPD and impact
health-related QOL needs further explanation. In a prospective, two-year
study, Cavanaugh et al examined clinical measures associated with
ambulatory activity decline among PwPD. The clinical measures assessed fit
into the major domains of the ICF model (Figure 7). Findings from this study
showed the potential to use ICF model to track long-term ambulatory function
among PwPD. Utilization of this model assessing and tracking PD progression
over longer periods of time is warranted.
Figure 7: Study measures for PwPD according to ICF model domains
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d. Care Model for Managing PD
Worsening of disease sequelae overtime, combined with declining
nutritional status negatively impact QOL132, which can further compromise
ability to perform ADL, making PwPD more reliant on caregiver.133,134 Due to
this increase reliance, caregivers are essential to healthcare and can partner
with healthcare providers to more effectively implement treatment and promote
adherence of PD treatment.70,135 Including caregivers in interventions can
address some of the nutritional concerns PwPD face, allowing caregivers to
help maintain the health of PwPD and their own health.41,70 Interdisciplinary
care is recommended for managing PD, but nutritional care and inclusion of
informal caregivers is often overlooked; Figure 8 has been modified to include
informal caregivers and nutrition services in interdisciplinary PwPD care.136
Figure 8: Modified Interdisciplinary Service Model for PwPD136
Informal
Caregivers
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Speech
Therapy

Nutrition
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In a mixed-methods study, Kessler and colleagues137 surveyed 57
PwPD and 30 caregivers and interviewed 13 PwPD, six caregivers, and six
healthcare providers to develop an integrated care program for managing PD.
The development of these program advocates for a collaborative approach,
integrating PD and caregivers as an active part of managing PD. The
collaboration calls for self-management, support and communication with and
between healthcare providers. To create this tertiary PD clinic, co-design was
utilized, which included viewpoints of key stakeholders, including PwPD and
caregivers. Promoting self-management of care provides PD dyads with the
skills and confidence needed to manage a chronic health condition on a day to
day basis. People with PD and caregivers wanted more support with goalsetting to promote self-management, follow up with healthcare providers and
access to services to better manage PD. Both PwPD and caregivers
expressed satisfaction when they were able to make decisions collaboratively
with their health care providers. Findings from this study should be considered
when designing healthcare services for PD dyads to promote access to
comprehensive care.
e. Resource Availability
Since many PwPD have limited access to healthcare due to disease
sequelae, age and location138,139, an improved model to address healthcare
access and need is critical.138,139 People with PD experience cognitive and
physical decline that can impact mobility and driving ability, which in turn can
reduce access to medical care.54 While more research is needed to determine
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if there is a higher occurrence of PD among rural vs urban populations,
research has found a link between occupational exposures and increased
incidence of PD. These occupations that appear to have an increased
occurrence of PD include agriculture, working with pesticides, and heavy
metals.140 Those PwPD living in rural areas are especially at increased risk for
inadequate access to treatment.
According to the current interdisciplinary care model, PwPD should see a
neurologist 2-4 times a year141, and physical therapists and speech language
pathologists up to 4 times a week for certain treatments.54,142 This can be
burdensome for PwPD and their caregivers, due to limited access to
transportation and compromised physical mobility. 50 Up to 40% of Medicare
beneficiaries with PD do not seek care from a neurologist within the first four
years after diagnosis.138 Additionally, while physical and speech therapies
exist to help manage PD sequelae, there are no recommendations for routine
appointments with allied health professionals, including speech-language
pathologists, physical and occupational therapists, exercise physiologists
and/or registered dietitians (RDs).41 Monitoring how PwPD change across the
domains of nutrition, cognitive-linguistic and physical functioning can help
better understand health needs of PwPD.38 Inclusion of allied health
professionals can help attenuate burden of disease sequelae, improve QOL
and may lower healthcare costs.143
Due to limited mobility, visuospatial impairment, decreased access to
transportation options, need for visual assessment and on-going care, PwPD
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are excellent candidates for digital health.26,139 However, nutritional services
via digital health are not utilized in this population and the individualized
nutrition care needed by PwPD is also an under-recognized component of
care.144 Monitoring the nutritional status of PwPD and caregivers can help
better understand nutritional needs and provide effective digital health nutrition
services. Tracking how PwPD change overtime can also help monitor and
track treatment efficacy provided across disciplines and further promote
interprofessional practice to manage PD.
I.

Theoretical Framework: Technology Acceptance Model
Obtaining PwPD preferences and opinions regarding features of

technology to manage health can help to inform the creation of a user-friendly,
evidenced-based digital health service.145 Formative analysis has been used
to effectively employ digital health technologies for older adults146,147, and in
the development of dyadic interventions for PwPD.148 Understanding PD
dyads preferences for technology to manage and track nutrition health can be
incorporated into the technology acceptance model (TAM).149
The TAM was created to explain computer usage behavior across a
broad range of user populations and end-user technologies.149 The model
seeks to provide a basis for understanding external factors that influence
internal beliefs, attitudes and intentions to use technology (Figure 9).149
External factors can directly impact perceived usefulness and perceived ease
of use related to various computing technologies. The model hypothesizes that
perceived usefulness and perceived ease of use jointly determine acceptance,
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which can influence intention to use and actual behavior use of technology.149
The TAM has also been modified to specifically examine technology
acceptance among older adults, known as the Senior Technology Acceptance
Model (STAM). The external factors STAM examines specifically relate to
aging populations that may impact technology use and attitudes toward
technology.150 These external factors include: self-efficacy to learn
technology, anxiety toward technology, facilitating conditions, self-reported
health conditions, cognitive ability, social relationships, attitude to life and
satisfaction and physical functioning.150 External factors that impact PD dyads
to use technology are important to understand to ensure usability and
utilization of digital health for managing PD.150 As a result, including PwPD
and caregivers in the formative stages of research can facilitate the creation of
user-friendly digital health nutrition services.145
Figure 9: Technology Acceptance Model149
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II.

Digital Health
A. Overview of Digital Health

Improvement in the current healthcare model for PwPD is needed to
effectively meet patient needs.54,138 Digital health describes technologies that
better manage and track health.151 Additionally, as technology adoption
increases, eight in ten (113 million internet users) seek health information
online.152 Specifically, 64% of adults living with one or more chronic diseases
seek health information from online sources.153 Most US adults (77%) report
owning a smart phone device.154 Recent efforts have been made to develop
and use digital health to assess, monitor, and provide therapeutic treatments
for PwPD.26,155 Such efforts can increase access to care and promote
efficiencies in providing care.156
More than 40% of PwPD are over the age of 65, and most PwPD living
in rural areas will not see a neurologist after diagnosis.138 Forty-percent of
Medicare beneficiaries with PD do not seek care from a neurologist within the
first four years after diagnosis.138 In addition to visits with neurologists 2-4
times per year141, multidisciplinary care models, including visits with physical
therapists and speech language pathologists, are encouraged and
effective.157,158 Some of these treatments require sessions four times per
week142 which can be a challenge for those with limited access to
transportation and compromised physical mobility, thus becoming burdensome
for PwPD and caregivers.54 Disease stage is associated with driving safety,
where stage 3 is significantly associated with a decline in driving ability.159 Due
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to immobility, limited means of transportation, and ongoing multidisciplinary
care, PwPD are excellent candidates for digital health.139
Digital health serves as a gateway to efficacious and convenient health
information and treatment.156 Digital health increases access to health
services, decreases healthcare inefficiencies, offers more personalized
services, and reduces burden and medical costs for those living with
neurological disorders, including PD.156 Technological advancements such as
cloud computing, sensors/wearable devices, mobile and video
communications160,161, and social networks151 increase access and quality of
care for PwPD.26
In addition to usability and increasing access to care, digital health
adoption can help minimize healthcare costs. In 2012, the Veterans Health
Administration served 150,000+ telehealth beneficiaries, and estimated an
annual savings of $6,500 per user; a billion dollar savings system-wide.162
People with PD that have utilized digital health services have saved on miles
traveled and commute time to healthcare providers.156 Specifically, PwPD
saved 100 miles of travel and three hours of time compared to in person visits.
156

Patients and clients are interested in utilizing digital health, and high

patient satisfaction is reported by those PwPD who have utilized digital
health.156,163
A. PwPD Viewpoints on Digital Health
Interests and opinions of digital health among PwPD and their
caregivers have been assessed. A recruitment webpage for a US-based
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randomized control trial utilizing virtual house calls for PwPD received 11,000
individual views worldwide.164 Caregivers are also receptive and willing to pay
for technologies that monitor and support care recipients.165 Specifically, 20%
of informal caregivers were willing to pay for kitchen (e.g., technologies that
assist with meal preparation and washing dishes) and self-care activities (e.g.,
technology to help the care recipient getting in and out of bed, dressing,
eating, bathing, or toileting).165 Of those caregivers willing to pay for such
technologies, these caregivers reported willingness to pay 50 dollars per
month for monitoring technologies and 70 dollars per month for technologies
that both monitor and provide assistance to the care recipient.165 Findings
indicate that a combination of private pay and government subsidy may
promote development and adoption of these technologies among informal
caregivers.165 Experts suggest when designing digital health interventions
specifically for PwPD, designed and developers should consider caregiver
views, needs and preferences.166
A large cohort study measured the proportion of PwPD interested in
telehealth (i.e., interactive videoconferencing with a healthcare provider) and
identified predictors of patient interest to use telehealth. Among PwPD who
currently use telehealth services, 85% chose to continue utilizing the
service.167 The five patients who discontinued telehealth were treated with
deep brain simulation (DBS), who required trained professional to be present
during the visit due too the lack of training/experience of the nurse/technician
with telehealth to manage DBS equipment and monitoring DBS programming.
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Approximately 65% of participants who continued to use telehealth reported
they wanted a combination of in person and remote services.167 Of those
PwPD who had never used telehealth before, 53% were interested in using
the services, believing utilization of the service could result in significant cost
savings.167 Others interested in telehealth were in the early stages of PD and
believed physical examinations by a physician were not necessary at every
appointment, so telehealth could serve as check-ins with their physician.167
In contrast to these findings summarized above, a cross-sectional
survey assessing PwPD views on using different electronic mediums for
communicating and exchanging information with healthcare providers, found
PwPD may have a less favorable views around technology for communicating
with health providers.168 Nearly 65% of PwPD reported they would be willing
to use electronic methods and 48% indicated that using technology to
communicate with providers would help PwPD better understand their care.
People with PD were asked which forms of technology would help with care.
Of the modalities suggested, ~15% supported electronic forms at check-in for
medical visits and 40% stated they would like a summary of care/home
instructions emailed to them. Of the participants surveyed, ~35% noted they
would like the ability to communicate with healthcare providers through email
and 33% indicated they would like video education about services offered to
PwPD.168 When stratifying participants by age, those over 65 and over were
less likely to believe using technology to communicate with a health provider
would enhance their understanding of care. Those 75 years of age and older
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had a lower odds of being willing to use electronic methods and believing that
technology would result in better understanding of medical needs or their
healthcare providers better understanding their medical needs.168 Findings
from this study indicate optimal communication mediums among PwPD may
vary on patient demographics and that training older PwPD to use technology
may be warranted. Qualitative interviews are needed to better understand
technology choices and preferences of PwPD. Additionally, research that has
implemented digital technology among PwPD shows implementation can be
advantageous to PwPD and their informal caregivers, including reduced
burden and timed saved, which further promotes digital health as a efficacious
medium for delivering healthcare services.169
B. Efficacy of Digital Heath for Managing Parkinson’s
Digital health, such as telemedicine, has been used successfully in a
variety of populations that have evaluated usability (Figure 10).170 A review of
138 studies was conducted, eight included end-users with neurodegenerative
diseases, including PD.170 People with PD have used telehealth for visits with
specialty physicians and multidisciplinary care providers, such as physical
therapy, speech therapy and mental healthcare.142,156 Digital health mediums
used for managing PD include wearable devices171, telehealth142,163, and
online communities.172 Telehealth, or interactive videoconferencing, provide
healthcare providers visual cues of patients, which makes the visit more
objective139,173. Wearable devices collect continuous data to provide a more
realistic portrayal of PwPD’s daily behaviors and clinical outcomes overtime
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unlike subjective data or cross-sectional assessments.171,174 Telehealth can
also provide social support and reduce burden and cost for PwPD and
caregivers.175,176 For example, speech therapy for PwPD via telehealth saved
each caregiver 48 actual hours involved in a speech therapy visit, 92 hours of
work time (time taken off from work), and over $1000.169 In addition to
economic benefits and reduced participation burden, telehealth increases
access to health information, provides effective quality of care, and influences
individuals to make healthy lifestyle choices.177,178 Telehealth is believed to
motivate patients to increase access to care, achieve greater control over
disease management, and serves as an effective medium for healthcare
management in older adults.179-181
Figure 10: Medical conditions and telemedicine170

Online communities are another form of digital health may empower PwPD
to be more active participants in their own care.172 Online health communities
are a form of communication technology that allow patients to interact with
their team of healthcare providers, other patients with the same diagnosis, and
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caregivers. These communities also allow patients to track their health
information and become involved in research.182
1. Telehealth
There have been successful telehealth interventions in PwPD across
various disciplines. Dorsey et al.156 conducted a 7-month, trial in which PwPD
were randomly assigned to receive specialty care from a neurologist in-person
or home via telehealth and found telehealth to be as effective as in personcare. Study findings indicate feasibility of telehealth for specialty visits, with a
93% completion rate of visits.156 Constantinescu et al.142 conducted an
intervention where PwPD were randomized to receive voice treatment therapy
via videoconference or in person and found that both groups saw an increase
in acoustic measures and reported high patient satisfaction. Findings from this
study confirmed the efficacy, validity and reliability of videoconference for
voice treatment.142 Additionally, there was no difference between quality of life
scores and motor scores between groups.156 Another randomized trial found
telerehabilitation could effectively assess ADLs and hand function compared
to an in-person assessment.183 Whether a comprehensive nutrition
assessment can also be conducted via telemedicine has yet to be explored.
Two studies support using telemedicine as part of patient care but not
in place of in-person care. Sekimoto et al.184 conducted a randomized
crossover pilot study of telemedicine via iPads using Facetime. During the
telemedicine visit, clinicians performed perform a structured interview,
medication review and motor examination in between in-person visits.
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Findings from this study indicate telemedicine service could be used in
conjunction with in-person visits, as no difference in quality of life was reported
between groups and PwPD in the telemedicine group reported high
satisfaction. Finally, Wilkinson et al.163 examined if telehealth delivered in the
home and at a satellite clinic compared to those receiving usual-care and
found no difference in patient satisfaction or clinical outcomes between
groups. Those in the telehealth group saw a significant decrease in travel time,
but compared to the usual-care groups the satellite arm had significantly lower
proportion of “no-shows’’/cancellations.163 Findings reiterate telehealth can
enhance usual care health services and can benefit patients who face barriers
to receive in-person care regularly.185
2. Devices, Wearables, & Sensors
Over the last decade, advancements in sensors and wearable
technologies have been made, allowing these innovative mediums to gain
popularity to complete and compliment evaluations of PwPD.186 Devices such
as Kinesia™ and Parkinson’s KinetiGraph (PKG™) can help detect
bradykinesia, record resting and postural tremors, and differentiate patterns of
bradykinesia and dyskinesia in the “on” and “off states.”186 Other wearables,
such as accelerometers, gyroscopes (device used for measuring or
maintaining orientation and angular velocity), and magnetometers (a noninvasive device that monitors heat function), can be integrated in garments or
accessories.187 These accessories can also be used in conjunction with webbased applications.
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People with PD report added value of wearable devices. Ozanne et
al.187 conducted focus groups among PwPD and found that participants saw
the potential for wearable sensors to improve treatment, and believed the
benefits outweighed the inconvenience of wearing sensors. When examining
facilitators and barriers to utilizing sensors, participants indicated that userfriendly and a simple design interface would promote usability, as well as
receiving interactive information from providers.187 However, participants were
concerned about unclear information, inconclusive recordings and had
concerns about protecting personal health information and integrity. In order to
encourage use of sensors, findings indicate PwPD need to feel well-informed
and find added value when using sensors.187 Wearables also need to be easy
to use, have an attractive design and be efficacious for improving disease
management.187 Findings further support the use of digital health to help
manage track Parkinson’s disease.
Devices, such as smart phones or iPads are becoming popular
mediums to deliver health services to PwPD. mHealth, or “the use of mobile
and wireless devices to improve health outcomes, healthcare services and
research,” has been effectively used in PD management. One study found
peer coaching through mHealth can promote physical activity among PwPD
and is safe, feasible and acceptable among participants.188 Both peer
coaches and PwPD were satisfied or very satisfied with the program and all
PwPD participating saw an increase average steps per day.188 These findings
are significant because delivering support by telephone may be a viable way
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to increase physical activity and promote other healthy lifestyle patterns
among PwPD. In a pilot study, Arrora and colleagues189 demonstrated the
ability of consumer-grade smart phones to accurately differentiate PwPD from
age-matched controls through effectively measuring symptoms. Findings from
this study reveal the potential for mHealth to evaluate disease severity.189
The integration of wearable technology with smart devices can enable
remote monitoring of PwPD and provide clinicians, caregivers and patients
with real-time feedback.26 Patel et al.190 found that combining wearable
sensors with a web-based application for home monitoring PwPD can provide
reliable quantitative information that can inform clinical decisions. The system
these researchers developed includes 8 accelerometers on the upper and
lower limbs which is relayed to a mobile device or computer. The system
promotes patient-clinician interaction through video-conferencing or real time
access to the sensor data. 190 The proposed system can successfully gather
data from PwPD to inform symptom severity and motor fluctuations in between
medication doses. Findings from this work indicate that this home monitoring
system has the potential to simplify the process of monitoring medication
effectiveness.190
3. Online Health Communities
Online support groups via forums, blogs and social media are becoming
popular sources for health information.191 Over 50% of American adults living
with a chronic disease have looked online for health information.192 It is
estimated that 90 million (84%) Americans have participated in online
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communities and that 43% of internet users are involved in online groups to
help manage career, medical conditions or parenting.152 Approximately, 12%
internet using adults with one or more chronic health conditions (e.g., cancer,
fibromyalgia, non-specified chronic pain conditions, diabetes, Addison’s
disease, bipolar disorder, celiac disease, trigeminal neuralgia, Parkinson’s
disease, systemic lupus erythematosus (SLE), rheumatoid arthritis, Sjögren’s
syndrome, schizophrenia, cystic fibrosis, and cerebral palsy) maintain a blog
and 28% read blogs about their condition written by others (Figure 11).192 A
2019 report examining social media use among Americans revealed 68% of
Americans between 50-64 years of age, and 46% 65+ report using
Facebook.193
Figure 11: Internet Activities Among Those With and Without Chronic
Conditionsn192
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Online discussion forums are one of the most popular ways people
interact with each other online. In a discussion forum, one person writes a
message/post that can be answered by other members, which forms a
conversation thread.194 Attard et al.191 examined positive and negative aspects
of online PD supports groups through analyzing forum posts from four different
support groups; membership within each group ranging from 1000 to 100,000.
Benefits of peer communication appeared to be: exchange of knowledge
between participants, formation of friendships and the development of support
systems to cope with living with PD. The results revealed that participation in
forums allowed patients to share experiences and knowledge, form friendships
and help each other cope with the challenges of living with PD.191
While less frequently reported, there were some drawbacks to
participating in online, peer-to-peer communication through forum posts.191
First, there are a lack of replies or lag time in between replies,191 which can
hinder the experience. Findings revealed that tremors and cognitive
impairments can hinder engagement in forum posting among PwPD. For
instance, tremors would hinder one’s their ability to answer posts when
desired.191 Another barrier of online forum posting is that many PwPD did not
want share personal information, as a result personal connections could not
be formed between participants. For some participants, online support was
not enough, and they felt lonely in their offline environment. Finally,
misunderstanding and disagreements occurred on the forums due to lack of
non-verbal cues. Findings from this study indicate online communities can
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offer PwPD emotional support and foster knowledge but should be used
alongside traditional forms of support.191 Additionally, health professionals
should partake in these online support groups through monitoring or facilitating
posts to ensure the accuracy of information exchanged.191 Health
professionals may also help guide PwPD using such online communities to
reputable websites and publications.191 Roles of healthcare professionals in
online communities is becoming especially important with the rise of online
blogs.
Illness blogs are a type of online blog, where patients freely describe
their experience managing their condition overtime.195 Readers have an
opportunity to respond to blog posts, and as readers become more involved in
the blog, a community is created.195 Shapira and colleagues195 completed a
thematic analysis of 78 illness blog authors with PD to explore medical illness
concerns blog authors had and found these authors typically discussed
diagnosis and symptoms, treatment, coping mechanisms and providing
information to their readers about PD. Treatments discussed included:
medication, exercise, supplements, nutrition, complimentary therapies and
surgeries. Only three authors blogged about nutritional modifications for PD,
which included experimenting with diets to optimize medication management,
trying vegan diets, fasting, and lowering sugar and protein intake.195 The
reason that so few PwPD discussed diet in blog posts could be because
nutrition is often excluded from the PD care plan.41 However, findings from this
study reveal analyzing illness blogs may be a viable way understand the
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health concerns and medical and nutrition issues raised by PwPD online and
in a non-medical setting.195
Personal online health communities have also been developed to
promote online communication between PwPD and their healthcare
providers.172 Visser et al.172 conducted semi-structured interviews and
observed the use of online health communities among PwPD for over a year.
Patients could communicate with their provider through diary entries or virtual
meetings/postings. Providers did not receive notifications when the PwPD
posted a diary entry but did with the virtual meeting post. Participants could
also update a stored list of health problems and upload health documents.
Three major themes that emerged from these analyses were: “number
of postings,” “coming across as a complainer,” and “hesitating about legitimacy
of knowledge.” In regard to “the number of postings,” many PwPD expressed
concerns about burdening their healthcare providers with too many questions
and limited their number of postings to only concerns that needed immediate
attention from their provider. However, PwPD found the diary section of the
online health community to be less disruptive to healthcare providers and
shared more information in their section of the community.172 The PwPD also
felt obligated to report and update symptoms, but did not want to come across
as a complainer, so refrained from expressing emotions or feelings regarding
PD sequelae.172 The use of online communities can change the powerdynamics between the provider and PwPD, especially when the provider can
no longer visually assess the PwPD and must depend on self-reported
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symptoms from the PwPD.172 Many PwPD believed the provider still
possessed the greatest amount expertise about their condition, despite the
change in delivery of care.172 As a result, PwPD presented their knowledge
and interpretation of their symptoms as an opinion and were hesitant to make
claims about their condition.
Findings from this study reveal even though online communities are
innovative mediums to deliver healthcare services they have not met the
expectation of creating more pro-active patients or changing the power
processes between provider and patient and pre-existing norms regarding
patient-provider dynamics persist. Future health communities need to focus on
creating a two-way exchange between provider and patient, where healthcare
providers share additional resources for managing PD to help PwPD gain
more knowledge about the disease. More research also needs to assess
digital health to manage the nutritional status and diet intake for PwPD or their
caregivers. This is because PwPD are likely at nutrition risk and as nutrition
concerns increase as PD progresses, caregiver responsibility to manage diet
increases, but nutrition is often excluded from the treatment plan of managing
PD.41
A. Efficacy of Digital Health for Managing Nutrition
Research has not directly examined the use of digital health for
managing nutrition and PD, but success with digital health for PD, as well as
digital health’s ability to help manage nutrition in other populations196,197,
compels expanded use of digital health nutrition services for PwPD. Digital
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health services can increase fruit and vegetable consumption196,197, decrease
fat intake198, self-efficacy to make healthy dietary choices197, and promote
sustainable dietary changes.198 Tailored digital nutrition interventions
addressing participants’ environment and learning preferences improved diet
quality more than providing generic nutrition information through online
modules (n=1349).199
Mobile devices can help track dietary intake.200,201 Using mobile
applications (e.g., Lose It! and MyFitnessPal) to track food intake can provide
instant feedback about all calories and nutrients consumed. Dietary selfmonitoring however takes time and effort and technological advances such as
Remote Food Photography Method are being developed to improve the ease
of self-tracking dietary intake.200 Through the Remote Food Photography
Method users submit photos pre and after consuming food to researchers and
researchers perform semiautomatic computer analysis to determine the
nutritional value of those foods.200 Neriah and Gelibeter201 conducted a
retrospective cohort study to determine the effectiveness of using photography
to track food intake via a smartphone weight loss application. Compared to the
traditional weight loss app group the group with the photography feature lost
significantly more weight and tracked their food for a longer duration. Weight
loss in the photography group was mediated by the duration of app use and
number of logged days in the program.
Telenutrition is another solution for PwPD and can help to increase
access to nutrition information in rural areas.202 Telenutrition is the remote
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delivery of medical nutrition therapy (MNT) by a registered dietitian using
interactive electronic information and telecommunication technology (e.g.
videoconferencing).202 A randomized controlled trial assessing the feasibility
of telenutrition weight loss intervention in middle-aged and older men with
cardiovascular risk factors, found telenutrition services demonstrated patient
satisfaction as well as good adherence and retention rates.203 During this 12week intervention, men were randomized to either the intervention group or
enhanced usual care group. The intervention group received three medical
nutrition therapy sessions from a registered dietitian at week one, five, and
nine to nine nutrition coaching sessions at weeks 2-4, 6-8 and 10-12.203 The
MNT sessions included individualized nutrition assessment, education and
counseling sessions. The coaching sessions were patient-led discussions
around topics such as, self-monitoring weekly weight, goal setting, and
overcoming barriers to dietary adherence. The enhanced usual care group did
not receive nutrition coaching in between their in-person sessions at weeks
one, six and 12.203
Both groups lost a significant amount of weight and there was no
difference in the amount of weight loss in between groups. Both groups saw
an improvement in total fruit (p=0.05), whole grains (p=0.004), and fatty acid
ratio scores (p=0.002). Participants lowered refined grain (p=0.04), sodium
(p=0.01), added sugars (p=0.01) and saturated fat scores (p=0.002) healthy
eating index (HEI) component scores. However, the intervention groups saw a
greater improvement in total fruit (p=0.04), whole fruit (p=0.04), and green
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beans (p=0.013). Findings from this study show promise for PwPD, as there is
a higher occurrence of PD among men than women.12,13 More information is
also needed to determine how digital health nutrition interventions may impact
caregivers and reduce caregiver burden, as caregivers are involved in
managing dietary intake for PwPD.24
B. Efficacy of Digital Health for Informal Caregivers
Technology, including digital health can support caregivers and
promote better coping.204 More than 30 million US adults provide home
caregiving and approximately 80% of these caregivers seek health information
online.205,206 Caregivers believe that technology can help provide more
efficient, effective and safer care and reduce stress when delivering care.204
Nearly 75% of caregivers stated they would be willing to pay for access to a
website for a complex care matter and 85% believe insurance should pay for
access to such websites.207 While digital health has been used to manage
chronic disease more information is needed to understand the impact of
telehealth interventions can have on informal caregivers and how digital health
can offer support and address informal caregivers’ health needs.204
Chi and Demiris204 conducted a systematic review assessing of 65
studies that included informal caregivers and utilized digital health
technologies to provide education, consultations, psychosocial therapy, social
support, data collection and monitoring systems, or deliver clinical services.
The most common medium used by studies reviewed was videoconferencing.
In 95% of the articles reviewed, caregivers reported improvements in
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outcomes, such as psychological health, satisfaction and comfort with digital
health, caregiving knowledge and skill, and social support.204 Nearly a quarter
of the studies reviewed, were conducted among caregivers living in remote or
rural areas and brought significant improvements in caregivers’ QOL and
psychological well-being. Findings from this review conclude telehealth can
provide acceptable care and save travel costs for caregivers of patients who
need long-term care and monitoring, such as PwPD.204
Several studies have specifically examined digital health interventions
delivered for caregivers of PwPD.176,208 These studies specifically looked at
virtual support groups and their impact on coping with caregiving
responsibilities, disease burden and QOL.176,208 In a study conducted by
Marziali et al.208, caregivers of persons with Alzheimer’s, Stroke or PD met
weekly for 10 weeks via videoconference in small groups lead by a support
group leader. At the end of 10 weeks and six-month follow up, 90% of
participants reported a positive experience and found the group helped with
coping with the stresses of caregiving. Findings revealed virtual support
groups were comparable to in-person groups. In a small pilot study, caregiver
tele-support groups was a feasible option and showed promise to potentially
improve depression scores and decrease caregiver burden.176 Whether
nutrition assessment and nutrition interventions can also be delivered to
caregivers of PwPD warrants exploration.
II.

Nutrition Assessment
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Poor nutritional status is an imbalance of energy and/or nutrient intake,
resulting in suboptimal body weight and composition, function, and/or clinical
outcomes, which can eventually lead to malnutrition in the forms of over- and
under- nnutrition.209,210 Assessing the nutritional status of PwPD includes the
traditional examination of dietary intake, anthropometrics, and biochemical and
clinical measures,209,210 as well as a focus on possible food-drug interactions,
duration of medications and history of depression and anxiety.70 A crosssectional study, examining nutritional intake of PwPD for nutritional and protein
risk, found that nearly 63% of PwPD would be categorized as with malnutrition
or at risk for malnutrition, ~53% exhibited weight loss in the last three months
but presented with elevated waist circumference.211
A. Dietary Intake and Diet Quality
Disease sequalae, physiological factors and treatments for PD can
compromise dietary intake and quality.61 Disease stage and side -effects from
medication or surgery can impact dietary choices by impacting appetite and
the ability to consume food.212 Other factors that related to PD that can impact
dietary choices include: nausea, delayed gastric motility, dehydration,
constipation, change in taste and smell, and dysphagia.61 Complaints relate
to change in taste and smell are among the most frequently reported from
PwPD. One study found 26% of PwPD complained of taste/smell issues,
compared to only 7% of controls.213 How change in taste and smell impact
nutritional status and diet quality has not been directly explore. Cognitive
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decline and depression, common among PwPD, can also compromise food
intake by impacting mealtime and appetite214
Dysphagia can also impact mealtime and the amount consumed as it
results in change in dietary choices and avoidance of certain foods, which can
impact weight status. Those with dysphagia are more likely to experience
unintentional weight loss, especially PwPD avoiding solid foods due to
swallowing issues.214 A longitudinal prospective study, examining dietary
intake, weight, and swallow function among, found that PwPD with weight loss
were more likely to avoid solid foods due to swallowing difficulties compared to
controls.214 Those PwPD who experienced weight loss also consumed less
vegetables, fresh fruit, meat on sandwiches and drinks without energy at the
first evaluation.214 However, whether this weight loss was associated with
swallowing difficulties was not explored. Avoidance of solid food and fluid can
result in nutritional imbalances and hydration. Variability in weight and
nutritional status is a concern because it can impact diet quality as well as
physical functioning, which can lead to muscle wasting and difficulties in
performing ADL.215
Though low dietary quality scores are associated with chronic disease
such as cardiovascular disease216, few studies have examined diet quality and
intake in PwPD. LoBuono et al.38 found low dietary quality scores among a
small cohort of PwPD. Cassani and colleagues217, further examined dietary
intake among PwPD and healthy controls, specifically regarding the
adherence to a Mediterranean diet, and found PwPD ate more fruit, cooked
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vegetables, cereals and baked items, as well as more sweets and
dressings.217 Those with PD also consumed less fish and alcohol and drank
significantly less water, coffee or milk, 217 and as a result, consumed
significantly less fluid overall.217 Overall PwPD had higher intake of calories,
iron, zinc, folate, and vitamins A ,and C, however PwPD also had significantly
lower BMIs compared to controls (26.2±4.9 vs. 28.5±6.4 kg/m2, p<0.001).217
Dysphagia was self-reported among 12% which resulted in a significant
decrease in fluid intake and preference for more vicious foods, but did not
impact adherence to the Mediterranean Diet. There are two major areas of
significance with these findings. First, the difference in dietary intake between
PwPD nad control warrants a similar exploration between PwPD and their
informal caregivers. Also, a prospective, longitudinal examination of how
dietary intake and quality relate to disease progression.217
Protein intake among PwPD is also a concern for those taking
levodopa. Dietary protein and levodopa compete for absorption and transport
across the gut, blood-brain barrier, and peripheral nervous system.218 It is
advised to wait 30 to 60 minutes between taking levodopa and eating a high
protein meal.211 Participants taking levodopa exceeded daily protein
recommendations, consuming 1.4±0.6 per day, rather than the 0.8
grams/kg/day. 211 Seventy-five percent of PwPD ingested levodopa with
food.211 Findings highlight the need for nutrition education on protein timing
and medication.
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B. Impact on Weight and Body Composition
Weight and nutritional status in PwPD varies during disease progression
(Figure 12)61 and can adversely affect body composition, cognitive and
physical functioning144,214,219, QOL and health outcomes.220 A decade before
diagnosis, an average 5.2 pound weight loss is reported, despite increased
energy intake.221 Much of this weight loss is attributed to the increase in
energy expenditure caused by untreated motor symptoms.221 Once treatment
is initiated symptoms are minimized, and weight gain is observed61,222,223

Figure 12: Nutritional Status Over the Course of PD61

Weight status changes throughout the course of PD (Figure 12), at the
beginning of treatment for PD excess weight is a problem, but as the disease
progresses, underweight and nutrition results.61 Weight gain among PwPD
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can result in overnutrition224 caused by excessive oral intake and/or
inadequate activity.225 One study found a majority of PwPD and their spouses
are overweight or obese226, indicating the need for early nutrition intervention
for PwPD and caregivers to reduce chronic disease risk.227 Side effects from
some PD medications, such as dopamine agonists, can increase impulsivity,
lead to overeating and result in weight again.227 Additionally, treatments can
reduce dyskinesia, which can decrease energy expended and result in weight
gain.61 Furthermore, anxiety and depression are common in PwPD and
prescribed medications can cause weight gain.228,229 Following the
implantation of deep brain stimulation (DBS), a mean weight gain of 3.1 to 9.3
kg within three months has been reported, and typically curtails about a year
after implantation. 227,230 Weight gain among PwPD first receiving DBS is
attributed to reduced energy expenditure since dyskinesias are reduced after
DBS.168 Being overweight increases risk of developing sarcopenic-obesity,
higher body fat and decreased muscle strength that can exacerbate a
deterioration in physical function.215
Due to disease-related decline in mobility, it is speculated the age-related
loss of skeletal muscle mass and muscle strength231 are prevalent in PwPD
and impact the ability to perform ADLs, increase fall and fracture risk, and
compromise QOL.232 People with PD often weigh less than healthy controls,
but have similar amounts of abdominal fat20 and a higher proportion of visceral
to subcutaneous fat233, excess visceral fat is linked with increased risk for
chronic disease.233 For PwPD, presence of central obesity is a risk factor for
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cognitive impairment234, and changes in body fat distribution may be attributed
to changes in macronutrient distribution.234 Conversely, other research
indicates PwPD have a higher fat-free mass and possibly a more favorable
body composition compared to healthy controls.235,236 Inconsistent findings
related to diet and body composition warrants a deeper understanding of
chronic disease in PwPD, such as cardiometabolic.237
A study assessing weight stability of PwPD over one year found a
significant amount of muscle converted to fat.224 However there was no
association between nutritional variables (BMI, weight, Seniors in the
Community: Risk Evaluation for Eating and Nutrition version II questionnaire,
mid-upper arm circumference, hand grip strength, triceps skin-fold) of interest
and motor and non-motor features of PD. Findings from this study warrant
longer observational studies to track nutrition outcome variables overtime to
better understand the relationship between nutrition outcome variables and
motor and non-motor sequelae. Findings from this study also indicate
malnutrition should be screened regularly among PwPD to help identify those
at risk of muscle loss and decrease mobility, and that nutrition professionals
should be included in the care plan of PD.
As PD progresses, levodopa tolerance develops, sequelae worsen, and
weight loss and under-nutrition are common.61 Undernutrition results from
inadequate intake to meet energy expenditure.225 Up to 25.5% of PwPD are
malnourished and up to 26.5% are at risk for malnutrition.70,220,238 After PD
diagnosis, PwPD weight can fluctuate up or down and very few maintain their
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body weight. One study found, despite increased energy intake, the average
weight loss in PwPD (n=174) was 7.7 pounds 8 years following diagnosis.239
Significant weight loss is experienced among both men and women.240
Unintentional weight loss can be caused by a variety of factors.70 Mobility
limitations make it challenging to buy, prepare, and cook food,61 and PwPD
may exhibit dysphagia and gastrointestinal problems, which can diminish
appetite.212 Higher levodopa dosages are associated with a lower BMI,229
which is associated with compromised motor and non-motor function.219
Weight loss among PwPD is negatively associated with cognition, suggesting
an association between cognition and nutritional status.214 Weight loss is also
exhibited among PwPD experiencing dementia or visual hallucinations. 241
Whether PwPD experience Despite under- or over-nutrition, malnutrition in
PwPD is under-treated.144,242 The variability in weight status, cognition, and
physical functioning warrants innovative nutrition care to improve health
outcomes.38 Caregivers should be part of/included when making
care/treatment plans for PwPD whose responsibilities increase as PD
advances25, in turn compromising the health of the caregivers.29 Fluctuations
in nutrition and weight status compromises body composition and can impact
cognitive and physical functioning.144,214,219 A decrease in fat-free mass and an
increase in fat mass is a natural part of aging and can accelerate decline in
physical function215, however the added effect PD has on age-related muscle
loss is unclear.144,235 How this fat free mass increase impacts cardiometabolic
status among PwPD also needs greater exploration.
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C. Cardiometabolic Risk in PD
Inconsistent research exists regarding cardiometabolic risk among
PwPD. In a small cross sectional study, six of seven participants had at least
one sub-optimal cardiometabolic lab value and two PwPD were on statinlowering drugs.38 Chahine et al243 examined vascular risk factors (diabetes,
hypertension, obesity) among early PD and found an association between the
presence of vascular risk and concentration of white matter hyperintensities
(WMH). Greater presence of WMH was predictive of decline in verbal memory
two years later.243 Cardiometabolic and vascular risk factors are associated
with cognitive decline.244 Research needs to exam how vascular risk factors
can impact cognition beyond two years needs to be assessed.
Previous research suggests a cardiometabolic protective effect of PD
and theorizes that optimal HDL-C levels among PwPD may explain this
theory.237 In a larger cross-sectional study (n=150), despite excess visceral
fat or poor nutritional status, longer PD duration was associated with optimal
high-density lipoprotein (HDL) cholesterol levels, indicating possible
cardiometabolic protective properties of PD.237 Cereda et al236 also
investigated the cardiometabolic status among PD and found compared to
healthy controls, PwPD exhibited a lower percentage of body fat and moreoptimal glucose levels and lipid profiles. However, there was no difference in
waist circumference between PwPD and healthy controls.236 Wei et al245
performed a retrospective study comparing serum lipid and lipoprotein levels
among PwPD (n=110), controls (n=130), persons with intracerebral
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hemorrhage (n=140) and with an acute cerebral infarction (n=140); findings
revealed PwPD had reduced serum levels of triglycerides, apolipoprotein B
and very low density lipoprotein (VLDL) cholesterol.245 Further research is
needed to explore the relationship between nutrition and the changes of lipids
and lipoproteins among PwPD.245 Additionally, how this protective
cardiometabolic profile may impact health outcomes overtimes warrants
further investigation.236
D. Nutrition Recommendations
Protein, water, fiber, vitamin D, and omega-3 fatty acids are nutrients of
concern for PwPD due to sequelae and medications.61 Over-time, patients with
higher dietary protein intake may require higher levodopa doses and
eventually the medication loses effectiveness.20 Common gastrointestinal
sequelae include delayed gastric emptying and constipation and warrant the
need to manage daily water and fiber intake.246 Reported low vitamin D status
in PwPD can impact bone health and increase risk of fracture with diseaserelated physical decline.247 Since PwPD are at increased risk for falls, helping
this population to optimize bone health to prevent fracture is essential.41 In
addition to neuroprotective effects52, omega-3 fatty acid can improve
depressive symptoms in PwPD.248
Formal, comprehensive dietary guidelines for PwPD have not been
established.249This is partly due to the heterogeneity of PD and the need for
individualized recommendations. There are multiple dietary recommendations
for PwPD that focus on weight management, protein intake, and constipation20
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and can be confusing for PwPD and their caregivers. Diets adequate in fiber
and probiotics are proposed for early phase PD to improve gastrointestinal
issues, increase absorption of levodopa250 and promote optimal cognitive
function.61,222 Planted-based, vegetarian, or Mediterranean diets are proposed
for early-phase PD prior to the introduction of levodopa containing medications
because they are adequate in fiber and pre- and probiotics. These specific
diets can improve gastrointestinal issues, increase absorption of
levodopa20,61,251 and promote optimal cognitive function.61,222
National organizations for PD provide dietary suggestions which
include: 25-35 grams of fiber per day,252 up to 70 fluid ounces of water252, and
encourage consumption of nuts, tuna, salmon and dark green leafy vegetables
to promote cognitive health.253 These organizations also advise to monitor
vitamin D status.253 Supplementing with vitamin E and omega-3 may also be
beneficial. A trial found co-supplementing with 400 IU of Vitamin and 1000
mg/day of omega-3 fatty acid from flax seed oil significantly improved overall
PD clinical outcome scores, total antioxidant capacity, insulin metabolism.
glutathione concentrations, and high-sensitivity C-reactive protein levels.254
Guidelines for managing dietary protein intake with levodopa also exist
and must be based on the frequency and timing of taking levodopa. As a
result, there is confusion among PwPD and their caregiver on how to optimize
medication timing and dietary protein intake.108 Recommendations include: 1)
a low protein diet; 2) a protein redistribution diet; 3) allowing thirty minutes to
two hours before or after eating to take levodopa medication.251,255 A low
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protein diet restricts protein intake to <0.8g/kg of ideal weight/day.256 A protein
redistribution diet recommends consuming the recommended dietary
allowance (RDA) of 0.8g/kg of protein/day to ensure adequate protein intake,
but requires the majority of dietary protein to be consumed at dinner to reduce
daytime motor symptoms and minimize interaction between medication and
protein.251 Cereda et al251 completed a systematic review examining the
effectiveness of the low protein and protein redistribution diets, and found
evidence supports the safety and efficacy of a protein redistribution diet.
Among PwPD there seems to be low adherence to protein the
redistribution diet and low protein diets due to low palpability and acceptability
as well as logistic difficulties for adopting the diet.223 As a result, waiting an 30
minutes to two hours for meals is encouraged by most PD organizations.223
More research is needed to understand long-term effects of the protein
redistribution diet on nutritional status and to help participants find them more
appealing and less burdensome.223 Increasing access to nutrition information
through innovative mediums such as digital health will allow PwPD and
caregivers to work with dietitians, pharmacists and physicians to manage
medication side-effects and interactions.
E. Nutrition and Quality of Life
Nutritional status is an important component of QOL and should be
incorporated in the care PwPD257, but is often an under-recognized component
of care for PwPD.144 Under-nourished PwPD receiving general nutrition
intervention or personalized dietary recommendations saw a significant
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improvement in emotional overall well-being.20 Many PwPD and their
caregivers experience decline in psychosocial health, and support groups and
group education can alleviate these feelings through promoting interactions
with other PwPD and caregivers.75,258,259 Health promotion programs designed
for PwPD increase overall wellbeing but also foster feelings of enjoyment and
sense of social self.260 Access to transportation due to disease sequelae can
be a barrier and increases caregiver burden.261 The observed variability in
weight status, cognition, and physical functioning may warrant innovative
nutrition care38, and should also include informal caregivers whose
responsibilities increase as PD advances.25
III.

Emerging Middle Range Theory of Transitions

Including caregivers in formative research targets elements of the
emerging middle-range theory of transitions (Figure 13).262 A transition
represents change from one state or condition to another, and includes life
development stages, such becoming an informal caregiver. The theory
promotes the exploration and understanding health and illness transition
experiences, through understanding facilitators and barriers to a successful
transition, and assessing the outcomes of successful transitions.148,262
Successful outcomes examined include: increase knowledge and skills that
promote self-efficacy, coping, and satisfactory relationships with family, friends
and formal services.262 The theory posits itself on helping informal caregivers
to acquire new skills and knowledge to cope with situations related to
caregiving, and creating feelings of informal support for caregivers, which play
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a central role in successful role transition.262 The theory has been
incorporated previously to guide the development of dyadic interventions for
PD148 and Alzheimer’ disease.263
Figure 13: Schematic of the Emerging Middle Range Theory of Transitions262

Research and services are beginning to identify the need for informal
caregivers to help manage long-term conditions such as PD.137,264,265
Development of more comprehensive approaches to help PwPD and their
caregivers adapt to changes they experience as a consequence of a long-term
condition are warranted.265,266 Caregivers of PwPD are often faced with
restricted work and social activities, increased worry and uncertainty about the
future, loss of income, and feelings of guilt, frustration and/or grief.267,268
Consequently, PD caregivers are at risk for compromised psychosocial
outcomes, which include poor QOL, emotional and financial strain, sleep
disturbances, social isolation and increased risk of chronic illness.28,267 Non165

motor sequelae among PwPD (e.g., depression, cognitive impairment) and
depression among caregivers are predictive of caregiver burden.267 While
social support may be a protective feature in minimizing caregiver burden.267
Whether caregiver burden is associated with poorer nutrition status for
caregivers or their loved one with PwPD has yet to be explored.
As a result, future programs and services for PwPD should incorporate
the preferences and needs of informal caregivers as their responsibility tends
to increase as the disease progresses.266 Comprehensive, interdisciplinary
services can help both PwPD and caregivers better cope and adjust with living
with PD and improve QOL.265 Including PwPD and caregivers will be
especially beneficial in digital health interventions and nutrition services as
caregivers will likely have an active role in managing both of these as PD
progresses and reliance on caregivers increase. Qualitative dyadic research
among PwPD and caregivers, show concerns about keeping both parts of the
dyad healthy.148 As a result, how the inclusion of caregivers can help promote
healthy dietary patterns among PD Caregivers warrants exploration.
IV.

Inclusion of Caregivers

Up to 6.5 million family caregivers provide substantial help, including
coordination of care, medication management, and personal care for older
adults living with disability.21One quarter of informal caregivers provide nearly
45 hours of care per week for their loved with PD,22 and over a quarter spend
more than 75 hours per week providing care.269 Additionally, caregivers
commonly support PwPD at visits with clinicians, but are only engaged by
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physicians 40-70% of the time.270 Compared to matched control caregivers,
caregivers of PwPD exhibit higher direct and indirect costs consistently over
five-years.271 When examining income progression over five-years, caregivers
of PwPD also exhibited a higher cumulative income loss (Figure 14).271
Figure 14: Cumulative Income Loss for PD caregivers versus matched
controls271

In addition to economic disadvantage, PD caregivers also experience
stress and burden for caring with their loved one with PD.29 Male PD
caregivers have decreased access to informal caregiving resources, despite
reporting less strain than female caregivers.272 Women with PD receiving care
from a male informal caregiver are more likely to use, formal, paid
caregivers.272 Caregiving is a fundamental and valuable part of PD treatment
but limited research has been conducted on caregiving patterns and needs for
caring for a loved one with PD.272 In particular, dietary concerns, nutritionals
status, and how technology can enhance dietary management caregiving has
not been explored. To help include caregivers in the healthcare team,
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innovative mediums are necessary to increase access to caregiving and
reduce disparities among PwPD.272
Caregivers experience primary stressors and secondary role strains as a
result of providing care for their loved one.56 Primary stressors include both
subjective and objective difficulties directly related to providing care.273
Examples of objective primary stressors include care tasks and the degree of
impairment of the care recipient.273 Subjective primary stressors are the
caregivers’ emotional and psychological response to objective stressors. 273
Primary stressors can negatively impact caregivers’ physical and mental
health.274 Secondary role strains are when hardships experienced in roles and
activities that originate from primary stressors proliferate to other life areas.273
An example of secondary role strain is decreased participation in non-care
activities or reluctance to partake in activities due to the time, energy and
resources required to providing care.275 Older caregivers and those providing
help with ADLs and healthcare management (e.g. scheduling appointments)
are more likely to decrease participation in non-care activities.56
Caregiver activity restriction is also associated with poor health outcomes
for the caregiver, such as reduced sleep quality and high blood pressure.276,277
Compared with matched controls caregivers, PD caregivers had higher rates
of comorbidities, such as headache, gastroesophageal reflux disease,
hypertension, and irritable bowel syndrome.271 Many of these diseases require
dietary modifications to minimize and manage symptoms and suggest
nutritional education may be beneficial. Further research is needed to assess
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the nutritional status and nutrition needs of PD caregivers. Additionally, given
the later-onset of PD, most caregivers are older adults and have their own
medical conditions.259
Informal caregivers for PwPD are at increased risk for poorer QOL, which
is partly attributed to observing disease-related physical and cognitive decline
in their loved ones.29 Informal caregivers are typically responsible for
performing the majority of ADL, including buying and preparing food, and
transportation.22 Caregiving stress can also resonate adverse consequences
on the patient-caregiver dyad, compromising the care provided, as well as
negatively impacting relations with the larger-family system.56
Studies have examined the lived experience of living with PD, needs and
preferences of PD-Caregiver Dyads related to managing Parkinson’s disease.
278

Smith and Shaw279exained the lived experience of both the PwPD and their

caregiver within a family unit and found partners share the impact of PD, were
learning to live in a new way to adopt to disease progression and felt a sense
of belonging from support groups. Additional research can help identify
services required to facilitate the process of learning to live with PD,279 such
research should include how nutritional management can help facilitate this
process. How dyads experience related to food and access nutrition
information has yet to be explore.
Habermann & Shin278 conducted a descriptive qualitative study among
caregiver and PwPD to explore how dyads discuss needs, concerns and
preferences for advanced PD. Findings indicated dyads wanted improved
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communication with healthcare providers and had concerns with choking, falls,
voice production, financial strain and the future of disease progression.278
Increasing access to nutrition services can help address some of these
concerns; nutrition professionals can provide education on optimizing dietary
intake when modifying textures and calculating nutrition support needs to
accommodate swallowing issues, as well as optimize dietary intake to promote
a healthy body composition to prevent fall risk.
Educating caregivers early at disease diagnosis and encouraging
caregivers to partner with healthcare providers can reduce stress and family
conflict.135 Couple-oriented interventions improve spousal coping strategies,
promote disease related stress and anxiety management, increase selfefficacy (one’s belief in his/her capability to perform, organize, or execute a
task or succeed in a situation280), and help couples manage changes caused
by PD.32 Innovative mediums, such as digital health via video, web-based,
telephone-based and remote-monitoring can have a significant improvement
on caregiver outcomes.204 The use of technology can enhance caregiving
experience and facilitate shared decision making, where patients and
caregivers are actively involved in the care process and participate in the
decision making processes.204
V.

Conclusion
Due to limited mobility, transportation access, need for visual assessment

and ongoing interdisciplinary care, PwPD are excellent candidates for digital
health26,139, which may help increase opportunities for nutrition services.
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Understanding how the nutritional status of PwPD change overtime can help
health care professionals better understand the nutritional needs of PwPD and
provide effective nutrition services via digital health. Therefore, the purpose of
this mixed-methods project is to: 1.) Understand how the nutritional status of
PwPD changes overtime; 2.) examine the perceptions, acceptance,
facilitators, and barriers for adopting digital health to improve the nutritional
health of PwPD and their informal caregivers; 3.) understand the nutritional
status and digital competence of PwPD and their informal caregivers.
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APPENDIX B
EXTENDED METHODOLOGY
Overview
The completed studies are part two major studies / projects at the
University of Rhode Island. Project 1 is part of a 5-year longitudinal study
examining the change in nutrition, physical function, cognition and swallowing
among those living with neurological disorders and neurotypical participants.
Project 2 is a formative, mixed-methods analysis, assessing people with
Parkinson’s disease (PwPD) and their informal caregivers. The specific aims
for this dissertation, the chapters of the dissertation they are addressed in and
the corresponding study project are summarized in Table 1. Enclosed is the
methodology for both projects and their aspects that address the specific aims.
Table 1: Specific Aims, Corresponding Chapter and Project Number
Overarching and Specific Aims
Aim 1: To assess the nutrition risk of PwPD overtime.
• Track the nutritional status of PwPD overtime
• Examine how disease sequelae may influence nutritional
status.
Aim 2: Evaluate the nutritional status in PwPD and their
caregivers
• Evaluate the diet quality among PwPD and their informal
caregivers;
• Describe the self-reported nutrition concerns among PwPD
and their informal caregivers;
• Explore if the nutrition concerns match the dietary quality of
PwPD and informal caregivers.
Aim 3: Examine PwPD’s and their caregivers’ perceptions and
acceptance of digital health
Aim 4: Describe digital competence among PwPD and their
caregivers.
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Chapter #

Project #

1

1

2

2

3

2

3

2

Project 1 Design and Methodology (Aim 1, Chapter 1)
This is an ancillary study of a five-year observational, longitudinal study
assessing the nutritional, cardio-metabolic, cognitive and physical function
status of PwPD, acquired brain injury (ABI) and neurotypical participants
(Longitudinal Study of Communication, Nutrition and Physical Activity, IRB
HU1314-006). Participants come to URI’s Speech and Hearing Clinic located
at the Kingston Campus and are assessed every six months for five years.
Participants are enrolled in the study on a rolling basis. Potential participants
aged 18-85 years are recruited via brochures and word-of-mouth; one-year
post-PD or -ABI diagnosis. The time commitment for participants is three
hours per evaluation for a total of 30 hours for the five years. Written data
were stored in a locked file cabinet in the Department of Communicative
Disorders. Prior to their first assessments, participants went through the
informed consent process (Appendix C).
For Chapter 1, those PwPD who completed an assessment their
baseline year, year 2 and year 4 were included in this study. These
participants completed their assessments from Fall 2013 through Spring 2019.
Table 2 summarizes the research timeline for chapter 1. Table 3 summarizes
the measures performed at each assessment visit.
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Table 2: Specific Aim 1 Study Timeline
Activities
IRB
Recruit
Assessment Visits
Data Entry
Data Analysis
Manuscript Preparation

Fa 2013 –
Sp 2017
X
X
X
X

Fa
2017
X

Sp
2018

Fa
2018

Sp
2019

X
X

X
X

X
X

X
X
X

Fa
2019

Sp
2020

X
X

X

Table 3: Assessment Protocols by Domain
Assessment Domain
Nutrition
Cardiometabolic

Assessment Tool
The Dietary Screening Tool (DST)*1
Lipid profiles and blood pressure*
Height, weight, body mass index (BMI), percent body
Anthropometric
fat*
Physical Functioning
Short Physical performance Battery (SPPB)2
Swallowing Quality of Life Survey (SWAL-QOL)3;
Swallowing
Timed Swallow Test4
Repeatable Battery for the Assessment of
Cognition
Neuropsychological Status (RBANS)5
Medical History
Past Medical History Questionnaire
*Assessments used to for Aim1

Data Collection
Nutritional Assessment Measures
Within the nutrition assessment, the dietary screening tool was used to
assess nutrition risk, and biochemical, clinical, and anthropometric data were
obtained Participants completed the dietary screening tool (DST, Appendix
D), a 25-item questionnaire validated and used to identify dietary patterns and
nutritional risk in older adults.1,6 A total of 105 points can be achieved. Scores
can be categorized as: at risk (<60), possible risk (60-75), and not at nutrition
risk (>75).The eight component scores from the DST were also examined,
which include: whole fruit and juice (15 points), vegetables (15 points), whole
grains (15 points), lean protein (10 points), processed meats (10 points), dairy
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(10 points), added fats, sugars and sweets (25 points), and supplements (5
points). We determined participants who achieved >80% for each DST
component score.
Biochemical and Clinical Data (Appendix E). Serum total cholesterol,
low-density lipoprotein cholesterol, high-density lipoprotein cholesterol,
triacylglycerol, and glucose will be obtained using a finger stick (Cholestech®
LDX system, Hayward, CA) after a 12-hour fast. Blood pressure will be
measured using automatic blood pressure machine (Omron Healthcare Inc.,
Bannockburin, IL).
Anthropometrics. Height was measured using a stadiometer (Seca,
Birmingham, UK) to the nearest 0.5 cm in duplicate and then averaged.
Measures were repeated if obtained height was not within 0.2 cm of each
other. Weight was obtained using a calibrated electronic scale (Healthometer
752KL, Jarden Consumer Solutions, Boca Raton, FL) to the closest 0.1 kg.
Weight measurements were taken in duplicate and averaged. The average
height and weight value were used to calculate body mass index (BMI, kg of
body weight/height in meters2). A BMI between 28 and 23 was considered
within an optimal range, aligning with older adults.7
Other measures
The measures described below were collected at each assessment visit
and analyzed to help better understand and explore factors that may influence
nutritional status among PwPD.
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Physical Functioning. The SPPB (Appendix F) assessed participants’
global physical functioning and includes gait speed, standing balance tests,
and five repeated chair stands.2 Scores <10 indicated mobility disability.2
Cognitive Evaluation. To measure attention, language, memory,
constructional and visual-spatial abilities, the RBANS (Appendix G) will be
used.5 The test includes 12 subtests that can be completed in 30 minutes. A
score <80 indicates cognitive impairment may be present.
Swallowing Evaluation. The SWAL-QOL (Appendix H) is a 44-item survey
that takes10 minutes to complete. Participants rate factors about 10 quality of
life concepts related to swallowing.3 A timed swallow test (ml/s) is
administered to assess strength, coordination, range of movement, and timing
of movement of swallowing muscles in those with neurological disorders
(Appendix I).4 The number of swallows and the time it takes to swallow the
water are counted.
Medical History. A medical history questionnaire (Appendix J) is used to
identify health-related conditions and takes ten minutes to complete.
Statistical Analysis. Data was analyzed in SPSSv26. Categorical
variables were represented as numbers and percentages and continuous
variables were reported as mean±standard deviations. Data was assessed for
normality and non-normally distributed data was transformed for analyses but
original mean±standard deviations were reported. To assess changes in
nutritional risk via DST scores, a repeated measures analysis of covariance
was completed with time since diagnosis as a covariate. A Bonferroni
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adjustment was made for multiple comparisons. Analyses were 2-tailed and a
p<0.05 will indicate statistical significance Paired sample t-tests were also
conducted among outcome variables from baseline to year 2, year 2 to year 4
and baseline to year 4 were also conducted. Analyses were 2-tailed and a
p<0.05 will indicate statistical significance. Participants were then individually
analyzed for suboptimal scores across each outcome variable and the
frequency of sub-optimal scores were reported.
Project 2 (Chapters 2 & 3, Aims 2-4)
Project 2 Overview
Chapters 2and 3 were from a descriptive, cross-sectional study collected
qualitative and quantitative data from PwPD (n=20) and their informal
caregivers (n=20) via dyadic semi-structured interviews (n=20),
questionnaires, and anthropometric assessment. The project was approved by
the Institutional Review Board (HU1819-001, Telenutrition and Parkinson’s
disease). The purpose of project 2 was to examine the perception and
acceptance of digital health technologies in PwPD and their caregivers, as well
as understand facilitators and barriers for digital health adoption for the
nutrition care process. This study also evaluated the nutritional status and
digital competence in PwPD and caregivers. A concurrent mixed-method
design8 was used to assess the nutritional status and nutrition concerns of
PwPD and their informal caregivers. This mixed-methods design was chosen
to gain a more complete understanding of nutritional needs of PwPD and
caregivers through comparing and synthesizing both quantitative and
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qualitative data.8 Data was collected over four assessments completed
between November 2018 and April 2019. A summary of activities that
occurred in each session is provided in Table 4. Sessions 1, 3, and 4 were
conducted by phone, while Session 2 was conducted in the participants’
home. The study timeline is summarized in Table 5.
Table 4: Aims 2-4 Proposed Study Timeline
Activities

Fall 2017

Proposal Defense
IRB
Recruit and
Consent
Assessment Visits
Data Entry
Data Analysis
Manuscript
Preparation
Defend Dissertation

Su
2018

Fall
2018

Spr
2019

Fall
2019

X
X
X

X
X
X

Spr
2020

X
X
X

X

X
X

X
X

X

X
X

Table 5: Description and Timeline of Evaluations for Project 2
Session
Session
1
Session
2

Location
Phone
call
In-person

Session
3
Session
4

Phone
call
Phone
call

Activities
Informational Phone Call; Cognitive
Screening
Informed Consent; Questionnaires;
Anthropometrics, Timed Swallow Test; SemiStructured Interviews
1st 24-hour Dietary Recall

Time
30 minutes

2nd 24-hour Dietary Recall

60 minutes

Total Participant Time

275 minutes

125 minutes
60 minutes

Assessment 1 was an informational phone call during which
participants were screened for eligibility and informed about the study protocol.
At the beginning of Assessment 2, the study protocol was reviewed and both
PwPD and their informal caregiver completed the informed consent process.
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Assessment 2 was an in-person home visit, which consisted of a timedswallow screening, questionnaires, and a semi-structured, dyadic interview.
Assessments 3 and 4 were phone calls during which participants completed
two 24-hour recalls.
Theoretical Framework. This mixed-methods study targeted elements of the
emerging middle-range theory of transitions.9 A transition represents change
from one state or condition to another, and includes life development stages,
such becoming an informal caregiver. Research shows helping informal
caregivers acquire new skills to cope with situations related to caregiving, and
creating feelings of informal support for caregivers, plays a central role in
successful role transition.9 Acquisition of subjective and objective data from
PwPD and caregivers was collected to help better understand the transition
dyads face as the patient-caregiver relationship changes, and the role of the
caregiver evolves9, especially in relation to dietary management. The
approach has been used to provide tailored health interventions for those with
neurodegenerative diseases and their caregivers.10,11
This study concentrated on the early stages of digital health nutrition
services, in which PwPD and caregivers provided personal opinions and
preferences to inform the creation of an user-friendly, evidenced-based, digital
health service.12 Formative analysis has been used to effectively employ
digital health technologies for older adults13,14, and in the development of
dyadic interventions for PwPD.10 Findings from the proposed study can be
incorporated into the technology acceptance model (TAM).15
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Inclusion Criteria. Both the PwPD and their informal caregiver were
required to participate and needed to be community-dwelling, English
speaking, and ≥18 years old. Participants also needed to score >18 on the
Telephone Montreal Cognitive Assessment (T-MoCA), a cognitive screening
tool, that was administered during Assessment 1.16,17 A list of inclusion criteria
for both PwPD and caregivers are summarized in Table 6.
Table 6: Inclusion Criteria for Project 2 (Specific Aims 2-4)
PwPD
18+ years old
English Speaking
Cognitive Function <18 on t-MoCA
Has identified an informal caregiver

Informal Caregiver
18+ years old
English Speaking
Cognitive Function <18 on t-MoCA
Performs majority of care

Recruitment and Data Saturation. Recruitment occurred following
study approval by URI’s Institutional Review Board (HU1819-001). Emails,
flyers (Appendix K), announcements at support groups, word of mouth and
current statewide collaborations and contacts were used to recruit participants.
Participants were recruited from support groups throughout New England,
New York and New Jersey via announcements and flyers at community
centers, via healthcare providers, the American Parkinson’s Disease
Association website, and through popular press coverage from the University.
Twenty-five dyads expressed interest. Five dyads did not continue with
the study due to scheduling conflicts or low T-MoCA scores. Eighteen dyads
were eligible, enrolled and interviewed. Two of these dyads included couples
who were both living with PD and identified as each other’s informal caregivers
and were double counted as a PwPD and a caregiver. As a result, 20 dyads
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were included in analyses. Dyads were from Rhode Island, Massachusetts,
New York, and Connecticut. We aimed to interview up to 20 dyads as
previous research among PwPD and caregivers indicates this is where data
saturation is reached.18,19 Saturation was reached after the fourteenth
interview.
Incentive Structure. Dyads who complete all 4 sessions will receive
tailored dietary recommendations based on individual assessments, and a
chance to win a wearable device to monitor health. Emerging themes and
general findings from interviews related will be provided
Informed Consent Process. Potential participants will receive an
informational phone call (session 1) to review the study purpose and
requirements. Consent was provided or declined from the PwPD and their
informal caregiver at the beginning of the in-person evaluations (session 2).
Both the caregiver and the PwPD were consented. Interested and eligible
dyads were enrolled in the study. (Appendix L & M). Enrolled dyads will
complete a demographic and medical history questionnaire, then the semistructured interview. During the informed consent, there was a request
authorization for disclosure of protected health information from primary care
physicians or neurologists for PwPD, which included: PD stage, date of
diagnosis, current medications and treatment. Permission to request personal
health information from PwPD’s neurologist was also obtained (Appendix X),
in order to obtain information regarding disease staging.
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Collection and Analyses of Qualitative and Quantitative Data
Qualitative Assessment and Analysis.
Semi-structured Dyadic Interviews. A 24-question moderator guide,
informed by the previous literature and the research team was organized to
capture three main domains: PD and Diet, Accessibility of Nutrition and Health
Information, and Digital Health for PD. From these domains, participants’
acceptance and perception were assessed. A copy of the moderator guide is
provided in Appendix L. The moderator guide included three key sections of
the moderator’s script: 1.) PD and Diet, 2.) Accessibility of Nutrition and Health
Information, 3.) Digital Health for PD. Prior to starting the study, interviews
were piloted with two dyads and questions were modified based on participant
feedback. Interviews were conducted in the participants’ homes (facilitated by
DL) and were audio-recorded using a digital recorder. The mean interview
duration was 39 minutes (range 21-64 minutes). During interviews,
participants were provided operational definitions of terms (technology, digital
health, smart phones, smart watches, apps, videoconferencing). Photo
prompts were used to help describe different technological devices and digital
health tools and this was particularly important for understanding acceptance
of devices.
Qualitative analyses related to digital health specific aims (Aim 3):
Qualitative data was analyzed using deductive and inductive reasoning.
Transcripts were deductively-coded using the framework analysis method20, a
seven-stage, systematic approach used in healthcare research. Transcripts
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were inductively-coded using Colaizzi’s Strategy in Descriptive
Phenomenology21; this interpretative approach draws an understanding of
participants’ “lived experiences”.22
The following steps were taken to analyze the data related to
perception and acceptance of digital health, facilitators and barriers and
identified features for a digital health service. Recordings were transcribed
verbatim and DL checked transcripts for accuracy (stage 1). Transcripts were
divided into three batches. DL and a trained research assistant (KS) analyzed
one batch at a time. Separately, DL and KS coded for the following a priori
themes related to digital health: perception (perceived usefulness, perceived
ease of use, awareness of digital health, image of technology) and acceptance
(accept, neutral, reject). These a-prior themes adopts components of the
technology acceptance model (TAM).15
Before coding individually, KS and DL read through an entire batch of
transcripts, met to discuss initial impressions, developed a list of initial themes
and then coded a-priori (stage 2). Both DL and KS coded one transcript from
the batch independently and in duplicate (stage 3). The two researchers
compared and reconciled coding, and there was a strong agreement between
authors on the transcripts reviewed. During this discussion the two
researchers developed a working analytical framework and agreed upon which
codes to use on the remaining transcripts (stage 4). The transcripts were
uploaded to NVivo12 (QSR International Pty Ltd, AU) and coded separately by
DL and KS. An inter-coder reliability was calculated and found acceptable23,
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with an agreement >80% achieved for each overarching theme across each
batch. DL and KS met to reconcile coding differences. The research
committee and DL met to collapse and finalize themes (stage 5). Data was
then charted into framework matrices using NVivo12 to display codes within
each theme (stage 6). Data was interpreted, and connections related to digital
competence and technological preferences of PwPD and their caregivers were
made (stage 7). Although a priori themes helped to inform this framework, a
phenomenological and iterative approach throughout each stage of the
analyses was also taken to identify emerging themes that may impact
technology use among this population. Both DL and KS contributed to the
framework development with the advisement of the dissertation committee.
Qualitative Analyses Related to Nutrition (Aim 2):
The two coders (DL and KS) took a similar approach to analyze the
interviews for nutrition concerns. Before coding individually, KS and DL read
through all of the transcripts and developed a list of initial impressions and
themes, which fell under three categories: Dietary Concerns Related to PD
Sequelae, Other Nutrition Concerns and Perceptions of Diet. Both DL and KS
coded one transcript from each batch independently and met to compare and
reconcile coding. At this point DL and KS created a working analytical
framework and agreed upon codes to use for analyzing the remaining
transcripts. The transcripts were uploaded to NVivo12 (QSR International Pty
Ltd, AU) and coded separately by DL and KS. An inter-coder reliability was
calculated, with an agreement >80% achieved.23
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DL and KS compared codes between each batch and reconciled
differences between codes, until a consensus was reached. Codes were then
finalized. To ensure information related to dietary intake was not overlooked in
other sections of the transcripts, DL went through all of the transcripts and
coded the remaining sections. KS reviewed these codes to verify coding
structure, added additional codes when needed and DL and KS discussed
differences in coding and collapsed themes. The larger research team and DL
met to further collapse and finalize themes.
Quantitative Data Collection and Analyses.
The following assessments will be completed and analyzed for both
PwPD and their informal caregiver, unless otherwise noted.
Dietary Data. Nutrition Risk and Diet Quality.
Within the nutrition assessment, the dietary screening tool was used to
assess nutrition risk, and biochemical, clinical, and anthropometric data were
obtained Participants completed the dietary screening tool (DST, Appendix
D), a 25-item questionnaire validated and used to identify dietary patterns and
nutritional risk in older adults.1,6
Both PwPD and caregivers completed two 24-hour recalls via telephone
(sessions 3 and 4). These recalls included one weekend and week day, and
were conducted using the gold-standard, multiple-pass interview method
(Appendix O).24 Participants received a food amounts booklet to estimate and
report accurate portion sizes. Twenty-four-hour recalls were entered into
Nutrition Data System for Research Software 2017 (NDSR, University of
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Minnesota, Minneapolis, MN) and analyzed for total energy, food group and
nutrient intake. The NDSR data was assessed for diet quality using the
Healthy Eating Index (HEI)-2015 scoring metric.25 Total scores can range from
1-100; the higher the score, the better the diet quality. Mean scores from the
two days were used. Outputs from NDSR were used to calculate HEI-2015
component scores (whole grains, whole fruits, total fruits, vegetable, greens
and beans, dairy, total proteins, seafood, plant protein and seafood, refined
grains, sodium, added sugars, and saturated fat) derived using USDA SAS
codes.26 Component scores help to provide insight into types of food
consumed and nutrients of interest for future interventions.
Anthropometrics. Height was measured using a stadiometer (Seca,
Birmingham, UK) to the nearest 0.5 cm in duplicate and then averaged.
Measures were repeated if obtained height was not within 0.2 cm of each
other. Weight was obtained using a calibrated electronic scale (Tanita HD351,
Japan) to the closest 0.1 kg. Weight measurements were taken in duplicate
and averaged. The average height and weight value were used to calculate
body mass index (BMI, kg of body weight/height in meters2). A BMI between
28 and 23 was considered within an optimal range, aligning with older adults.7
The bioelectrical impedance analysis (InBody, Korea) device27,
assessed body composition28,29, and has been used with PwPD.30 The
analysis takes five minutes to complete. Body composition was not be
obtained for participants with implantable medical devices. Guidelines
proposed by the American Council on Exercise were used to assess percent
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body fat31, with values of <32% for women and <25% for men considered
acceptable.31 Standardized protocol was used to measure waist
circumference with Gulick anthropometric tape (Fabrication Enterprises Inc.
White Plains, NY).32 Waist circumference was measured in the horizontal
plane at the superior border of the iliac crest. Measurements were taken in
duplicate and averaged.
Digital Competence and Technology Use. In addition to digital health
data gathered during semi-structured interviews, questions related to
technology competence, technology use and digital health use will be
gathered through two questionnaires. Questions will be adopted from
“Measuring Digital Health Skills across the EU: EU Wide Indicators of Digital
Competence,” (Appendix P)33 which assessed use and level of comfort using
various aspects of technology via 15 questions/statements.33 For each
statement, participants responded strongly disagree, slightly disagree, slightly
agree or strongly agree. We also collected data regarding device use,
frequently and purposes of device use.
Digital health was assessed using questions from the “2015 Health
Information National Trends Survey”, Section B (Appendix Q), which contains
11 yes/no questions, as well as questions describing technology use and how
health information is accessed.34-36 Questions from this questionnaire also
asked participants where they go first to search for health information, rate the
amount of effort it took to find the information and the describe the confidence
in finding quality health information. Questions also asked PwPD and
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caregivers to rate the level of trust they had for obtaining nutrition and health
information from an array of sources, including doctors, other health
professions, family and friends, organizations and online blogs.
Other Measures. Assessment tools measured cognition, anthropometrics,
disease related QOL, caregiver burden, swallowing function, medical history,
and demographics. These variables were used to help describe participants.
Cognitive Status. Cognitive status was assessed using the T-MoCA
(Appendix R).16,17 The test takes about 10 minutes to complete and is
validated in community-dwelling adults with mild cognitive impairment.17 It
includes eight subtests assessing digit span, attention, calculation, repetition,
verbal fluency, abstraction, recall and orientation.16 Participant who have less
than 12 years or less of formal education will receive one point toward their
total score. Scores <18 out of a possible 22 points indicate mild cognitive
impairment.
Swallowing Function. A timed swallow test (ml/s) was administered to
assess swallowing muscles in those with neurological disorders.4 Specifically,
it assesses: strength, coordination, range of movement and timing of
movement of swallowing muscles (Appendix I). The Eating Assessment Tool
(EAT-10)37, a validated 10-item questionnaire, screened for self-reported
swallowing difficulties (Appendix S). Scores on the EAT-10 range from 0-40;
higher scores indicate a swallowing problem.
Disease Related Quality of Life. The 39-item Parkinson’s Disease
Questionnaire (PDQ-39) is a disease-specific tool that assessed the health-
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related quality of life of PwPD (Appendix T).38,39 The questionnaire contains
eight sub-scales (mobility, emotional well-being, stigma, social support,
cognitions, communication and bodily discomfort), which were used to
calculate global health-related quality of life. Each item scores from 0 (never)
to 4 (always), with the highest possible score of 156, and higher scores
indicate worse quality of life.38,39 Results are reported using an index
percentage (0%=no disability and 100%=maximum disability).
Caregiver Burden. The Multidimensional Caregiver Strain Index (MCSI)
assessed caregiver burden.40 This 18-item tool collected subjective
information from informal caregivers across six domains: physical strain, social
constraints, financial strain, time constraints, interpersonal strain, and elder
demanding/manipulative. Response to individual questions are reported on a
0 (never) to 4 (a great deal) scale. Scores range from 0-64 points and are
reported as an index percentage130; higher scores indicate higher caregiver
strain130. The scale has been previously used successfully in the PD
population131.
Medical History and Demographics. To identify health-related conditions
and past medical history, a non-validated medical history questionnaire was
used. Topics covered included: questions related to neurological, endocrine
and cardiovascular and gastrointestinal health. Demographics (age, gender,
race/ethnicity, employment status) were collected. Health information and
demographic information was obtained from both PwPD and their caregivers
(Appendix V and W).
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Quantitative Statistical Analyses. Quantitative data was analyzed using
SPSS v26 (IBM Corp, Summers, NY). Descriptive statistics are reported as
mean±standard deviation for continuous variables and percentages and
frequencies for categorical variables. Data was examined for outliers, and
outliers were found among the following HEI-2015 variables: HEI-2015 Total
Scores, Protein, and Refined Grains component scores. Independent t-tests
explored differences between PwPD and caregivers for all normally distributed
continuous variables. A Mann-Whitney U test examined group differences
between non-normally distributed continuous variables. A chi-square analysis
explored differences for categorical variables. A p-value of <0.05 indicated
statistical significance. Finally, the percent and frequency of PwPD and
caregivers who met >80% of adequacy and moderation HEI-2015 components
scores were calculated.

Data Integration.
Manuscript 2: The research team reviewed both data sets and
considered the themes coded from the qualitative research in conjunction with
the findings from the statistical analyses of the HEI-2015 scores. Qualitative
data was mapped into framework matrices and reported as frequencies using
NVivo12 to quantify codes within the over-arching category of Dietary
Concerns Related to PD Sequelae. This frequency data stemmed from the
qualitative themes and a side-by-side comparison of themes were compared
with individual HEI-2015 Scores for each participant. Data was interpreted for
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consistent patterns between HEI-2015 scores and frequency of self-reported
Dietary Concerns Related to PD sequelae from PwPD and their caregivers
were made.
Manuscript 3: Acceptance of digital health was analyzed by assessing
current technology use and purpose from questionnaires and through themes
coded from qualitative interviews. Phrases/sentences from qualitative
interviews related to acceptance were categorized as Accept, Neutral or
Reject. To calculate average acceptance rate among qualitative interviews,
the number of phrases coded as Accept, Neutral or Reject were counted and
totaled. The total number of phrases coded as Accept were divided by the
total number of phrases coded across the three acceptance categories to
calculate acceptance rates among each dyad. The percentages were
averaged to calculate an average acceptance rate (n=20). Codes from the
qualitative interviews were transformed into variables and reported as percent
and frequencies. Side-by-side table displays of frequencies derived from
perceptions and acceptance (qualitative data) and digital competence scores
(quantitative data) were created and interpreted to better describe the
population and readiness for a digital health intervention. A Pearson
correlation was used to explore if there was an association between the
percentage of phrases coded as hard to use and the mean average
acceptance rates.
Resources Required and Utilized:
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Partial funding for Project 1 came from the URI Spark Grant and
Enhancement for Graduate Research Award. There was no funding for Project
2. Data collection for Project 1 took place in Independence Square in the URI
Speech and Hearing Clinic. Data for Project 2 was collected through phone
calls and home visits. Department equipment included: stadiometer, bioelectric impedance scale, electronic scale, cholestech analyzers, portable
automatic blood pressure machines, and measuring tape. Data was analyzed
using software found on the lab computers in the Lipid Metabolism Lab,
including Nvivo 12, SPSS, SAS and NDSR.
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APPENDIX C: Longitudinal Study Consent Form (Study 1)
Longitudinal Study of Communication, Nutrition and Physical Activity
Leslie A. Mahler, PhD, Principal Investigator
Ingrid Lofgren, PhD, co-Investigator
Matthew Delmonico, PhD, co-Investigator
CONSENT FORM FOR RESEARCH: Participant
Version 5: May 24, 2016
The University of Rhode Island
Department of Communicative Disorders
25 W Independence Square, Suite I
Kingston, RI 02881
Purpose of the Consent:
You have been invited to take part in a research project described below. The purpose
of the consent form you are about to read is to provide you with details about the
research study and to inform you of your rights if you agree to participate in the study.
Your participation is completely up to you. The researcher will explain the project to
you in detail. You should feel free to ask questions. If you have more questions later
you can call, Dr. Leslie Mahler, the person mainly responsible for this study, at 401874-2490. You may also contact Dr. Ingrid Lofgren at 401-874-5706 or Dr. Matthew
Delmonico at 401-874-5440, who are co-Investigators on the study. You must be at
least 18 years old and speak English to be in this research project.
Description of the project:
This is a research project designed to look at communication, nutrition, and physical
activity characteristics of adults who have a stroke, traumatic brain injury or Parkinson
disease and healthy adults with no known neurological disorder or head injury to be a
control group. All evaluations will be conducted at one of two University of Rhode
Island locations; in Independence Square on the Kingston Campus at 25 West
Independence Way, Kingston or in Independence Square at 500 Prospect Street in
Pawtucket.
You are being asked to be in this study because we want to determine the long-term
impact of neurological disorders on communication, nutrition, and physical activity.
We are looking for 200 people who have a stroke, traumatic brain injury or Parkinson
disease to participate in this project. Participation in this study is entirely your choice.
If you decide to take part in this study, you should understand that the evaluations are
investigational and you may not experience any benefit from participation.
Participation may also involve additional risks as listed in the Potential Risks and
Discomforts section. The consent form will help make sure you understand the tasks
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included in the study before you decide whether you want to take part in the study.
You may also quit the study at any time.
What will be done:
If you agree to take part in this study, you will be asked to complete up to 11
evaluations over five years. Evaluations will take place every six months. The
evaluations will include a variety of tasks such as reading sentences and describing a
picture, an assessment of how your muscles move, a cognitive screening, an interview,
a clinical swallowing evaluation, and questionnaires regarding swallowing, diet and
physical activity. The total time for each evaluation will be approximately 3½ hours.
All evaluations will be conducted in a quiet private room at one of the University of
Rhode Island Speech and Hearing Clinic locations (Kingston or Pawtucket).
With your permission, we will request health information from your physician about
the following specific items only:

• Date of diagnosis
• Current medications
• Imaging information about where the brain damage is located (if
appropriate)
• Stage of Parkinson disease (if applicable)
You will sign a separate form to indicate whether you give your permission to release
this health information for the study. This information will not be requested for
healthy adults enrolled in the study
Potential risks and discomforts:
There are minimal foreseeable risks associated with these evaluations. There have
been no reported adverse affects from clinical evaluation of speech and swallowing.
There may be some unknown or unanticipated risks, but every precaution will be
taken to ensure your personal safety. Even though experienced personnel will obtain
the blood samples from a finger prick, there is a chance of discomfort and minor
bruising from the finger stick. For physical function testing there is a risk of muscle
soreness or other muscle injury as well as skeletal injury but we will minimize these
risks by using standard safety practices.

Purpose and benefits of the study:
The purpose of this study is to describe communication, nutrition, and physical
activity behaviors over time to see how they change and affect quality of life. The
information obtained is important because it will help us to understand how to provide
services to meet the needs of people with neurological diagnoses. This is an
investigational study and there is no guaranteed benefit to your communication or
nutrition or physical function as a result of participation in this research study. You
will receive personal health information such as your height and weight, physical
function determined by a physical assessment, your blood lipids such as cholesterol
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and triglycerides. In addition, you will receive information about your thinking skills
and language skills and dietary choices.
Drugs, devices or instruments to be used:
Drugs will not be used in this study. The equipment for the evaluations include:
microphone, sound level meter, tongue blade, a digital tuner, tape recorder, and video
cameras. All equipment used to collect cognitive-linguistic and physical function data
is considered non-invasive. A lancet and capillary tube will be used to obtain the blood
sample from a finger prick and the sample will be analyzed on a small portable
machine that is on a table.
Cost to participant:
There is no cost to you for participation in the evaluations. Parking is available for
free.
Confidentiality:
Your part in this study is confidential. Your individual privacy will be maintained in
all published and written data resulting from this study. No names of participants will
be published or included in written data resulting from this study. Results of this
study may be used for purposes of research, educational lectures, and/or professional
presentations. When you are entered into the study you will be assigned a code that
does not include any identifying information. For example, the first participant will be
coded as Long01. The code number will be used on all response forms and in the
analysis of the data.
Dr. Mahler and her research team will have sole access to all contact information and
evaluation results containing your name. This information will be kept in a locked
filing cabinet in a locked office. However, the U.S. Department of Health and Human
Services, and the University of Rhode Island Institutional Review Board have the right
to inspect all of your records relating to this research for the purpose of verifying data.
Because of the need to release information to these parties, absolute confidentiality
cannot be guaranteed. Following completion of this project, contact information will
be destroyed for those participants who wish, for any reason, not to be contacted in the
future. All other information will be archived and kept in a locked filing cabinet with
the study results at the University of Rhode Island. All research data will be retained
for a minimum of three years following completion of the study and then will be
destroyed. Research data will be located in a locked filing cabinet in the principal
investigator’s locked office.
Cognitive-linguistic evaluations will be audio and video recorded to allow for data
analyses. At times these recordings can be useful for teaching students or
professionals about the disorders of people with a neurological diagnosis such as
yours. Please indicate by signing below whether you give your permission to use your
samples for lectures and presentations. Audio and/or videotapes may be used for
teaching for up to 3 years after completion of the study. If you agree, you will never
be identified by name in the presentations or lectures. Your decision to give
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permission to use audio and/or video samples in lectures has no impact on your
participation in the study.
_____________________Yes, I give permission to use audio samples in lectures and
presentations.
_____________________Yes, I give permission to use video samples in lectures and
presentations.
______________________No, I do not want audio samples used except for research
analysis.
______________________No, I do not want video samples used except for research
analysis.
In case there is any injury to you during the study:
If this study causes you any injury, you should immediately contact Dr. Leslie Mahler
at (401) 874-2490 or contact the University of Rhode Island Speech and Hearing
Clinic at (401) 874-5969. You may also call the office of the Vice President for
Research Integrity, 70 Lower College Road, University of Rhode Island, Kingston, RI
at (401) 874-4328. If you are injured during an evaluation or during treatment every
effort will be made to get you medical attention but you will be responsible for paying
for the medical treatment needed.
Decision to quit at any time:
The decision to take part in this study is up to you. You do not have to participate. If
you decide to take part in the study, you may quit and stop participating in this study
at any time. You have the right to refuse to answer any question(s) or participate in
any procedure for any reason. Deciding not to participate will have no effect on your
potential to receive services from a speech-language pathologist. If you wish to quit,
simply inform Leslie Mahler at 874-2490 of your decision. If you wish to pursue an
alternative treatment instead of completing the study you will be provided with
information on how to obtain those services.
Rights and complaints:
If you are not satisfied with the way this study is performed, you may discuss your
complaints with Dr. Leslie Mahler (lmahler@uri.edu; 401-874-2490), Dr. Ingrid
Lofgren (ingridlofgren@uri.edu, 401-874-5706), or Dr. Matthew Delmonico
(delmonico@uri.edu; 401-874-5440), or you may contact the office of the Vice
President for Research for concerns or any questions about your rights as a research
subject at: 70 Lower College Road, University of Rhode Island, Kingston, RI at (401)
874-4328 and speak to them anonymously if you choose.
Authorization:
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Your authorization means that you have read this paper and know the purpose of the
study and the possible risks and benefits. It also means you know that being in this
study is voluntary and you choose to be in this study. You can also withdraw at any
time. Your questions have been answered. Your signature on this form means that
you understand the information and you agree to participate in this study.
________________________
Signature of Participant

________________________
Signature of Researcher

_________________________
Participant Typed/printed Name

________________________
Researcher Typed/printed name

__________________________
Date

_______________________
Date

________________________
Signature of Guardian

________________________
Signature of Researcher

_________________________
Guardian Typed/printed Name

________________________
Researcher Typed/printed name

__________________________
Date

_______________________
Date

Please sign both consent forms, keeping one for yourself.
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Appendix I: Time Swallow Test
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APPENDIX J: Past Medical History

INTERVIEW
Longitudinal Study of Communication, Nutrition and Physical Activity
Leslie Mahler, PhD, CCC-SLP, Principal Investigator
Ingrid Lofgren, PhD, co-Investigator
Matthew Delmonico, PhD, co-Investigator
Version 1: 7-3-13

Participant Name:_________________________
ID#: ______________

Initials: ___ ___ ___

Name of Interviewer:_____________________________
Date:_________________
Emergency contact name and address & phone:
_______________________________________
_______________________________________
DIRECTIONS: Read the following questions out loud to each prospective volunteer
and record the answers. Any answers that require clarification should be written in
the space below the question or on the back of the sheet. Indicate whether any
follow-up is necessary or if any referrals are appropriate.
What is your neurological diagnosis? __________________________
When were you diagnosed? _________________________________
What were your symptoms at that
time?____________________________________________
_____________________________________________________________________
_______
What are your symptoms now?
___________________________________________________
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_____________________________________________________________________
________
What is your communication
like?_________________________________________________
_____________________________________________________________________
________
What is your diet like?
___________________________________________________________
What is your physical activity like?
_________________________________________________
Does your speech sound clear to other people?
_________________________________________
If not, how does it sound?
___________________________________________________
Can you think of the words that you want to say?
______________________________________
If you do have trouble, how often does it happen?
__________________________________
Are you experiencing any symptoms of a swallowing disorder?
_____________________________
If yes, what is the problem with your swallowing?
__________________________________
_____________________________________________________________________
________
What would you say is your most significant problem with speech or swallowing
today?
_____________________________________________________________________
_________
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Did you experience any changes in your speech or swallowing before your diagnosis?
________
_____________________________________________________________________
________
Does medication affect your speech or voice or swallowing? _________ If yes, in
what way?
_____________________________________________________________________
___
Speech
How many hours of speaking do you do in a day?
____________________________________
What is a typical day of communicating like for you?
__________________________________
_____________________________________________________________________
________
Do you pronounce your words clearly?
____________________________________________
Do people ask you to repeat yourself?
______________________________________________
Do people have a hard time understanding you?
______________________________________
What do you do when you want to be as easy to understand as possible?
__________________
_____________________________________________________________________
________
What percent of your speech do you think is understandable?
____________________________
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Has your neurological diagnosis caused you to talk less?
________________________________
If so, how much less? _____________

Why?

____________________________________
_____________________________________________________________________
________
Swallowing
Do you have any difficulty with swallowing?
___________________________________
Do you cough during mealtimes? _____________________
If yes, do you cough more with water or solid food?
_________________________________
Do you have difficulty making the food go down (need to swallow twice)?
____________
Does it take you longer to finish a meal than before your neurological diagnosis?
________________
Have you experienced any unintentional recent weight loss? _____________
Have you ever been diagnosed with pneumonia? ____________ If yes, when?
_____________
Have you changed your diet since your neurological diagnosis?
___________________
If yes, what did you modify? ___________________________________
Musculoskeletal system:
Has your doctor ever told you that you have: (circle all that apply)
•

Osteoarthritis or degenerative arthritis

•

Rheumatoid arthritis

•

Osteoporosis
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•

Ankylosing Spondylitis

•

Unknown or other type of arthritis

•

Any other disease of joint or muscle:

•

Comments:

Cardiovascular system:
•

Has any family member had a heart attack prior to the age of 55?
o If so, how are they related to you?

•

Have you ever had frequent cramping in your legs while resting?
o If yes, is it a current problem?

•

_____________________________

Have you ever had pain or cramping in your legs while walking?
o If yes, is it a current problem?

________________________________

•

If yes, is this pain relieved by rest or by discontinuing walking?

•

Have you ever been told that you have high blood pressure
o If yes, what was the date of onset? ____________________
o Were you given any medications?

•

______________

Did a doctor ever tell you that you had a heart problem?
o If yes: What was the date of onset? _______________________

•

What did the doctor call it? _________________________________
o Were you given any medications?

____________________________

• Do you have any history of high cholesterol in your blood as evidenced by a
previous blood lipid tests?
________________________________________________________
Comments:

______________________

Endocrine system:
Have you ever had any of the following: Thyroid problems, adrenal problems,
diabetes mellitus?
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•

_______________________________________________________________
_

•

If yes to diabetes, which type?

Type 1 or Type 2

Date of onset- _________________________
Are/were you on any medication, or is it diet controlled?
_________________________
Neurological system:
•

Do you have any significant problems with your memory? (circle all that apply)
o When answering the telephone, do you recall what you were doing
before it rang?
o Can you give the directions to your house/apartment?
o Can you keep appointments without a reminder?
o Can you remember what clothes you wore yesterday?

•

Any problems with vision other than corrective lens changes?
o If yes, which of the following conditions- Blindness, temporary loss
of vision, double vision, glaucoma, cataract, macular degeneration or
others.
_________________________________________________________
_____

Do you have and of the following?: (circle all that apply)
•

Vertigo (a feeling of spinning, or unsteadiness)

•

Seizure or convulsions?

•

Migraine or severe headaches?

•

Paralysis of arm or leg?

•

A head injury with loss of consciousness?

•

Pain, numbness or tingling in your limbs?

•

Pain in your lower back?
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•

Do you have pain in any part of body including headaches while exercising?

•

Have you been told that you have a peripheral neuropathy?

•

Tremors?

•

Problems with walking? If yes,
o Do you fall frequently?
o Is your walking problem related to pain, weakness or loss of balance?

•

Have you ever had an operation on skull or brain?

•

Have you ever had meningitis or Brain fever?

Comments:
Previous Treatment
Have you had previous speech or swallow treatment, occupational therapy or
physical therapy? __________________________________________
If yes, please describe (when, what)
_______________________________________________
_____________________________________________________________________
_______
Was it beneficial?
_____________________________________________________________
If yes, what changes did you notice?
______________________________________________
_____________________________________________________________________
_______
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Employment
Are you employed?
___________________________________________________________
Type of employment
__________________________________________________________
How much speaking do you do at your job?
___________________________________________
_____________________________________________________________________
_______
Other
Have you noticed any difficulty with your memory?
_____________________________
Have you experienced any changes in your mood?
_______________________________
Is it difficult for you to pay attention long enough to finish a task?
___________________
Do you have any difficulty reading? ____________________________________
Do you have any difficulty writing? ___________________________________
Do you have any other health problems or conditions that would affect
communication, nutrition or physical activity?
_____________________________________________________________________
________
_____________________________________________________________________
________
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APPENDIX K: Recruitment Materials
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Dear ______________________
The University of Rhode Island’s Lipid Lab is looking for people with
Parkinson’s disease and their caregivers (18 years+) to participate in a
research study to
collect information related to diet, access to health information and technology
use. The total time
commitment for the study is approximately 4.5 hours and is completed over 4
time
points.
Dr. Ingrid Lofgren, Department of Nutrition and Food Sciences, is the principal
investigator for this study. We are asking you to display our recruitment flyer in
your office, meeting area and/or lobby to help us recruit participants for this
study. The flyer is attached to this email. If you know of any participants who
are interested, please direct them to our
recruitment flyer with our contact information.
Thank you for your time and support. If you have any questions regarding the
study
please feel free to contact us.
Sincerely,
Dara LoBuono MS RD LDN
PhD Student
Department of Nutrition and Food Sciences
University of Rhode Island
401-874-2785
dara_lobuono@my.uri.edu
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APPENDIX L: Parkinson's and Telenutrition
Consent Form for Person with Parkinson’s Disease
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APPENDIX M: Parkinson's and Telenutrition
Consent Form for Caregiver
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APPENDX N: Moderator Guide for Semi-Structured Dyadic Interviews
Moderator Guide and Script
Script: Hello my name is Dara LoBuono. I am a PhD student at the University of Rhode
Island in the Department of Nutrition and Food Sciences. Today we will discuss how
you get health information, how you would like to get health information and what
would help you get this information more easily. Remember, there are no right or
wrong answers, so please answer questions as best as you can. As a reminder, I will
be recording our discussion and taking notes for research purposes. Before we begin,
do you have any questions?
Transition: Great! Let’s get started. The first few questions will be about Parkinson’s
disease and what you eat.
PD and Diet
1. Do you make different food choices as a result of having PD? Please explain.
a. Probes: Sugar intake? Fluid Intake? Types of food you eat?
b. Prompt: In what ways is eating more difficult for you as a result of
Parkinson’s disease?
Follow up: How does Parkinson’s disease impact the amount you eat?
c. Probes: Changes due to: Taste and smell? Constipation? Appetite? Time it
takes to cook a meal or limited time to cook meals?
2. What food choices or diet modifications help you manage the symptoms of your
Parkinson’s disease? Why or why not?
a. Probes: Changing textures to minimize difficulty chewing and swallowing?
Eating certain foods to manage constipation?
Transition: Now we will discuss your ability to get nutrition and health information
and ways that may help you increase access to these services.
Accessibility of Nutrition and Health Information
3. How does having Parkinson’s disease influence your ability to get health
information? (Are you able to find the health information you need for managing
Parkinson’s?)
4. How do you access health information for managing Parkinson’s disease?
5. Where do you get information about foods and diets for people with Parkinson’s
disease?
a. Follow up: Please describe what information was provided.
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6. What information related to eating do you want to learn more about? Please
explain.
7. How would you like to receive information about food and eating?
a. Probes: At visits with a healthcare provider, pamphlets, the internet, support
groups
b. Follow up: How often?
Transition: Thank you for that information. Now we are going to explore information
related technology* for managing Parkinson’s disease. For the purposes of this
interview, technology will be defined as: tools that support independent living, social
interaction and assist in managing and providing care. Examples include computers
and internet. When responding to these questions, please think about forms of
technology that either of you may use or be interested in using.
Digital Health for PD:
8. What forms of technology do you currently use and for what purpose?
a. Probes: computers, tablets, internet, e-mail, smart phones*, smart-watches*
*Smart phones – a cell phone that also includes internet access,
camera, email access, and storage. (Example: iPhone, Pixel, Android)
* Smart watches – a wristwatch that can also perform tasks similar to
a smart phone or computer. (Example: Apple Watch)
9. What does the term digital health* mean to you?
Transition: So, for the purpose of this study, digital health is a broad term used to
describe technologies that better manage and track health.
10. What digital health products do you currently use?
a. Probes: Apps* for medication management, devices to monitor
gait/speech/blood pressure, videoconferencing*
*Apps – also known as mobile or computer applications are programs
designed to perform a function, task or activity that can benefit the
user
*Videoconferencing – is a technology that allows two or more people
to communicate from different locations through video and audio
signals. Like talking on the phone, but you can see the person
(Example: Facetime, Skype)
11. What (additional) digital health products would you be willing to try and why?
a. Probes: Apps, devices to monitor gait/speech,* wearables*,
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videoconferencing, websites
i. Wearable device to Monitor Gait/Speech à sensors (ankle
bracelet or sock) that measure your stride length and time.
Information collected can determine if you are shuffling or
taking short steps and can provide information about disease
progression.
ii. wearables such as fit bits and apple watches are devices that
can track steps taken, heart rate, calories burned and sleep
quality. There is also one that helps manage tremors and
writing.
12. What digital health products would you be willing to try to help manage food and
eating for Parkinson’s disease and why?
13. The following scenarios are possible ways digital health can be used to make
information Tell me if you would be interested in learning more about utilizing
the following example of digital health and explain why.
a. Using videoconferencing to have nutrition counseling sessions from home.
b. Wearing a watch at meals and snacks that counts your bites*.
Bite Counter - a watch that tracks wrist motion to count bites and estimate
calories while you eat. It provides real-time feedback on amount consumed.
c. Taking pictures of meals and snacks for a nutrition professional to review.
d. A website that allows you to post questions to nutrition professionals and
other people living with Parkinson’s disease and their caregivers about
nutrition.
e. Using phone applications and websites to track the food you eat. (example:
MyFitness Pal, Lose it,
14. What makes technology and digital health useful for you?
15. What makes it difficult for you to use digital health (more)?
16. What else should I know about how digital health could help you with your eating
to optimize your management of Parkinson disease?
Transition: Thank you for answering all of my questions. We have a few more
questions related to the information we discussed today. I will read you the
question/statement and the possible responses. Please select one choice that most
closely aligns with your response.
Quantitative Questions.
17. How important is knowledge about your disease to you?
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1. Unimportant 2. Somewhat Important 3. Neutral 4. Important 5. Very
important.

Unimportant

Somewhat
Important

Neutral

Important

Very
Important

18. Which of these is your main source of knowledge about your disease? (Please
Pick one).
1. Healthcare
2. Patients organizations
3. Found myself online
4. Other patients
5. Family, relatives, and friends
6. Other sources.
19. Have you been able to find the knowledge you need about your disease?

Not at all

Rarely

Some of the
time

Most of the
time

Absolutely

20. How strongly do you agree or disagree that it is important to follow an eating
plan for managing PD?

Disagree

Somewhat
Disagree

Neutral

Somewhat
Agree

Agree

21. How easy or difficult is it to find information related to healthy eating for
Parkinson’s?
__ Very Difficult
__ Difficult
__ Somewhat Difficult
__ Easy
__ Very Easy
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22. How helpful would it be to work with a nutrition professional to manage eating
for Parkinson’s disease?
___Very Unhelpful
___Unhelpful
___ Somewhat unhelpful
___ Neither unhelpful or helpful
___ Somewhat Helpful
___ Helpful
___ Very Helpful

23. Since being diagnosed with Parkinson’s disease my appetite has:
Decreased

Slightly
Decreased

Stayed the
Same

Slightly
Increased

Increased

24. Since being diagnosed with Parkinson’s disease the overall amount you eat each
day has:
Decreased

Slightly
Decreased

Stayed the
Same

Slightly
Increased

Increased

Script: This concludes the interview. Thank you for all your valuable information and
participation in this study.
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APPENDIX O: Supporting Documents for 24-Hour Dietary Recall Data
Collected

24-Hour Recall Questions
Spring 2018
All enrolled participants will complete two 24-hour recalls. During Sessions 3
and 4 (via telephone), PwPD and caregivers will complete two 24-hour dietary
recalls; detailed information about food and beverages intake from midnight to
midnight the previous day. Each 24-hour recall will last about 30 minutes per
participant.
A 24HR is when a person is asked to list and describe all the foods they ate
the previous day. Since people consume different foods and beverages,
different questions are asked during each 24-hour. Participants will be
encouraged to have labels of foods they eat available during the assessments
so exact information can be entered. This project will be utilizing the Nutrition
Data System for Research from the University of Minnesota to collect the
dietary data. Information on the program is attached. For the most part, all
participants will be asked the following questions. Many of these questions will
be asked multiple times.
• At what time did you get up yesterday?
• What was the first thing you had to eat or drink after getting up
yesterday?
• What else did you have to eat with that (insert food or beverage)?
• What was added to that beverage?
• What else did you have at that meal?
• Was the (insert food or beverage) eaten plain or did you put something
on it?
• What did you eat after that meal?
• What did you have for snacks yesterday?
• What was the brand of (insert food or beverage)?
• How many cans/bottles or juice/soda/water did you have at that time?
• What was the last thing you ate and drank yesterday?
• What did you snack on after you last meal?
• Did you get up during the night and eat anything?
• About what size was the (insert food or beverage)?
• Was the (insert food or beverage) an original product or was it modified
in anyway? For example, was it low sodium, low fat, cholesterol free,
etc.?
• When was the first time you took your levodopa or levodopa containing
medication?
• When was the next time you took your levodopa or levodopa containing
medication? Did you have anything to eat at this time?
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Depending on dietary intake, these additional questions may be asked. Many
of these questions could be asked multiple times.
• Did you add any cream, milk, milk substitute to the coffee or tea?
• Did you add any sugar or sugar substitute to the coffee or tea?
• How much of the (insert food or beverage) did you eat?
• Were you able to finish all of that (insert food or beverage)?
• Was this (insert food) prepared with fat? If so, what type of fat?
• When preparing (insert food) was salt added?
• Was there frosting on the (insert food)?
• If so, about how much frosting?
• What was the flavor/color of the frosting?
• Did you add any condiments to (insert food)?
• If so, what condiments and how much of each?
• Was there ice in the (insert beverage)?
• Was the cake a single, double, or triple layer cake?
• Were there any seeds on the bagel?

Session 3: Phone Call Script
“Good Morning/Afternoon/Evening ____________,
Today we will be discussing your dietary intake as part of the URI Parkinson’s disease
research
study. This is the third of four sessions. Both you and your loved one will each be
completing a 24-hour recall today.
We will go over all of the foods and beverages that you consumed yesterday, from
midnight to midnight. This phone call should last approximately 60 minutes or about
30 minutes per recall.”
•

Study staff will proceed to administer the 24-hour dietary recalls, one with
the PwPD and one with the caregiver. Each recall is anticipated to be about 30
minutes.

“Thank you for your participation in this third assessment, I will be calling in the near
future to complete your fourth and final session, another 24-hour dietary recall
session by phone. “

Session 4: Phone Call Script
“Good Morning/Afternoon/Evening ____________,
Today we will be discussing your dietary intake as part of the URI Parkinson’s disease
research

274

study. This is the fourth and final session. Both you and your loved one will each be
completing a 24-hour recall today.
We will go over all of the foods and beverages that you consumed yesterday, from
midnight to midnight. This phone call should last approximately 60 minutes or about
30 minutes per recall.”
•

Study staff will proceed to administer the 24-hour dietary recalls, one with
the PwPD and one with the caregiver. Each recall is anticipated to be about 30
minutes.

“Thank you for your participation in this final session. Both you and your loved one
will be receiving individual dietary analyses and recommendations in the mail in the
next few weeks “
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APPENDIX P: EU Indicators of Digital Competence
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APENDIX Q: 2015: Health Information National Trends Survey (HINTS)
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APPENDIX R: Telephone Montreal Cognitive Assessment
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APPENDIX S: EAT-10 Questionnaire
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APPENDIX T: PDQ-39
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APPENDIX U: MCSI Questionnaire
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APPENDIX V: Past Medical History Questionnaire – Person with Parkinson’s
Disease
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APPENDIX W: Past Medical History Questionnaire for Caregiver

295

296

297

298

299

300

APPENDIX X: Request for Personal Health Information
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